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ABSTRACT 
 
Epidemiological data suggest a positive relationship between increased calcium 
intake and decreased fat and total body mass in healthy people (McCarron et al. 
1984, Davies et al., 2000). An in-vitro model suggesting the role of cyclic Adenosine 
Monophosphate (cAMP) and phosphodiesterase 3B (PDE 3B) has been implicated in 
the relationship between calcium and lipolysis (Xue et al., 2001). The objective of 
the series of studies presented in this thesis was to investigate the ergogenicity of 
supplementary calcium in endurance exercise via studying its influence on substrate 
metabolism and body composition. 
Study 1 examined the effects of four weeks of calcium (citrate) supplementation 
(1000 mg elemental calcium/day) on 60 minutes of cycling at a submaximal intensity 
of 50%Wpeak. The results of this study indicated that calcium supplementation 
significantly improved body composition of the participants with a greater fat loss 
and increased lean mass observed in highly trained athletes as compared to the 
recreationally trained participants. In addition, four weeks of calcium 
supplementation also showed an enhanced trend of availability of fatty substrates in 
the plasma and consequently an increased trend towards higher fat oxidation during 
submaximal exercise. 
Study 2 and 3 thus examined the effects of calcium supplementation directly on 
performance during endurance events (25 and 10 mile cycling time trials (TT)) in 
highly trained athletes. Results from these studies indicate that following calcium 
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supplementation there was a meaningful improvement in power output (PO) (~4%) 
during the 25TT and ~2.7% in 10TT with corresponding better completion times in 
both the time trials. This amounts to an increase in ~2-3% higher PO%peak and ~3-5% 
increase in power output at lactate threshold, with the higher percentages attributable 
to the 25TT and the lower end to the 10TT. This increase in PO was achieved 
without the corresponding increase in oxygen consumption, thus significantly 
improving the gross efficiency of the cyclists. In addition, four weeks of calcium 
supplementation once again exhibited the same trends in body composition as 
observed in study 1 of decreased fat mass and a concurrent increase in lean mass.  
The results from this set of investigation indicate that calcium plays a multifactoral 
role in performance enhancement of endurance events. This may have been achieved 
via a combination of influence on substrate metabolism and body composition. The 
impact of calcium on fatigue mechanisms and vascular tone may have also played a 
part in increasing PO and thus efficiency of the athletes. Thus the potential of 
calcium to enhance performance needs further investigation in studies with larger 
sample sizes and different training status of athletes. 
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CHAPTER 1 
INTRODUCTION 
 
“On his way back to Japan in 1960, he passed through Britain and took the 
opportunity of coming to Cambridge to visit Alan Hodgkin and myself.  
He told us of his observations, and also said that Lipmann had been unwilling to 
accept that anything as simple as a calcium ion could perform such an important and 
specific function, and that this had delayed Ebashi‟s publication of his results.  
Later, Ebashi told me that he had been much encouraged by my enthusiastic 
response to what he told us”. 
(Huxley, 2007) 
 
The identification of factors that influence energy balance is an important issue in 
the research field of nutrition. Specific sport populations are concerned with energy 
balance from a number of perspectives. Maintaining ideal body mass/composition 
for competitions, making weight in certain sports are some of the primary concerns 
for athletes. Apart from genetic differences, energy intake and physical activity 
levels as well as the macro-nutrient composition of the diet are generally considered 
some of the major factors that explain variations in energy balance. However, recent 
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experimental evidence has emphasized that a positive or negative energy balance 
may happen via the influence of factors that have no a priori calorific value.  
This is the case for calcium intake. Gruchow et al. (1988) analysed a survey database 
(NHANES1) in a study designed to investigate the relationship between diet and 
hypertension. An inverse relationship between dietary calcium and body weight was 
subsequently reported. Following that, data that established a mechanistic link 
between calcium intake and energy/fat balance were reported (Zemel et al., 2001). 
Based on these epidemiological and in-vitro studies there has been a flux in 
intervention trials in the recent years to establish a link between dietary calcium via 
dairy and/or supplemental route and energy balance. Most of the studies have looked 
at different dosages, experimental conditions and outcome measures with mixed 
results. Part of the confounding issue lies in the fact that it is generally accepted that 
the uncertainty associated with optimal calcium intakes and requirements exists 
primarily because the body is able to homeostatically adapt to various levels of 
dietary intake. Thus, it does not seem that the in-vitro data can lend itself in a 
straightforward manner to more physiological dose responses of dietary calcium  
in-vivo. Most of the studies in this area have been conducted on overweight and 
obese population, or if they have been conducted on „normal weight‟ populations it 
has generally been sedentary participants with or without recreational exercise.  For 
highly trained athletes these studies do not lend to a representative population from 
which they can make use of the data for multiple reasons. First of all being trained, 
athletes have well adapted metabolically regulated pathways for optimal energy 
utilisation specific to their training (Noakes, 2000, Holloszy and Booth, 1976). 
Secondly, the physiological mechanisms governing energy balance over a long 
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period of time, which apply to overweight and obese populations, may differ in the 
athletic population (Bloom et al., 1976).  
Fat oxidation is an important substrate in exercise that lasts for more than 20 min 
(Romijn et al., 1993). Therefore if calcium supplementation improves lipolysis it 
may be an important area for consideration in endurance event. Moreover, the effect 
of calcium on body composition might also be important to endurance athletes where 
power-to-weight ratios play a defining role in endurance performance.  
Therefore, the purpose of this investigation was to evaluate the role of 
supplementary calcium in submaximal exercise and endurance performance in a  
non-calcium deficient population. Two outcomes were hypothesised through which 
these links may enhance performance; one, via changes in fuel metabolism and 
second via reduced body fat and/or increased lean mass.  
Thus, the aims of this thesis are to assess the effects of calcium supplementation on  
1. Substrate metabolism during submaximal exercise. 
2. Body composition changes in athletes.  
3. Endurance performance.  
Accomplishment of these aims should enable a greater understanding of the role of 
calcium in endurance performance via changes in fat metabolism during exercise 
aswell as its longitudinal effects on body composition of the athletes.  
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These aims will be accomplished by means of the following objectives –  
1. To determine the effect of four weeks of calcium supplementation on 
changes in fat metabolism as well as total energy expenditure during a 
submaximal cycle ergometry test exercise. 
2. To examine the affect of the training status of the athlete on the putative 
metabolic changes due to calcium supplementation.  
3. To examine the effect of calcium supplementation on changes in body mass 
and composition of athletes during a four week period. 
4. To assess the effect of calcium supplementation on endurance cycling 
performance indicators such as time to completion, power output and gross 
efficiency.  
5. To identify the optimal range of endurance events that may benefit from the 
ergogenic effects of calcium.  
Achievement of these objectives requires at first an exploratory experiment to study 
the metabolic changes in a broad range of athletic population, ranging from 
recreational to well-trained. Further experiments designed to study performance 
indicators in endurance events of differing duration are required.  
 
1.1 Organisation of the thesis  
The thesis begins with the review of the current and relevant literature (Chapter 2) 
providing a background summarising the research that has lead to our current 
knowledge of the relationship between dietary calcium and energy balance, proposed 
mechanistic links, and the potential merits of calcium as an ergogenic aid in certain 
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sporting conditions. Following this, a section on the general methodology and 
instrumentation (Chapter 3) used in all the experiments during the investigation are 
described and includes suitability, validity, reliability and sensitivity of the measures. 
Chapter 4 is a report on the experiment conducted to study shifts in substrate 
metabolism due to calcium supplementation during steady state submaximal exercise 
(50% Wpeak) as well as changes in body composition over four weeks in a mixed 
gender heterogeneous sample of recreational and well-trained athletes. Based on the 
results in Chapter 4, further experiments were designed to highlight the ergogenic 
role of calcium in sport performance with a more homogenous sample that showed a 
greater response to the intervention in Chapter 4. Thus, Chapter 5 reports these 
effects in a moderate intensity event (25 mile cycling time trial) and Chapter 6 
reports the effects of calcium supplementation on a more intense endurance event 
(10 mile cycling time trial) using highly trained cycling time trialists. Chapter 7 
provides a synthesis of the findings along with the limitations encountered during the 
process of investigation, whilst, Chapter 8 outlines the inferences drawn from the 
investigations and identifies further directions for research. 
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CHAPTER 2 
LITERATURE REVIEW 
 
2.1 Introduction 
This chapter reviews the current research regarding calcium and its role in 
metabolism. It highlights the role of calcium in the cellular processes that regulate 
fuel utilisation with the help of studies conducted on in-vitro, animal and human 
models. The review also aims to concurrently describe the metabolic changes that 
happen as a consequence of exercise and the impact of duration and intensity of 
exercise on substrate metabolism. Finally, it consolidates the role of calcium in 
substrate metabolism in exercise with relation to due changes in energy balance and 
body composition studies.  
 
2.2 Dietary calcium  
Milk and dairy foods are the main sources of calcium in the British diet, contributing 
to 27 to 51% of the total calcium intake (Finch et al., 1998).  However the 
contribution from cereals is also significant as these products (many of which are 
fortified with calcium) are consumed in relatively large amounts.  Table 2.1 provides 
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the calcium content of a range of commonly consumed foods. There is no marked 
difference between ages or gender in proportion of calcium intake accounted for by 
different food groups. The contribution of dietary supplements to calcium intake is 
negligible apart from the oldest age group of adult women (50-64 years) who 
increased their mean daily intake by 10% with supplements (Henderson et al., 2003).  
 
Table 2.1 Calcium content of commonly consumed foods (mg/100g) 
Food Calcium content mg/100g 
Cheddar cheese 
720 
Sardines (canned in oil) 550 
Milk, skimmed/semi-skimmed 120 
Milk, whole 115 
Bread, white 110 
Eggs, boiled 57 
Bread, wholemeal 54 
Apples 4 
Source: Manual of Nutrition (Food Standards Agency (FSA), 2008) 
 
Table 2.2 presents the Reference Nutrient Intakes (RNI) for calcium for males and 
females within different age groups (Henderson et al., 2003). These are considered 
sufficient to meet the nutritional requirements of 97.5% of the population. According 
to the trends in British national dietary surveys, average dietary calcium appears to 
exceed this and may even be increasing. In the United States (US) for example, the 
Recommended Dietary Allowances (RDA) for calcium differ slightly: 1000 mg/d for 
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children aged 4-8; 1000 mg/d for adults aged 19-50 (both men and women); and 
1200 mg/d for female adults over 50 (Ross et al., 2010). Furthermore the trend in 
calcium intake appears the same in the US and Canada (Ross et al., 2010).  
 
Table 2.2 Recommended Nutrient Intakes for calcium (mg/d) 
Age RNI (mg/d) 
Children 
Up to 12 months 525 
 1-3 years 350 
 4-6 years 450 
 7-10 years 550 
Males 11-18 years 1000 
 19+ years 700 
Females 11-18 years 800 
 19+ years 700 
 Pregnancy 1000 
 Lactating + 550 
Source: COMA-Committee on Medical Aspects of Food Policy (1991) 
 
Data from the National Diet and Nutrition Survey (NDNS) for adults aged 19 to 64 
years indicate that the mean intake of calcium is 1007 mg/d (144% of the RNI) for 
men and 777 mg/d (111% of the RNI) for women. However, in young women and 
teenage girls, intakes are generally < 400 mg/d (Smithers et al., 2000, Henderson et 
al., 2003).  As peak bone mass is achieved during late adolescence/early adulthood, a 
low intake of calcium during periods of growth could have implications for bone 
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health in later years (for example, by increasing the risk of osteoporosis) (Theobald, 
2005a).  
Calcium intakes are an important consideration for athletic population, since athletes 
are exposed to physiological stressors above and beyond those of sedentary 
individuals. Petrie et al., (2004) have reported an increased need for vitamins and 
minerals in general in athletes due to decreased gastrointestinal absorption, increased 
sweat losses, losses incurred via urine and faeces, and increased needs associated 
with tissue maintenance and repair. However, it has been shown that exercise and the 
elevated metabolism associated with exercise itself does not increase the body‟s need 
for dietary calcium. However electrolytes are often lost in high amounts due to sweat 
concentration and so dietary calcium intake may need to be augmented to 
compensate for those losses and to prevent deficits from occurring (Petrie et al., 
2004). As such there are no increased RNI suggested for athletes, except for 
amennorheic athletes where 1500 mg/d is recommended in the US (Kunstel, 2005) 
 
2.3 Role of calcium in the body 
Calcium is quantitatively the most abundant mineral of the body and a vital 
electrolyte. Besides structural support, calcium is required for critical biological 
functions such as nerve depolarisation (conduction), muscle contraction, cell 
adhesiveness, mitosis, and blood coagulation (Alberts et al., 2004). An average adult 
body contains about 1.5 kg of calcium of which is 99% is in the skeleton (Dickerson, 
2003).  
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Calcium in blood maybe protein bound, complexed and ionised, or free. The ionised 
fraction is the focus of metabolic control, especially through parathyroid hormones 
and vitamin D, and is kept constant at 1.0 – 1.2 mmol/l by processes that 
continuously add or remove the calcium (Vaskonen, 2003). Para-thyroid hormone 
(PTH), which is produced by chief cells located in two pairs of parathyroid glands 
situated adjacent to the thyroid gland, increases plasma calcium concentration 
through three types of actions :- 
 Mobilization of calcium out of the bone by PTH which is released rapidly by 
stimulation of S nerves in the thyroid glands or circulating catecholamines, 
and thus stimulation calcium mobilization from the bone after acting on 
osteoclasts for several hours (Abe and Sherwood, 1972). 
 More rapid mobilisation of calcium out of osteoid or recently formed bone, 
mediated by osteocytes in the presence of Vitamin D and without resorption 
of mineralised bone (Borer, 2003).  
 PTH increase of calcium reabsorption in distal tubule of the kidney by PTH 
and stimulation of synthesis of Vitamin D3 in the proximal tubule (Friedman 
et al., 1996).  
During hypocalcaemia, the decreased calcium is sensed in the parathyroid glands by 
the calcium sensing receptor (Borer, 2003). PTH secretion is increased and acts to 
restore calcium to normal by its effects on bone and kidney. By stimulating renal  
1-hydroxylase it accelerates the conversion of 25-hydroxy vitamin D (25(OH)D) to 
calcitriol (1,25(OH)2D3); the latter acts on intestinal calcium absorption in 
conjunction with PTH on bone and kidney to restore calcium levels to normal  
(Borer, 2003). PTH secretion is returned to normal by restoration of normocalcemia 
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and also by direct suppressive and anti-proliferative effects of calcitriol on 
parathyroid glands. Vitamin D receptors are present in the parathyroid glands and act 
as sensors for the detection of adequate levels of calcitriol, thus regulating PTH 
synthesis and release (Schulkin, 2001). 
 
2.3.1 Calcium distribution and tissue concentrations  
For an organism to carry out its varied functions and even to survive the calcium 
concentration in biological fluids must be maintained within narrow limits. The total 
plasma calcium concentration (2.15 to 2.55 mmol/l) which normally fluctuates only 
by ± 3% - is maintained by a number of homeostatic mechanisms, most notably 
PTH, vitamin D and thyrocalcitonin (Bowers and Rains, 1988).  These three 
substances regulate the calcium concentration as a resultant of three actions: net 
absorption from the gut, net loss through the urine and net deposition in the bone. 
Approximately 99% of the total body calcium is present in the bone, which acts as a 
reservoir to maintain the requisite supply of calcium to the tissues via the circulation. 
The remaining 1% in the circulation is not completely biologically active since 50% 
of the plasma calcium is bound to plasma proteins. Plasma ionised calcium 
concentrations range from 1.0 to 1.2 mmol/l in healthy adults (Robertson et al., 
1981). The calcium concentrations of most tissues tend to cluster around the value of 
1µ mole/gram wet weight. This is true for muscle (skeletal, cardiac and smooth) as 
well as peripheral nerve and brain (Bowers Jr and Rains, 1988).  
Most of the calcium in a cell exists in the bound state. It is bound to plasma and 
cellular membrane components, to collagen and mucopolysaccharides, and other 
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negatively charged constituents of cells (Alberts et al., 2004). The basis for this avid 
binding may, at least in part be ascribed to the interaction between calcium and 
acidic phospholipids (Hauser and Dawson, 1968).  
While exact quantification of each component of cell calcium has proved quite 
difficult to measure, it is even more difficult to discern a shift in calcium from one 
cell compartment to another. Experiments which have employed radioactive calcium 
(
45
C) to localise different cell fractions have shown them to be multi 
compartmentalised and kinetically definable into different cell fractions (Alberts et 
al., 2004). There is a fraction that is readily interchangeable with the extracellular 
medium with a half-life (t½) of 1-5 min, a less readily exchangeable fraction with a 
t½ of about 30 min, and a non-exchangeable fraction (Blaustein, 1974). However, 
that fraction may represent a summation of efflux from more than one compartment, 
which makes it difficult to relate these fractions to a specific cellular entity 
(Blaustein, 1974).  
 
2.3.2 Role of calcium as a second messenger 
The role of calcium as an intracellular second messenger is based on its regulation at 
a nanomolar level. While the extracellular calcium concentration is about  
1.2 to 2.0 mmol/l, i[Ca
2+
] is usually about 100 to 200 nmol/l (Rasmussen, 1971). In 
most cells large calcium gradients exists across the intracellular membranes of 
calcium storage organelles such as the endoplasmic and sarcoplasmic reticulum. 
i[Ca
2+
] stores do not have a homogeneous structure and cannot be attributed to a 
single cellular organelle (Rasmussen, 1971). In order for calcium to exert its effects, 
it must gain access to critical intracellular sites but the plasma membrane limits the 
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entry of calcium. In most excitable cells the resting permeability to calcium is quite 
low (Rasmussen, 1971). But during contraction this may transiently increase many 
folds. It is the molecular diversity of the associated proteins in calcium signalling 
that determine the specific interactions between stimulus and change in the state of 
the organelle. Since most of the cellular calcium exists in the bound state, it seems 
reasonable to contemplate that at least certain substances initiate secretion by acting 
on calcium storing structures to release bound calcium. There is evidence to indicate 
that stimulation of secretory process in some glands may be effected by altering the 
state of bound cellular calcium (Rasmussen, 1971). This appears to be the situation 
in regard to the action of pituitary hormones on the adrenal cortex (Borer, 2003) and 
thyroid gland (Alberts et al., 2004). Whether the critical calcium fraction is 
extracellular or intracellular, translocation of this cation is a fundamental 
requirement for many physiological processes. 
In skeletal muscle four important apparatus have been identified that play an 
important role during contraction and relaxation. The ryanodine receptor that is the 
sarcoplasmic reticulum Ca
2+
 release channel, the troponin protein complex that 
mediates the Ca
2+
 effect to the myofibrillar structures leading to contraction, the Ca
2+
 
pump responsible for Ca
2+
 reuptake into the sarcoplasmic reticulum, and  
calsequestrin, the Ca
2+
 storage protein in the sarcoplasmic reticulum (Alberts et al., 
2004). Different calcium gradients are established by active transport mechanisms. 
The calcium pumps are located either in the plasma membrane (plasma membrane 
calcium-ATPases, PMCAs) or in the membrane of i[Ca
2+
] stores (as 
sarco/endoplasmic reticulum calcium-ATPases, SERCAs) (Carafoli and Brini, 
2000). For both types of calcium pumps, various isoforms have been described that 
differ in their activation and regulation properties.  
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Upon electrical stimulation of intact muscle fibres, cellular calcium increases 
because of a release of calcium from intracellular stores or through a calcium entry 
across the plasma membrane, or both. The sequence of these processes depends on 
the cell type and type of stimulation (Carafoli and Brini, 2000). The amount of 
calcium inside the stores is limited. Therefore calcium release from the stores is only 
a transient signal. However, for a cellular activation, often a sustained change of 
intracellular signal is needed, making a calcium entry via plasma membrane calcium 
channels necessary (Berridge et al., 2000). When the surface membrane and 
transverse tubular are depolarised it leads to the release of calcium from the 
sarcoplasmic reticulum via ryanodine receptors (RyR), this elevates cytosolic 
calcium levels to ~100 fold higher. The calcium then binds to one of the troponin 
sub-units on the filament, leading to muscle contraction (Fig. 2.1).  
 
 
Fig. 2.1 A schematic representation of the role of calcium in initiating muscle contraction 
(Berchtold et al., 2000) 
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Different types of calcium channels have been described with regard to their 
structure and their mode of activation: voltage dependant, stretch activated, receptor 
operated and store operated (Alberts et al., 2004). The complex nature of cellular 
calcium regulation and signalling is responsible for temporally and spatially distinct 
calcium signals such as calcium transients and for plateaus as well as calcium 
oscillations and calcium waves (Berridge et al., 2000). There is now growing 
evidence that these different calcium signalling patterns encode for different cellular 
effector functions (Clapham, 2007).  
The amount of calcium taken up during contraction may be related to the 
extracellular calcium concentration and enhanced influx may not be maintained 
during prolonged stimulation but may decrease with time (Bianchi and Shanes, 
1959). The inactivation of the calcium current prevents the intracellular calcium 
concentration from increasing to a point where it would be deleterious to the cell and 
may, at least in part, account for the decrease in the response commonly observed 
during prolonged stimulation of intact fibres in in-vitro experiments (Bianchi and 
Shanes, 1959).  If the Ca
2+
 control mechanisms cannot compensate for the release, 
the excess of cytoplasmic Ca
2+
 causes sustained muscle contraction and rigidity, 
increased energy production and consumption, as well as ADP, CO2, and heat 
production. Finally, the activation of degradative enzymes leads to membrane 
damage and cell death (Fig. 2.2).  
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Fig. 2.2  A schematic representation of the effect of sustained increased intracellular calcium is 
implicated in various metabolic disturbances. 1. Structural changes in RyR leads to 2. 
opening of the calcium channels, which then cause the 3. activation of SERCA. 
Malfunctioning at any of the points may lead to long term metabolic disturbances 
(Berchtold et al. 2000) 
 
Thus, Changes in i[Ca
2+
] concentrations can evoke a number of cellular responses 
including proliferation, motility, oxidative burst, secretion of cytokines and gene 
expression and are involved in the pathogenesis of several diseases such as 
inflammatory diseases (Resnick, 1999), cardiovascular diseases (Resnick, 1999) and 
neurological disorders (Greenberg, 1997). 
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2.4 Regulation of substrate metabolism in exercise 
2.4.1 Regulation of fat metabolism during exercise 
Lipid fuel sources are important energy substrates for skeletal muscle metabolism 
during endurance exercise. Their contribution to total oxidative metabolism is 
dependent on a variety of factors, including exercise intensity and duration as well as 
dietary and training status. Oxidizable lipid fuels include circulating plasma 
triacylglycerols (TAG) and non-esterified fatty acids (NEFA), as well as 
intramuscular triacylglycerols (IMTG). However the specific rate of oxidation is 
determined by energy requirements of working muscles, non-esterified fatty acids 
(NEFA) delivery to muscle mitochondria and the oxidation of other substances 
(Achten and Jeukendrup, 2004). 
After an overnight fast most energy needs at rest are provided by oxidising NEFA 
derived from adipose tissue triacylglycerols. At rest the amount of NEFA released 
from AT typically exceeds the amount oxidised (Coppack et al., 1994); such that the 
rate of NEFA appearance in the plasma (Ra) is approximately twice the rate of 
NEFA oxidation. Therefore large portions of NEFA liberated by lipolysis of adipose 
tissue triacylglycerols are re-esterified back into TAG, principally by the liver 
(Ranallo and Rhodes, 1998). However, during exercise NEFA do not account for 
more than 60% of the maximal rate of oxygen consumption (Klein et al., 1994). A 
high concomitant glucose oxidation is required for high intensity endurance exercise 
and power output falls when glycogen stores are exhausted. It is not clear whether 
this limited rate of oxidation of NEFA represents a limitation in the rate at which 
they can be delivered to and transported in the plasma (Klein et al., 1994, Sidossis et 
al., 1998) or in the rate in which they can be taken up and oxidised by the muscle 
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(Wolfe et al., 1990). Fig 2.3 shows the maximal contribution of energy expenditure 
derived from glucose and NEFA, taken up from the blood and minimal contribution 
of muscle triglyceride and glycogen stores after 30min of exercise, expressed as 
function of exercise intensity (Romijn et al., 1993). 
 
 
Fig.2.3 Maximal contribution of different substrates towards energy expenditure after 30mins 
of exercise at different intensities. Adapted from Romijn et al. (1993) 
 
To obtain the energy stored in the NEFA they must be sequentially oxidised. Firstly 
NEFA must be released from the TAG stored within the adipocytes which are 
stimulated by hormones such as adrenaline during both exercise and in the fasting 
state (Horowitz and Klein, 2000a). NEFA released when TAG molecules are 
hydrolysed has two major fates, re-esterification to a TAG following attachment of 
Coenzyme A (CoA) to the NEFA and leaving the adipocyte, as a NEFA in the blood 
stream. If all the NEFAs released during lipolysis exit the adipocyte then there 
should be a NEFA to glycerol ratio of 3:1 in the blood (Galbo et al., 1975, Klein et 
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al., 1994). However, because of the reutilization of some of the NEFAs in the 
formation of new TAG molecules, this 3:1 ratio is seldom observed. Indeed, during 
inactivity nearly two thirds of the NEFAs produced during lipolysis are re-esterified 
(Coppack et al., 1999). On the other hand, during light to moderate intensity exercise 
most NEFAs produced by lipolysis leave the adipocyte (Hodgetts et al., 1991). Thus 
neurohumoral stimulation or inhibition is the determining factor for the extent of 
lipolysis.  
Plasma NEFA turnover is also highly dependent on the recent dietary intake. After 
an overnight fast, fat supplies virtually all the energy demands of the body at rest in 
healthy individuals, with a plasma NEFA turnover rate of 4-5 µmol/kg/min being 
sufficient to meet this requirement (Horowitz and Klein, 2000a). Peripheral lipolysis 
is highest during low intensity exercise (25%V O2max) (Watt et al., 2002, Hawley, 
2002) and does not increase further with more intense exercise (at 65-85%V O2max) 
(Hawley et al., 2000, Sidossis et al., 1997). However, total fat oxidation is about 
40% higher at 65%V O2max compared with exercise at 25%V O2max (Romijn et al., 
1993). The implication of this being that at higher work intensities there is a greater 
contribution of IMTG to total fat oxidation. Both IMTG and plasma NEFA provide 
equally to fat oxidation at 65%V O2max. There are several explanations to this such as, 
uptake of plasma NEFA by the exercising muscle is less than the measured rate of 
fat oxidation (Klein et al., 1994). Aas well as a decline in , IMTG concentration (55-
75%V O2max) (Bergman and Brooks, 1999). 
At higher work intensities (85%V O2max) most of the required energy is derived from 
carbohydrate sources (Romijn et al., 1993). This is a result of the recruitment shift 
from type I and type IIa to type IIb muscle fibres for this intensity of work, and fast 
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twitch muscle fibres do not have the oxidative capacities of slow twitch fibres 
(Hawley et al., 2000). Whole body lipolysis of peripheral adipose tissues does not 
decrease during high intensity exercise (85%V O2max) this is demonstrated by the Ra 
of glycerol which remains high throughout the exercise period (Klein et al., 1996). 
One reason for the decreased oxidation of NEFA could be explained by an 
entrapment of NEFA in the adipose tissue during exercise with a release after 
exercise. Bülow and Madsen (1976) have reported large increases in adipose tissue 
blood flow (ATBF) during exercise (Fig. 2.4) in response to the β-adrenergic 
stimulation. As seen in the graph, even though the ATBF increases multiple fold 
during prolonged exercise, it does not match the systemic NEFA concentration 
increase.  
 
 
Fig. 2.4  Relative changes in ATBF (white bars) and systemic NEFA concentrations (lined bars) 
during prolonged exercise (Bülow and Madsen, 1976) 
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Thus the plasma NEFA concentration increases dramatically during the minutes 
immediately after high intensity exercise, despite a simultaneous reduction in 
lipolysis (decreased rate of Ra of glycerol) (Klein et al., 1996).  Also the hydrophobic 
molecules of NEFA can be limited in their transport in the blood due to the limited 
binding capacity of albumin (Ranallo and Rhodes, 1998). At higher intensities of 
exercise there is a higher concentration of lactate in the blood. In contrast to the 
understanding that lactate inhibits lipolysis, it is possible that lactate probably 
increases re-esterification of NEFA into adipose tissue triglycerides (Dyck et al., 
1993). A reduction in the blood flow to the adipose tissue can also reduce the release 
of NEFA during high intensity exercise (Wolfe et al., 1990). 
During moderate intensity exercise, in the range of 55% to 75% of V O2max, that can 
be maintained for 60 minutes or longer, there is a progressive decline in the 
proportion of energy derived from muscle glycogen and muscle triglycerides, and a 
progressive increase in plasma NEFA oxidation (Gollnick et al., 1981, Ranallo and 
Rhodes, 1998, Romijn et al., 1993). During the first 30 minutes or so of moderate 
intensity exercise in the fasting state, plasma NEFAs and IMTG provide roughly 
equal amounts of the fat that is oxidized. When the exercise is continued beyond 30 
minutes, oxidation of plasma NEFAs provides progressively more of the total energy 
requirements, compensating for the decreased utilization not only of IMTG but also 
of muscle glycogen (Sidossis et al., 1997) (Fig. 2.5). This increase in plasma NEFA 
oxidation during prolonged exercise is made possible by a progressive rise in plasma 
NEFA concentration, and is necessitated by a progressive depletion of muscle 
glycogen and triglyceride stores (Romijn et al., 1993). 
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Fig. 2.5   Relative contribution of blood borne and intramuscular substrates to energy 
production during 120 min of exercise at 65% V O2max (Romijn et al., 1993) 
 
It has been suggested that IMTG is an important energy source for skeletal muscle 
metabolism, especially during prolonged exercise. These suggestions are based on 
the fact that isotopically determined plasma NEFA oxidation does not match 
estimates of total lipid oxidation as calculated from respiratory exchange ratios 
(RER) measurements during prolonged exercise (Klein et al., 1994). In post 
absorptive exercising men the oxidation of circulating plasma NEFA can account for 
little more than half of the total lipid oxidation (Sahlin et al., 1990). These results 
have led researchers to suggest that NEFA released either from intramuscular TAG 
pool or from adipose tissue located between muscles fibres are utilised for oxidative 
metabolism in exercising muscles. At 25%V O2max muscle TAG breakdown occurs to 
a minimum (< 10%) as the availability of NEFA derived from the plasma is adequate 
to meet the substrate requirements for that intensity of exercise (Sahlin et al., 1990, 
Wolfe et al., 1990, Romijn et al., 1993). At increasing intensities (65%V O2max) 
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muscle TAG supplies about 50% of the total fat metabolism during the first 60mins 
of cycle ergometry. However with an increase in exercise duration at the same 
intensity muscle TAG could only supply about 30% of the total fat metabolised after 
120 min of exercise (Romijn et al., 1993, Ranallo and Rhodes, 1998). These results 
support the notion that the breakdown of IMTG occurs to compensate for the 
sluggish response of NEFA release at the onset of moderate exercise. The more type 
I fibres involved in the exercise the greater the depletion of TAG not stored in the 
muscle fibres. With increasing recruitment of type IIa fibres during moderate to 
heavy exercise there is an increase in depletion of IMTG (Horowitz and Klein, 
2000a). IMTG utilisation could also be influenced by the mode of exercise, bicycle 
and heavy resistance exercise are associated with marked increases in the plasma 
catecholamine levels, whereas one legged knee extension exercise is associated with 
catecholamine levels that are barely above resting concentrations. This lower 
catecholamine response could possibly affect the utilisation of IMTG since it has 
been shown in exercising humans that non selective β-adrenergic blockade prevents 
muscle TAG lipolysis (van Loon, 2004). 
Among other factors that affect substrate metabolism the rate of lipolysis is highly 
dependent on the actions of several hormones which in majority include the 
catecholamine – epinephrine and norepinephrine and insulin. The other hormones 
that exert their influence on the rate of stimulation of lipolysis are – growth 
hormone, adrenocorticotropic hormone, thyroid stimulating hormone and 
parathyroid hormones (Ranallo and Rhodes, 1998). Because only catecholamines 
can effectively stimulate lipolysis at physiological concentrations, they appear to be 
the major important stimulators of lipolysis in the human adipose tissue in-vivo. In 
human adipose tissue, catecholamines have both ά-adrenergic inhibitory and β-
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adrenergic stimulatory effects on the rate of lipolysis via corresponding changes in 
the activity of adenlyl cyclate and in the intracellular production of cyclic adenosine 
monophosphate (cAMP) (Hodgetts et al., 1991, Galbo et al., 1975). 
Insulin is another hormone which regulates lipolysis. The action of insulin is 
opposite to that of the catecholamines, in that it is antilipolytic. Thus insulin prevents 
lipolysis via a sympatho adrenally mediated alpha adrenergic stimulation (Bergman 
and Brooks, 1999). During exercise of long duration, the insulin level is either 
unchanged or slightly decreased although lipolysis progressively increases. Thus the 
insulin level is unlikely to be the controlling mechanism for the rate of lipolysis 
(Wolfe et al., 1990). It is possible that the decrease in insulin levels in the early 
stages of exercise has a permissive effect that facilitates an amplification of lipolysis 
in the later stages (Horowitz and Klein, 2000a). 
 
2.4.2 Integration of fuels during prolonged exercise 
It is well established that a mixture of carbohydrates and lipids are used as fuels in 
skeletal muscle at rest and during exercise (Wolfe et al., 1990, Romijn et al., 1993, 
Watt et al., 2002, Sahlin et al., 1990). Studies using Respiratory Exchange Ratio 
(RER) demonstrates that both carbohydrates and lipids are used during exercise and 
that their relative contribution changes as a function of exercise intensity and 
duration and pre exercise diet (Romijn et al., 1993, Romijn et al., 1995). Low power 
outputs are associated with greater oxidation of lipids, while higher exercise 
intensities result in greater reliance on carbohydrates. The release of NEFAs into the 
blood from adipose tissue stores rises in parallel with exercise intensity to 
approximately 50% of V O2max, and then gradually declines. On the other hand 
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release of glucose into the blood from the liver increases with exercise intensity. 
(Brooks, 1997) has proposed a crossover concept to explain the fuel utilisation 
during exercise in terms of the balance between carbohydrate and fat (Fig.2.6). The 
crossover point is that relative exercise intensity where adenosine tri-phosphate 
(ATP) formation from the use of carbohydrate exceeds that of lipid. Exercise at 
power outputs beyond this point will rely more and more on carbohydrate oxidation 
and less and less on fat (Brooks, 1997). 
 
 
Fig.2.6 Crossover point concept as proposed by Brooks (1997) 
 
There are several sites in the pathways of carbohydrates and lipid metabolism where 
fuel selection during exercise may be regulated. These include regulation at sites 
controlling carbohydrate metabolism and oxidation as in the glucose-fatty acid cycle 
(Randle et al., 1963). The relationship between glucose and NEFA metabolism is 
reciprocal and not dependant. The essential mechanism involves an allosteric control 
which inhibits CHO oxidation prior to conversion to pyruvate dehydrogenase. An 
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increase in plasma NEFA levels increases uptake and oxidation of fatty acids. This 
leads to an increase in the acetyl CoA to CoA ratio in the mitochondria. Increase in 
citrate due to β-oxidation in the TCA cycle leads to leakage of citrate from 
mitochondria into the cytosol. Here citrate binds to phosphofructokinase decreasing 
the rate of glycolysis (Fig. 2.7). 
 
 
Fig. 2.7  A schematic representation of the glucose-fatty acids cycle. Increase in long chain fatty 
acid (LCFA) oxidation leads to increase acetyl CoA/CoA ratio. This leads to citrate 
accumulation in the cytosol, inhibiting phosphofructokinase-1 (PFK-1) and thus 
reducing glycolysis. Adapted from Hue and Taegtmeyer (2009) 
 
An alternative hypothesis to the classic Glucose-fatty acid cycle is that malonyl CoA 
concentrations can reflect the availability of carbohydrates as a substrate  
(i.e. fuel sensing) with increased glycolytic flux producing more pyruvate and thus 
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increasing acetyl CoA/CoA and malonyl CoA, thus reducing NEFA oxidation by 
reducing transport of long chain NEFAs into the mitochondria via inhibition of 
carnitine palmitoyl transferase (CPT) (McGarry et al., 1977) (Fig. 2.8). 
 
 
Fig 2.8  A schematic representation the regulation of fat oxidation via carbohydrates. Increased 
glycogenolysis increases acetyl CoA/CoA ratio, leading to citrate accumulation in the 
mitochondria. This leads to increase in malonyl CoA in the cytoplasm where it inhibits 
CPT-1 leading to decreased transport of fatty acids into the mitochondria. Adapted 
from Hue and Taegtmeyer, (2009) 
 
Under hemodynamic stress conditions, the inhibition of carbohydrate oxidation by 
fatty acids is markedly reduced leading to an activation of AMP-activated protein 
kinases (AMPK) (Goodwin and Taegtmeyer, 1999). AMPK is also activated during 
exercise and physical activity (Vavvas et al., 1997). Changes in i[Ca
2+
] can also 
activate AMPK independently (Kahn et al., 2005). Unlike the situation in liver, 
where malonyl-CoA can be actively converted into fatty acids, muscle contains very 
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low levels of fatty acid synthase (FAS). Accordingly, in muscle cells, malonyl-CoA 
is thought to act as a "fuel sensor" whose primary role is to regulate the rate of fatty 
acid oxidation. Furthermore, its concentration appears to be controlled by the relative 
activity of acetyl-CoA carboxylase-2 (ACC-2) and malonyl-CoA decarboxylase 
(MCD), both of which are regulated by AMP-activated kinase (AMPK) (Andersson 
et al., 2004) (Fig. 2. 9).  
 
 
Fig. 2.9   A schematic representation of the interaction of glucose and fatty acid metabolism in 
muscle (Andersson et al., 2004) 
 
Also, an increasing body of evidence is now suggesting the role of malonyl CoA in 
the regulation of energy balance and thus obesity (Ruderman et al., 2003). The 
possibility that malonyl CoA and AMPK sense fuel availability in the hypothalamus 
where they play a role in initiating signalling events that regulate food intake is an 
important consideration in fuel metabolism (Ruderman et al., 2003)  
Therefore, in conclusion, during submaximal exercise lipolysis and the release of 
NEFA from the adipocytes exceeds uptake by the peripheral tissues and the net 
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result is an increase in plasma NEFA. As the intensity of exercise increases, lipolysis 
declines with a relative decrease of fat contribution and a concurrent increase in 
glucose metabolism. At workloads above 65%V O2max, the limiting factor for 
prolonged exercise appears to be the glycogen stores. Thus regulation of the fuel 
substrates during exercise is dependent on the intensity and duration of the exercise, 
in addition to the training status, mode, dietary status and hormonal regulation.  
 
2.5 Putative mechanistic theories of the role of calcium in energy and 
substrate metabolism  
 It has been shown that a low calcium intake tends to be a marker for a poor diet 
generally (Barger-Lux et al., 1992). Historically, primitive human diets were calcium 
rich; with calcium to energy ratios two to four times that of modern humans (Eaton 
and Nelson, 1991). The hormonal response to a low calcium intake is an increase in 
calcitropic hormones such PTH and a corresponding increase in  
1, 25, Dihydroxy cholecalciferol (1,25(OH)2D3) concentrations. Because a low 
calcium intake would have been tantamount to a low food intake, it may be that the 
PTH and 1,25(OH)2D3 response evoked by a low calcium intake to regulate its 
energy metabolism and thereby adapt to imminent food shortage (Davies et al., 
2000). Today, with the calcium intake disconnected from energy intake, the 
primitive energy conserving response with a low calcium intake may predispose to 
weight gain.  
The framework for understanding this „anti-obesity‟ effect of dietary calcium derives 
from studies of the mechanism of action of agouti, the first obesity gene to be 
cloned. Obese agouti mutant mice (viable yellow, A
vy
) exhibit increased i[Ca
2+
] in 
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several tissues (Zemel et al., 1995). The increase in i[Ca
2+
] is closely correlated with 
both the degree of ectopic agouti expression and body weight. This correlation has 
led to several mechanistic links between agouti, i[Ca
2+
] and regulatory enzymes in 
lipid metabolism. In the forefront of this research is the work of Zemel and 
colleagues who demonstrated that agouti protein stimulates calcium influx and 
promotes energy storage in human adipocytes by inhibiting lipolysis and stimulating 
de novo lipogenesis (Zemel et al., 2000). When dietary calcium is limited, plasma 
calcium levels fall, stimulating the secretion of PTH, which in addition to increasing 
calcium release from bone through increased bone resorption and reduced renal 
calcium loss, also promotes the hydroxylation of  25 Hydroxy Vitamin D 
(25(OH)2D) to its active form, 1,25(OH)2D3. Both PTH and 1,25(OH)2D3 are 
implicated in the increase of i[Ca
2+
] (Xue et al., 1998). This has lead to the 
hypothesis that calcitropic hormones may play a role in adipocyte fat metabolism. 
Xue et al. (2001) reported the link between increased i[Ca
2+
] and lipogenesis in rat 
adipose tissue. They suggested that the anti-lipolytic effect of i[Ca
2+
] may be 
mediated by the activation of phosphodiesterase 3B (PDE-3B) leading to a decrease 
in cyclic adenosine monophosphate (cAMP) and phosphorylation of HSL and 
consequently inhibition of lipolysis (Fig. 2.10). 
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Fig. 2.10  Schematic representation of the role of calcium in fat metabolism in-vitro 
 
 
In addition to the anti-lipolytic role of 1,25(OH)2D3 it may also be involved in the 
regulation of thermogenesis and energy metabolism in humans. 1,25(OH)2D3 acts 
via a nuclear Vitamin D receptor (nVDR) to inhibit the expression of uncoupling 
protein 2 (UCP2) (Shi et al., 2001b). UCPs are mitochondrial transporters present in 
the inner membrane of mitochondria. They have been shown to stimulate 
mitochondrial proton leak and therefore exhibit a potential role in thermogenesis and 
energy metabolism (Schrauwen and Hesselink, 2002). Suppression of 1,25(OH)2D3 
by feeding high calcium diets to mice, resulting in increased adipose tissue UCP2 
and skeletal muscle UCP3 expression and thereby attenuating the decline in core 
temperature that would otherwise occur on energy restriction has been reported 
(Zemel and Sun, 2008). In addition physiological concentrations of 1,25(OH)2D3 
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seem to have an anti-apoptopic effect on adipocytes, mediated by suppression of 
UCP2 (Zemel and Sun, 2008) (Fig. 2.11). 
 
Fig. 2.11  Schematic representation highlighting the possible mechanistic routes in which dietary 
calcium plays a role on energy metabolism via the influence on UCPs in energy 
restricted ap2-agouti transgenic mice. Adapted from Shi et al. (2001a) 
 
Another possible mechanism by which dietary calcium intake might affect adiposity 
is its effect on the absorption of triacylglycerol from the gastrointestinal tract 
because of formation of non-digestible calcium soaps. Denke et al. (1993) reported 
that calcium fortification (2200 mg elemental calcium/d) increased the percentage of 
dietary saturated fat excreted in 72 hour faecal collections from 6% to 13% per day. 
The high calcium diet also significantly reduced total cholesterol by 6%, LDL 
cholesterol by 13% and apo-lipoprotein B concentrations by 7% when compared to 
the low calcium diets. In an 85 day dietary intervention trial, Papakonstantinou et al. 
(2003) fed rats were fed a high calcium diet containing dairy protein or a control 
diet. Rats on the high calcium diet gained 29% less carcass fat.  
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Welberg et al. (1994) studied the effects of calcium supplementation on quantitative 
and qualitative faecal fat excretion in 24 participants. They reported a dose 
dependant increase in NEFA excretion with supplemental calcium at 0, 2 and 4 g of 
calcium per day. These studies on faecal fat excretion predict small effects on total 
body lipid flux. A person consuming a 2500 kcal/d (~10.5 MJ/d) diet containing one 
third of energy from fat, taking an additional 2 g elemental calcium/d might be 
expected to excrete an additional 1% of energy from fat per day and would be 
anticipated to lose ~3010 kcal/year (~12.6 MJ/year) in stool. This amount of lost 
energy might explain a change in body weight of ~0.4 kg/year (Parikh and Yanovski, 
2003). Thus these data suggest that faecal fat excretion may only explain a small 
proportion of the effect calcium seems to have on body weight changes.  
 
2.5.1 Calcium and fat metabolism  
Based on the above mentioned in-vitro studies and epidemiological data, the 
association between calcium intake and 24-hour fat oxidation in young non-obese 
humans was first examined by Melanson et al. (2003). They examined the 
association in both self reported habitual calcium intake (mean 1222 ± 116 mg/d) 
and acute intake (640 ± 44 mg/d), and found a positive and significant correlation 
between 24-hour fat oxidation and acute calcium intake but not habitual calcium 
intake. It is interesting to note that in this study that total calcium and not dairy 
calcium remained significant predictors of 24-hour fat oxidation in backwards 
stepwise regression models. They suggested the possibility of a difference in the 
results between habitual and acute calcium intake on the self-reporting method of 
calcium estimation. These results have been supported by Cummings et al. (2006) 
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who reported that, regardless of the source, calcium intake acutely stimulated 
postprandial fat oxidation and there was a lesser suppression of NEFA following 
calcium rich meals.  
It is also possible that some of the effects of calcium on lipid metabolism could be 
generated rather quickly as 1,25(OH)2D3 has been reported to exert physiological 
non-genomic effects on calcium metabolism and its putative effects on increasing 
i[Ca
2+
] (Jones et al., 1998). And indeed in a follow up study Melanson et al. (2005) 
found a ~10% reduction in circulating 1,25(OH)2D3 concentrations but not in plasma 
calcium, urinary calcium excretion and plasma PTH levels. In a study by Boon et al. 
(2005) though not as acute as Melanson et al. (2003) have also reported a significant 
difference in change in plasma 1,25(OH)2D3 concentrations from 175 ± 16 pmol/l to 
138 ± 15 pmol/l in a high dairy/high calcium (1259 ± 9 mg/d ca) group intervention, 
when compared with a change in plasma 1,25(OH)2D3 concentration from 164 ± 13 
pmol/l to 198 ± 19 pmol/l in a low dairy/low calcium (349 ± 8 mg/d) group in a three 
7 day dietary intervention study. Thus there seems to be a need for further work to 
study the effects of an acute load of high calcium foods and its effect on fat 
metabolism via non-genomic actions of 1,25(OH)2D3 or possible other mechanisms.  
 
In terms of long term interventions, Gunther et al. (2005) have studied the effects of 
chronic high (1000-1400 mg/d) and low (< 800 mg/d) dairy calcium intake for one 
year on 19 healthy normal weight women on their respiratory exchange ratio (RER) 
and fat metabolism after a high (> 500 mg) and low dairy calcium (< 100 mg) meal 
challenge, before and after the intervention. The intervention group had a greater 
decrease in RER after both the low calcium (-0.20 ± 0.09 and 0.004 ± 0.08,  
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p < 0.0001) and high calcium (-0.12 ± 0.09 and -0.06 ± 0.08, p < 0.006) meal 
challenges. They also reported a corresponding increase in fat oxidation in the 
intervention group as compared to the controls after both, the low calcium  
(0.10 ± 0.05 and 0.005 ± 0.04 g/min, p < 0.0001) and high calcium (0.06 ± 0.05 and 
0.03 ± 0.04 g/min, p < 0.009) meal challenges. These results suggest that chronic 
increased dietary calcium results in the long term adjustment in the ability to oxidise 
fats and utilise calories, even without high calcium content in the meal. This 
however contradicts the findings of Melanson et al. (2003) who have reported no 
significant changes in fat oxidation rates with a high self reported habitual calcium 
intake (mean 1222 ± 116 mg/d). Gunther et al. (2005) have not looked at plasma 
1,25(OH)2D3 concentrations, however they have reported no significant changes in 
plasma log PTH for the control group (0.18 ± 0.62) as compared to the intervention 
group (0.07 ± 0.49) after one year of the intervention, nor any significant correlations 
with fat oxidation even when corrected for changes in body composition. But they 
have reported a negative partial correlation between the one year change in log PTH 
and one year change in whole body fat oxidation in response to a high calcium meal 
but not a low calcium meal. This probably suggests that the homeostatic 
concentration of PTH suppression may be modified by the chronic intake of calcium. 
 
If the increase in calcium intake is then combined with a caloric restriction then the 
effects on fat oxidation rates seem to get more pronounced. In a follow-up dairy 
intervention study by (Melanson et al., 2005) the authors found that under energy 
balance conditions there was no effect of low-dairy (LD) (~500 mg calcium/d for 
7days) or high-dairy (HD) (~1400 mg calcium/d for 7 days) treatment on respiratory 
quotient (RQ) or 24-hour macronutrient oxidation. However, under energy deficit  
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(-600 kcal/d) conditions, 24-hour fat oxidation was significantly increased on high 
dairy diet (HD = 136 ± 13 g/d, LD = 106 ± 7 g/d, p < 0.05). One important 
distinction between the energy balance and the energy deficit interventions was that 
energy deficit was achieved via a combination of calorie restriction (~100 kcal) and 
exercise (~400 kcal from an exercise with workload of 70%V O2peak). Fat oxidation 
did not differ between HD and LD in energy deficit conditions when the participants 
were resting, but only increased during the exercise session and during another two 
10 min stepping bouts (96, 72, 96 steps/min). The authors have thus suggested that 
the increase in fat oxidation rates and decrease in RER during the energy deficit 
trials could be due to exercise rather than calcium. However, the energy balance 
trials also included the step bouts without any difference in fat oxidation rates 
between the two dietary conditions. This could lead to a possible effect of increased 
lipolytic effect via increase in dietary calcium intakes under energy deficit conditions 
but not energy balance conditions. This increase in availability of NEFA during 
exercise conditions could then translate to a higher fat oxidation rate but not in 
resting conditions where the available NEFA in the blood could be re-esterified due 
to lower energy demands at the time. 
 Another study on high (~1700-1800 mg/d) and low (~475 mg/d) calcium for 7 days 
by Jacobsen et al. (2005) found a small but non-significant increase in fat oxidation 
with a high calcium + normal protein diet (11.5 ± 8 % EI) but not with high calcium 
+ high protein diet (7.9 ± 6 % EI) when compared to low calcium + normal protein 
diet (7.4 ± 9 % EI). This was matched with a small but non-significant increase in 
NEFA after the high calcium + normal protein diet (66 ± 212 µmol/l) as compared to 
a non-significant decrease (-117 ± 235 µmol/l) in participants who were on a low 
calcium + normal protein diet and the ones on a high calcium + high protein diet  
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(-17.5 ± 151 µmol/l). However, unlike the study by Melanson et al. (2005) there was 
no specific exercise provision in this study. Only spontaneous activity was measured 
via microwave radar detectors and accounted for as part of the 24-hour energy 
expenditure (EE). Thus considering the NEFA data, in light of the fat oxidation data, 
it seems to lend itself to the explanation that the increased availability of NEFA with 
increased calcium intakes could be an important factor in determining the increased 
rates of fat oxidation without any change to TEE. Boon et al. (2005) with a similar 
research of randomised crossover design with isocaloric diets of high calcium/high 
dairy (1259 ± 9 mg/d), high calcium/low dairy (1259 ± 9 mg/d) and low calcium/low 
dairy (349 ± 8 mg/d) have also reported very modest non significant increase in fat 
oxidation rates (108 ± 7 g/d) following high dairy/high calcium diets as compared 
with low dairy/low calcium group (100 ± 6 g/d).  
Considering that most studies have reported very modest changes in fat oxidation 
rates and it seems that the relation between calcium intakes and substrate metabolism 
may be more interrelated with lipolysis than oxidation of NEFAs at least in 
sedentary participants over a 24 hour period. This is evident with observed 
significant changes in circulating 1,25(OH)2D3 concentrations which has a direct 
impact on increasing i[Ca
2+
] levels at least in-vitro and in animal studies affecting 
lipolytic and lipogenic hormonal milieu as reported by numerous studies (Shi et al., 
2001b, Xue and Zemel, 2000, Xue et al., 2001). It is possible that these effects may 
not reflect normal physiological situations. Another reason for these studies to have 
reported small but not significant changes in fat oxidation may be due to low 
statistical power in most human intervention studies described above. Most of these 
studies have reported studying between 7-20 participants. Boon et al. (2005) have 
stated that from a post hoc power analysis, it was calculated that to reach significant 
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differences in substrate metabolism with the variances and differences observed 
between groups, the required number of participants would at least be 43 in their 
study. Thus the relationship between fat oxidation rates and calcium intakes in 
humans requires more in-depth examination particularly the impact of lipolytic 
mechanisms on substrate metabolism in-vivo as that might provide some 
understanding of the role of calcium in its influence on body composition as seen 
consistently from epidemiological (McCarron et al., 1984, Zemel et al., 2000, Pereira 
et al., 2002) and meta analytical (Davies et al., 2000) data. 
 
2.5.2 Calcium and glucose metabolism 
Since transport of glucose is a rate limiting step in energy metabolism, the effects of 
calcium homeostasis on glucose transport may have a valuable role to play in 
understanding the wide ranging effects of i[Ca
2+
] in substrate metabolism; especially 
during exercise. As early as 1914 in the Sheffield laboratory at Yale University, 
scientists were investigating the influence of calcium in glucose metabolism. The 
researchers injected normal grown rabbits with different doses of epinephrine, to 
disturb the sugar homeostasis in the blood and then participanted the rabbits with 
different doses of calcium salts (lactate and chloride). They reported that rabbits with 
hyperglycaemia, induced by adrenaline in conjunction with calcium salts resulted in 
increased elimination of „sugar‟ in the urine. Also, withdrawal of calcium produced 
hypoglycaemia (Underhill, 1916). This suggests that calcium plays an important role 
in regulating blood glucose. 
Many of the current molecular concepts regarding the regulation of glucose uptake 
have been derived from efforts in the insulin signalling field. The influence and 
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effects of calcium in the role of glucose uptake is not only complex but also 
surrounded by controversies and disagreements. It is possible that insulin may 
increase cytosolic calcium by regulating the activity of calcium channels (Zemel et 
al., 2000, Shi et al., 2000) which in turn may influence lipolysis (Xue et al., 2001). 
However, the role of calcium in insulin signalling is reported to be subtle, relying on 
small, localized changes in intracellular concentration rather than large i[Ca
2+
] 
changes mediated by influx from extra- and intracellular compartments (Whitehead 
et al., 2001). Although calcium is required for proper insulin signal transduction, 
high concentrations of i[Ca
2+
] diminish insulin sensitivity (Zemel, 1998). Obese and 
type 2 diabetic participants exhibit elevated i[Ca
2+
] levels in many cell types, 
including insulin target tissues (Kim et al., 1996, Zemel, 1998, Zemel, 2001). Thus 
changes in calcium levels manipulated either through a dietary route or 
pharmacologically may have an effect on glucose transport via both insulin 
signalling and perhaps in the longer term even affect insulin sensitivity. A metabolic 
shift achieved via increased dietary calcium may therefore influence glucose 
transport during exercise as well and in turn influence substrate utilization during 
exercise.  
The transport of glucose into the skeletal muscle and other tissues is dependent on a 
family of facilitative transporters (GLUTs) of glucose. Currently, there are five 
established functional facilitative glucose transporter isoforms (GLUT 1-4 and 
GLUTX1), with GLUT-5 being a fructose transporter (Alberts et al., 2004). GLUT-4 
isoform is the major insulin-responsive transporter that is predominantly restricted to 
striated muscle and adipose tissue (Alberts et al., 2004). Calcium seems to be 
involved in glucose transport via the final stages of docking of GLUT-4 storage 
vesicles with plasma membrane (Whitehead et al., 2001). Under normal resting 
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conditions, most of the GLUT-4 molecules reside in membrane vesicles inside the 
muscle cell (Alberts et al., 2004). In response to insulin or muscle contraction, 
GLUT-4 translocates to the cell membrane where it inserts to increase glucose 
transport (Watson and Pessin, 2001). The amount of GLUT-4 protein is a primary 
factor in determining the maximal rate of glucose transport into skeletal muscle 
(Rose and Richter, 2005). The mechanism behind the movement of GLUT-4 to 
surface membranes and the subsequent increase in transport by muscle contractions 
is largely unresolved, but it is likely to occur through intracellular signalling 
involving Ca
2+
-calmodulin-dependent protein kinase, 5'-AMP-activated protein 
kinase (Kurth et al., 1999), and possibly protein kinase C (Kurth et al., 1999, 
Persechini and Cronk, 1999).  Here calcium plays either a permissive role in insulin 
stimulated glucose transport or even actively drive the glucose in the tissues 
(Whitehead et al., 2001). 
 For more than 30 years the transient "spikes" in i[Ca
2+
] that occur with muscle 
contractions have been hypothesized to be involved in contraction-stimulated 
glucose transport. Holloszy and Narahara (1967) proposed the role of increase in 
i[Ca
2+
] by demonstrating that the greater the amount of calcium entering a muscle 
during a contracture, the greater the increase in glucose transport in the muscle. 
Other studies have sought to resolve the role of calcium by examining Ca
2+
 activated 
enzymes. Conventional isoforms of protein kinase such as AMP-activated protein 
kinase (AMPK) are activated in response to increases in cellular calcium 
concentrations (Richter and Ruderman, 2009). AMPK is a fuel sensing enzyme that 
is conventionally activated by increased cellular AMP concentrations, for example 
during exercise (Richter and Ruderman, 2009). Thus the effect of calcium on AMPK 
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activation may in part play a role in fuel metabolism, especially during exercise  
(Fig. 2.12) 
 
 
Fig. 2.12  A Schematic representation of the role of calcium in the activation of AMPK 
 
Apart from the above mentioned mechanism of muscle contraction driving glucose 
transport via a calcium dependant mechanism another perspective involves the role 
of insulin in increasing free cytoplasmic calcium concentration and this in turn may 
trigger the stimulation of glucose transport system (Schudt et al., 1976). In their 
study insulin increased the free cytoplasmic calcium concentration, which may be 
the intracellular signal for the stimulation of glucose transport. Thus they report that 
calcium dependency of insulin response could either reflect a calcium controlled 
transduction of the insulin signal across the plasma membrane or signify that insulin 
increases i[Ca
2+
] concentration via enhanced influx from the extra cellular space 
(Schudt et al., 1976). Thus, these studies indicate that perhaps an increase in dietary 
calcium may change the extracellular ionic environment which in turn could have 
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important influences on the uptake of glucose by skeletal muscles during rest and 
exercise.  
 
2.5.3 Calcium and energy expenditure  
To explain the inverse relation between dietary calcium and body weight, a few 
studies have looked at calcium intakes and its effects on 24 hour energy expenditure 
(EE) (Jacobsen et al., 2005, Bortolotti et al., 2008, Teegarden et al., 2008). But 
despite increases in fat oxidation in some studies (Melanson et al., 2005, Boon et al., 
2005) there does not seem to be much evidence in relation to increase in Total EE 
(TEE) with an increase in calcium, intake. Jacobsen et al. (2005) found that calcium 
intake had no effect on 24 hour EE or fat oxidation after calcium supplementation 
(1800 mg/d for 1 week). A similar finding by an earlier study by Melanson et al. 
(2003) found no relation between habitual or acute calcium intakes with 24 hour EE. 
A recent study by Bortolotti et al. (2008) have also reported no increase in resting EE 
in overweight or obese individuals on a 800 mg/d supplemental calcium for five 
weeks. However, Teegarden et al. (2008) reported that overweight women on calorie 
deficit diets (-500 kcal/d) on supplemental calcium (1200 mg/d) for 12 weeks 
showed an inverse relationship between PTH and TEE and trunk fat mass. But this 
relationship was not correlated directly to calcium intakes when compared with 
controls. However, the same study has reported mean plasma 25(OH)2 D to 
positively correlate with a 12 week change in thermic effect of meal (TEM)  
(R
2
 = 0.17, p < 0.05) independent of group assignment. This is in contrast to the 
findings by Gunther et al. (2005) who have reported a higher TEM after a high 
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calcium (1000-1400 mg/d) intervention compared with a low calcium (< 800 mg/d) 
meal challenge, suggesting a metabolic change in TEM mechanisms. 
 
Some studies looking at surrogate measures of calcium metabolism and its effects on 
EE and resting metabolic rate (RMR) have also not found any effect on energy 
metabolism with changes in calcitropic hormone levels. Boon et al. (2006) have 
investigated the effect of 7 day oral supplementation of 2000 IU cholecalciferol on 
energy and substrate metabolism. Although the oral supplementation in combination 
with low-calcium (352 ± 31 mg/d) and low cholecalciferol (1.6 ± 0.3 mg/d) diet 
induced significant changes in plasma 1,25(OH)2D3 concentrations, no differences in 
RMR or fat oxidations were observed. These are interesting observations in light that 
tight regulation of blood calcium levels are maintained through hormonal control of 
PTH and calcitriol and one of the side effects of calcitriol treatment for 
hypocalcaemia is weight loss (Bortolotti et al., 2008). Many of these studies that 
have looked at TEE or RMR have also looked at fat oxidation changes with calcium 
supplementation. Some of them (Boon et al., 2005, Melanson et al., 2005) have 
reported an increase in fat oxidation levels on the same doses of calcium 
supplementation perhaps suggestive of a shift in substrate partitioning independent 
of changes in EE.  
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2.5.4 Calcium and body composition  
Although energy balance is the most critical factor in weight regulation, studies have 
suggested the calcium supplementation could aid weight loss, in any form of tablet, 
powder or dairy product. More than 20 years ago a study on the relation between 
blood pressure and nutrient intake based on data of the 1
st
 National Health and 
Nutrition Examination Survey (NHANES1) in USA found a significant inverse 
association between calcium intake and body weight (McCarron et al., 1984). 
Similar relationships have also been demonstrated in the Australian population, 
based on an examination of the data from the National Nutrition Survey 1995 
(Soares et al., 2004). 
A potential relationship between weight loss and calcium supplementation has been 
noted in animal studies (Papakonstantinou et al., 2003, Tordoff, 2001, Tordoff et al., 
1998, Zemel, 2001, Zemel et al., 2000), large epidemiological studies (Pereira et al., 
2002) and human intervention trials (Zemel, 2004, Zemel et al., 2005). But, 
systematic (Trowman et al., 2006) and non systematic reviews (Barr, 2003) have 
failed to show a definitive statistically significant correlation between calcium 
supplementation and weight loss. On the other hand Davies et al. (2000) showed a 
significant negative association between calcium intake and weight for all age 
groups; on analysing five clinical studies (one intervention and four observational 
studies). These findings have been confounded by differences in calcium sources, 
doses, participant demographics, habitual calcium intakes, intervention length and 
incorporation of exercise and/or energy restriction. Also the imprecision of the 
methods of estimating habitual (or baseline) calcium and protein intakes renders 
estimates of the independent variable inherently uncertain. Methods such as seven 
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day diet diaries and calcium to protein ratios are less prone to errors as compared to 
the usual food frequency questionnaires. 
A recent meta-analysis of data collected over twelve years from a prospective cohort 
of men in the United States found that total and dietary calcium intakes were 
associated with lower weight gain in age-adjusted models in the change analysis. 
But, they failed to reveal a significant association between dietary calcium intake 
(dairy or no dairy) with long term weight gain with a multivariate model of analysis 
(Rajpathak et al., 2006). This suggests that other diet and lifestyle factors may 
explain some of the observed changes in the age-adjusted models. Interestingly, the 
men with the largest increase in total dairy intake gained slightly more weight  
(3.14 ± 0.11 kg) than did the men who decreased intake the most (2.86 ± 0.11 kg)  
(p < 0.05). This association was primarily due to an increase in high fat dairy intake. 
These findings have been supported by other studies; Venti et al. (2005) were unable 
to find an association between calcium intake and body size (r = 0.05) or adiposity  
(r = 0.16) in Pima Indian adults and children. They hypothesised that part of the 
reason may be their high fat and high energy diet as observed by Rajpathak et al. 
(2006). These findings from the observational studies have also been substantiated 
by various controlled randomised trials (Shapses and Riedt, 2006, Thompson et al., 
2005, Gunther et al., 2005, Lorenzen et al., 2006) in the recent years.  
In addition to the differences in habitual diet related discrepancies, Gunther et al., 
(2005) found contradictory results from two studies from their own laboratory  
(Lin et al., 2000) looking at body mass differences with calcium intervention with 
healthy normal weight women. Apart from demographical and length of intervention 
differences they also report that physical fitness of the participants may have a role 
to play in the differences in observations in the studies from their laboratory. Even 
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though the physical fitness of the participants in Gunther et al. (2005) have been 
reported as higher compared to Lin et al. (2000), where sedentary women with no 
prior history of physical activity were enrolled on to a 2 year exercise intervention 
with no supplemental calcium added to their diet (mean reported habitual intake  
781 ± 212 mg/d). Interestingly Lin et al. (2000) have reported calcium/Kcal ratios as 
significant predictors of weight change (p < 0.01) and decrease in fat mass (p < 0.01) 
only in women with energy intakes below the noted mean (~1893 ± 373  kcal/d) of 
their data set. It is therefore possible that not only the physical fitness of the 
participants but the exercise intervention itself lent to some of the reported changes 
in body composition and influenced the different outcomes of the two studies.  
There seems to be two emerging trends in terms of understanding the inconsistency 
in reported data on the relationship between calcium intake and body compositional 
changes. Energy balance; high energy/high fat diets and/or exercise protocols seems 
to have an overriding influence on any small effect that increased dietary calcium 
may exert via a molecular mechanistic pathway of control of lipid metabolism and/or 
thermogenesis.  
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2.5.5 Other mechanistic concepts for the ergogenicity of calcium 
2.5.5a Calcium and cellular fatigue  
Muscle fatigue has been defined as a temporary loss of force or torque generating 
ability due to recent muscle contraction (Bigland-Ritchie and Woods, 1984). The 
mechanisms underlying muscle fatigue are numerous and may have their origins 
anywhere from central nervous system to cellular cross bridge cycling. Until recently 
muscle fatigue was thought to be caused by lactic acid accumulation or a lowered pH 
within the muscle due to a rising hydrogen ion concentration, at least in high 
intensity exercise (Westerblad et al., 1991). In the recent years, Cairns and Lindinger 
(2008) have implicated exercise induced ion shifts, water movements, 
physiochemical reactions and metabolic processes that lead to ion changes in 
compartments proximal to the sarcolemma as the major cause of fatigue (Fig. 2.5).  
 
 
Fig. 2.13  A schematic representation of transsarcolemmal ion fluxes and ion concentration 
changes in various muscle compartments (interstitial, t-tubular, intracellular) during 
electrical stimulation or exercise (Cairns and Lindinger, 2008) 
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Accumulating evidence has implicated altered i[Ca
2+
] regulation as a major 
contributor to fatigue particularly due to these changes in these ionic constituents. 
Specifically, increase in i[Ca
2+
] levels influences slowing of relaxation in skeletal 
muscle which occurs due to repeated contractile activity (Westerblad and Allen, 
1993). Westerblad et al. (1991) have demonstrated that calcium removal from the 
myoplasm was markedly reduced in fatigue. However, they have argued that this 
increase could be counteracted by decreased calcium sensitivity in muscle cells, but 
this is yet to be proved. One of the possible reasons offered for this increase in 
myoplasmic calcium in fatigued mammalian skeletal muscle is a reduction in the 
uptake of calcium by sarcoplasmic reticulum (Allen et al., 1989). Also, lowered 
extracellular calcium or blockers of various calcium entry pathways, exacerbates 
fatigue during repeated or continuous tetani (Zhao et al., 2005, Cairns et al., 1998) 
and raised extra cellular calcium or availability of more calcium entry pathways 
attenuates fatigue (Cairns et al., 1998, Zhao et al., 2005).  
Numerous other studies (Allen et al., 2008b, Nummela et al., 2008, Marino et al., 
2009) have demonstrated that metabolic changes during intense exercise such as 
accumulation of inorganic phosphates, increased ADP/ATP ratio and concurrent 
acidosis all play a role in reduction of maximum contraction. However, in the study 
by Westerblad and Allen (1991) where exercise lasted longer the muscles did not 
display any marked acidosis during fatigue but increased i[Ca
2+
]. Fatigue during such 
exercise is attributed to failure of calcium release from the sarcoplasmic stores (Chin 
and Allen, 1997, Kabbara et al., 2000) which in part can be explained by increased 
myoplasmic calcium levels which inhibit the feedback loop for release of calcium 
from sarcoplasmic stores (Allen and Westerblad 2001). However, it is the resting 
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i[Ca
2+
] levels that normally increase alongside calcium fluxes during fatigue with 
repeated tetani (Allen et al., 2008a) (Fig. 2.14).  
 
 
Fig. 2.14  Increased resting calcium levels in fatigued muscle fibres compared to control and 
return to normal levels upon recovery. Adapted from Allen et al. (2008a) 
 
 
This increased resting levels of intracellular calcium upon repeated tetani is a 
hallmark of what is termed as low frequency fatigue (LFF) (Keeton and Binder-
Macleod, 2006). This type of fatigue is characterised by slow recovery of force 
taking hours or days, persisting in the absence of gross metabolic or electrical 
disturbance of the muscle (Keeton and Binder-Macleod, 2006). It is multifactorial 
resulting from high intensity, moderate to high force, repetitive eccentric or stretch-
shortening cycle activities (Fowles, 2006). Impairments in excitation-contraction 
coupling have been suggested to play a role in LFF, involving reduction in calcium 
release from the sarcoplasm (Edwards et al., 1975, Allen et al., 1995). Chin et al. 
(1997) have identified two components to this reduction in calcium release from the 
sarcoplasm. The first is a metabolic component which in the presence of glucose 
recovers within an hour, and the second is a component dependant on the elevation 
of the time integral of the concentration of calcium in the interstitial space of a 
muscle cell. This second component recovers more slowly. Westerblad et al. (1993) 
50 
 
have proposed a i[Ca
2+
]- tension relationship curve (Fig. 2.15). It proposes that since 
i[Ca
2+
] at high frequencies is on the horizontal part of the curve, moderate falls in 
i[Ca
2+
] have no effect on muscle tension. At low frequencies i[Ca
2+
] is on the steep 
part of the curve, so falls in the i[Ca
2+
] produce large changes in tension. The main 
effect of this change in i[Ca
2+
] levels lead to decreased muscle forces in response to 
low frequency activation.  
 
Fig. 2.15 A hypothetical i[Ca
2+
]- tension curve (Keeton and Binder-Macleod, 2006) 
 
In-vivo these may be interpreted in the range of exercise more than 30 min in 
duration (Bigland-Ritchie and Woods, 1984). The decreased tension due to increase 
in i[Ca
2+
] during exercise may result in the need for higher levels of activation by the 
CNS (Keeton and Binder-Macleod, 2006).  
In summary, during submaximal exercise ion gradients show moderate perturbations 
(McKenna et al., 1996, Fitts and Balog, 1996, Lunde et al., 1998). However, a few 
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studies have demonstrated that fatigue is both task dependant and multifactorial, but 
ionic interactions such as increase in i[Ca
2+
] levels are key factors for force loss in 
exercise ranging from 5 to 20 min (Allen et al., 2008b, Cairns et al., 2005). This also 
involves calcium–potassium interaction since elevated extracellular calcium restores 
force in potassium depressed muscle (Cairns et al., 1998). In addition LFF 
experienced by athletes due to an increased i[Ca
2+
] levels during exercise may all 
lead to increased need for CNS drive. Therefore, if changes in i[Ca
2+
] are affected via 
dietary calcium levels, it is possible that the fatigue mechanisms involving increased 
calcium levels at rest and during exercise may attenuate skeletal muscle fatigue and 
thus improve performance.  
 
2.5.5b Calcium and vascular tone 
McCarron et al. (1984) demonstrated that low calcium intakes in the diet were 
associated with a higher incidence of hypertension. Calcium intakes of less than 300 
mg/d were associated with a risk of being hypertensive of 11 to 14% while calcium 
intakes greater than 1500 mg/d carried a risk of only 3 to 4% (McCarron et al., 
1984). Zemel (2001) have also implicated a threshold intake of 600-700 mg/d 
calcium based on the data in the original NHANES I presented by McCarron et al. 
(1984) in the association of increased risk for hypertension. This association hardly 
seems surprising, given the role of increased i[Ca
2+
] in peripheral vascular resistance 
(Resnick, 1992, Resnick, 1999, Kuriyama et al., 1982).  Hypertensives exhibit an 
increase in urinary calcium losses (exacerbated by high salt diets) resulting in 
decreased plasma ionised calcium levels. This stimulates PTH release, which 
activates 1-α-hydroxylase resulting in increased 1,25-(OH)2-D production (Zemel, 
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2001) (Fig. 2.16). This calcitropic hormone response eventually increases i[Ca
2+
] and 
peripheral vascular resistance.  
 
Fig. 2.16 A schematic representation of the role of calcium in vascular resistance (Zemel, 2001) 
 
Increasing dietary calcium prevents this sequence in a similar mechanistic pathway 
described earlier. Therefore the role of increasing dietary calcium can be important 
in maintaining vascular tone and decreased peripheral resistance during exercise. 
This will have implications on maintaining blood flow and oxygen supply further 
improving performance.  
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2.6 Calcium and exercise performance 
Most data on calcium homeostasis in the blood during exercise is derived from 
studies looking at bone health and exercise. There are not many specific studies 
looking at calcium intakes and its relation to substrate metabolism during exercise. 
White et al. (2006) have reported no significant treatment effect of acute calcium 
(500 mg) intervention on endurance trained female runners. On a 90 min glycogen 
depletion trial followed by a 10 km time trial performance the researchers found no 
difference in fat oxidation rates of appearance of glycerol in the blood stream nor 
changes in respiratory exchange ratios during the performance test. Acute calcium 
intake also did not seem to have any influence on time to finish on the 10 km time 
trial. Melanson et al. (2005) used a 70% V O2peak protocol in their seven day high and 
low dairy intervention study to achieve a ~400 Kcal energy deficit. They found a 
significant increase in 24 hour fat oxidation rates when their participants were on the 
exercise protocol between high dairy (HD~1400 mg/d) and low dairy  
(LD~500 mg/d) groups (HD = 136 ± 13 g/d, LD = 106 ± 13 g/d; p < 0.05). They 
have not looked at any performance measures and perhaps it would be speculative to 
infer that the increase in fat oxidation rates would translate into glycogen sparing 
action and thus would have improved performance in this experiment, especially 
since this population were untrained individuals. The main role of lipid mobilisation 
during exercise is played by β-adrenoreceptor-mediated activation of hormone 
sensitive lipase in the adipocytes (Holloszy and Coyle, 1984). And since Xue et al. 
(2001) have demonstrated that i[Ca
2+
] activates PDE 3B reducing the intracellular 
pool of cAMP and thereby suppressing the phosphorylation of HSL, there seems to 
be merit in a high calcium diet and its purported effects on increased availability of 
NEFA, which in turn should increase fat oxidation during endurance exercise.  
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There are no studies that have looked at ionised calcium in blood in relation to 
exercise with a calcium supplementation intervention, either acute or chronic. 
Men'shikov (2004) have reported an increased availability of NEFA with a 
corresponding decrease in plasma ionised calcium after exercise in trained athletes as 
compared to untrained controls when doing a endurance cycle ergometer test of  
90 min duration without any calcium related intervention however. In addition, they 
have reported a multiple correlation between post-exercise plasma NEFA, ionised 
calcium and oxygen consumption in athletes (r = 0.72; p < 0.05) suggesting an 
involvement of calcium in NEFA metabolism. Thus even though there does not seem 
to be a direct effect of acute calcium load on performance parameters, the influence 
of calcium on body composition may still be an avenue for further research with 
respect to its ergogenic properties.  
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2.7 Summary and research questions 
Calcium plays a variety of roles in the human metabolism (Fig.2.17). In-vitro and 
animal studies have suggested a strong correlation between increased i[Ca
2+
] and fat 
metabolism with a concurrent chronic effect on body weight and composition.  
 
Fig. 2.17 Schematic representation of the role of dietary calcium in metabolism 
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However, studies conducted in humans are inconclusive towards supporting those 
results. With calcium levels being tightly regulated in the body, any intervention 
designed to study its specific role in energy metabolism has obvious challenges in 
terms of methodology and control of confounding factors. Over and above 
differences in the source of calcium (dairy and supplemental forms), the 
measurement of energy expenditure in free living organisms (especially in simulated 
laboratory conditions) all further complicate the comparison of different 
experimental conditions. As seen from the evidence presented that even though 
experiments in total energy expenditure are inconclusive in supporting the 
hypothesis of calcium aiding EE, there seems to be an emerging bank of data 
favouring the shift in substrates towards increased fat oxidation with higher dietary 
calcium intakes especially under energy deficit conditions. 
Studying the calcium-induced shift of substrates during exercise with relation to 
training adaptations in athletes would enhance our understanding in this research 
field immensely. Trained athletes are better able to utilise fat as a source of energy 
during sub-maximal exercise (Holloszy and Coyle, 1984). If dietary calcium plays a 
role in lipolysis and thus increasing the availability of NEFA, it may aid in increased 
fat oxidation rates during a given exercise bout. This in turn may help spare 
glycogen in certain endurance events, leading to performance enhancement and/or 
delay in fatigue. These metabolic shifts may help change the athlete‟s body 
composition favourably towards higher fat loss.  
Thus in the view of the literature presented, the following experimental chapters will 
address the aims and objectives laid down in Chapter 1. 
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CHAPTER 3 
GENERAL METHODS 
 
This chapter outlines the common methodologies undertaken for all studies. Where 
methods for the various studies differ specific methodologies are then described in 
the relevant chapters. 
 
3.1 Participant recruitment 
All investigations were approved by the Ethics Health and Safety Committee, 
Faculty of Science and Technology, University of Central Lancashire. Prior to 
participation in all the studies, each participant was provided with an information 
sheet (appendix C and D) outlining the purpose of the research, how it was to be 
undertaken, the potential risks and benefits, the points and sources of registering 
complaints and grievances regarding any aspect of the research and anticipated 
degree of commitment.  
Inclusion criteria involved participants being healthy and free of known 
cardiovascular, respiratory and circulatory dysfunction, not taking calcium 
supplements nor vitamin D preparations, anticonvulsant medications, diuretics, 
adrenocorticosteroids, oestrogens or other drugs that could alter calcium metabolism 
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for the past 12 months. This was assessed via a health screening questionnaire 
(appendix E) and Physical Activity Readiness – Questionnaire (PAR-Q) (appendix 
F). Minimum training load and volume specifications of the recruitment criteria are 
defined individually in all studies as they varied in these different trials. Prior to 
testing all participants returned a signed copy of their informed consent (appendix G 
and |H) to participate in the trials. 
 
3.2 Equipment  
3.2.1 Cycle ergometry 
A stationary electromagnetically braked cycle ergometer (SRM ergometer; 
Schoberer Rad Messtechnik, Jülich, Germany) was used in studies 2 and 3. This 
system is a crank-based device that measures the mechanical Power Output (PO) 
using 20 strain gauges attached to components inside the crank. The measured torque 
and cadence values were digitalised inside the crank and converted to a high 
frequency, pulse-width modulated electrical signal. The data was transmitted to a 
microcomputer on the handlebar and also displayed on a computer using the 
SRMWin software (Schoberer Rad Messtechnik, Jülich, Germany), where the torque 
was averaged over each complete pedal revolution and multiplied by the cadence to 
calculate the PO reading using the following equation - 
PO = ([measured frequency – zero offset frequency] x cadence x 2π) / (slope x 60) 
The slope for each SRM crank dynamometer is calculated dynamically at the SRM 
factory. Positions of the handlebars, seat height and crank length were adjusted to the 
measures used by the athletes own racing bikes. The SRM crank system has been 
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previously confirmed as a valid and reliable device for determination of PO in 
cycling (Balmer et al., 2000). During each exercise test, torque and angular velocity 
data from the bicycle crank were relayed to a power-control unit attached to the 
ergometer (Fig. 3.1). Subsequent power output data were obtained at 1 sec intervals 
from the power-control and transferred to the SRM software and downloaded to a 
personal computer (Appendix L).  
 
Fig. 3.1 Powercontrol unit on the SRM ergometer 
 
Reliability of the power measurements was calculated (n = 2) by performing two 
graded incremental trials (20 W/min until voluntary exhaustion) on the SRM 
ergometer four days.  Data points at 60s average at each min were used to calculate 
the change in mean, typical error (TE) and Pearson‟s product moment correlation 
coefficient (R
2
) (table 3.1). Bland and Altman plots were produced as described in 
Lamb (1998) (Fig. 3.2). The data in the Bland and Altman plots is presented as log 
transformation due to its heteroskedastic nature.  
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Table 3.1  Change in mean, typical error and correlation coefficient for power output 
                           Units ± SD (95% CI upper to lower limits) 
 Change in mean 
 
Typical error 
 
(R
2
) 
PO -7.8 ± 4.6 (-10.5 to -5.1) 3.3 (2.3 to 5.7) 0.99 (0.98 to 1.00) 
 
 
 
Fig. 3.2 Bland and Altman plots of mean (log) power output (W) of graded incremental tests  
(n = 2) 
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3.2.2 Respiratory gas collection and analysis  
Expired gas samples were collected throughout using the Cortex Metalyzer 3B 
laboratory Breath-by-Breath spiroergometry System (Cortex Biophysik GMBH, 
Version ML3B 2.1). During cycling, the expired air was collected via a bi-
directional digital volume transducer attached to a facemask of appropriate size for 
the participant which was secured over the mouth and nose ensuring all gas breathed 
in and out passed through the flow sensor and sample line. The expired air was 
continuously and simultaneously measured for volume; O2 and CO2 concentrations 
in conditions of standard temperature pressure and dry (STPD). The CO2 output was 
determined by an infra-red sensor and O2 uptake during each breath was determined 
by an electrochemical cell (Cortex Biophysik GMBH). Data sampled were 
transferred breath by breath to a personal computer (PC) for immediate display. The 
data recorded was saved in the internal databases of Metasoft V3.7. The Metalyzer 
underwent a 2 point calibration immediately before each test with the use of ambient 
air (O2 20.93% and CO2, 0.03%) and a gas of known composition  
(O2 15%, CO2 5% BOC, Guildford, UK). The DVT turbine, digital volume 
transducer was calibrated prior to each test with a three litre calibration syringe 
(Hans Rudolf). Heart rate was recorded throughout using short range telemetry. The 
chest transmitter belt (Polar Electro T60, Kempele, Finland) was placed inferiorly to 
the xiphisternal joint. Data was transmitted to a heart rate (HR) receiver housed in 
the portable body of the Metalyzer 3B. Data was recorded breath by breath and 
average calculated for every 30 sec for the purpose of analysis. 
Reliability of the gas analysis measurements was calculated (n = 2) by performing 
two graded incremental trials (20 W/min until voluntary exhaustion) on a cycle 
ergometer four days apart.  The participants met all conditions described in section 
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3.1 prior to the test. Data points at 60 sec average at each min were used to calculate 
the change in mean, typical error (TE) and Pearson‟s product moment correlation 
coefficient (R
2
) (table 3.2). Bland and Altman plots were produced for V O2 (Fig. 
3.3) and V CO2 (Fig. 3.4) after the data was participant to all fulfilment of all 
conditions as described in Lamb (1998). The data in the Bland and Altman plots is 
presented as log transformation due to its heteroskedastic nature.  
 
Table 3.2 Change in mean, typical error and correlation coefficient for gas exchange analyser. 
Units ± SD (95% CI upper to lower limits) 
 Change in mean 
 
Typical error 
 
(R
2
) 
V O2 
-0.70 ± 3.7 (1.05 to -2.45) 2.68 (3.92 to 2.04) 0.93 (0.97 to 0.82) 
V CO2 
-0.10 ± 0.5 (0.14 to -0.33) 0.36 (0.52 to 0.27) 0.89 (0.96 to 0.76) 
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Fig. 3.3 Bland and Altman plots of mean (log) oxygen consumption (ml/kg/min) of graded 
incremental tests (n = 2) 
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Fig. 3.4 Bland and Altman plots of mean (log) carbon dioxide production (l/min) of graded 
incremental tests (n = 2) 
 
To determine the variability in the gas analysis measurements during the average 
testing time period for the trials (~80 min) calibration gases (O2 15%, CO2 5% BOC, 
Guildford, UK) were measured immediately after calibration and repeated after the 
machine had been left running for 80 min. The readings for oxygen and carbon 
dioxide were same at 0, 40 and 80 min.  
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3.2.3 Rating of perceived exertion 
Rating of perceived exertion (RPE) was measured using the 15 point Borg Scale 
(Borg, 1973). The scale runs from 6 to 20 with 6 being very, very light and 20 being 
very, very hard. Participants were instructed to non-verbally score their perception of 
exertion immediately before every blood collection stage in all studies.  
 
3.2.4 Haematological variables 
3.2.4a venous sampling  
A 3 ml venous blood sample was taken from the median cubital vein in the 
antecubital fossa using a syringe containing ethylenediaminetetraacetic acid (EDTA) 
as an anti coagulant (S-Monovette, Sarstedt, Germany) for analysis at rest before the 
start of each trial. All samples were transferred to Eppendorf tubes, mixed 
thoroughly and immediately centrifuged at 10,000 rpm for 6 min and the supernatant 
was frozen at -80°C until further analysis for plasma intact parathyroid hormone 
(iPTH) and NEFA (study 1) 
 
i. Plasma intact parathyroid hormone  
 
iPTH concentration in the plasma was determined using a two-site quantitative 
immunoenzymometric assay kit (OCTEIA® Intact PTH, Immunodiagnostic Systems 
Ltd., Tyne and Wear, UK). The procedure consisted of incubation of duplicates of 
200 µl of the sample, six standards (lyophilised porcine plasma containing PTH with 
0.09% (w/v) sodium azide in varying concentrations of 0.0 pmol/l, 1.5 pmol/l,  
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4.8 pmol/l, 7.5 pmol/l, 17.3 pmol/l, 39.1 pmol/l) and controls (distilled water) in  
antibody coated (N-terminal specific mouse monoclonal anti-PTH) polystyrene 
micro titre wells for four hours at 4°C before aspirating and manually washing three 
times by adding 300 µl of wash solution (phosphate buffered saline) and decanting to 
remove unbound sample. The micro titre plate was then inverted firmly on an 
absorbent tissue to remove excess wash solution. The wells were then incubated at 
4°C overnight with 200 µl of enzyme conjugate (affinity purified goat anti-PTH 
coupled to horseradish peroxidase). Following a further aspiration and wash step, 
colour was developed using 200 µl liquid TMB substrate reagent and the wells were 
incubated at room temperature for 30 min. 100 µl of stop solution (0.5M 
hydrochloric acid) was used to stop the reactions. The micro titre plate was then read 
immediately in a plate reader (SpectraMax Plus384 Microplate Spectrophotometer, 
CA, USA) at 450 nm. The colour intensity developed is directly proportional to the 
amount of PTH in sample.  
Calculation of iPTH concentration (pmol/l) from mean absorbance of the duplicates 
was read on a calibration curve prepared by plotting the mean absorbance of each 
standard concentration on the x axis against concentration of iPTH on the y axis 
(Fig. 3.5). The %CVs of the standards are presented in table 3.3.  
Quality control of the assay was performed by measuring the within-run CVs which 
ranged from 0.62 – 4.13% (Appendix B) and the between-run CV was 6.81% 
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Table 3.3 Standard absorbance and %CV for iPTH assay 
Std 
Concentration 
(pmol/l) absorbance absorbance 
mean 
absorbance StdDev %CV 
      0 0.066 0.065 0.066 0.001 1.1 
1.5 0.107 0.109 0.108 0.001 1.3 
4.8 0.198 0.188 0.193 0.007 3.7 
7.5 0.309 0.32 0.315 0.008 2.5 
17.3 0.605 0.617 0.611 0.008 1.4 
39.1 1.347 1.359 1.353 0.008 0.6 
 
Fig. 3.5 Standard calibration curve for iPTH assay 
 
ii. Plasma non esterified fatty acids  
Plasma NEFA concentration was determined using a NEFA C test kit (WAKO 
Chemicals GmbH, Neuss, Germany). The half-micro test determined NEFA 
concentrations by an optimised enzymatic colorimetric assay. The procedure 
involved mixing 5 μl of plasma (sample) or 5 μl of distilled water (control) with 100 
R² = 0.9923 
0.000
0.200
0.400
0.600
0.800
1.000
1.200
1.400
0 1.5 4.8 7.5 17.3 39.1
 M
ea
n
 A
b
so
rb
an
ce
 
Plasma iPTH (pmol/l) 
Standard calibration curve (iPTH) 
68 
 
µl of surfactant buffer solution containing ATP, coenzyme A, ascorbate acetate, 
acyl-CoA-synthetase (Acyl CS) and. Once the mixture had been incubated in a water 
bath at 37°C for 10 min, 200 µl of acyl-CoA-oxidase and peroxidase in surfactant (3-
methyl-N-ethyl-N-(β-hydroxyethyl)aniline) solution was added and incubated for a 
further 10 min at 37°C. The absorbance of the sample (E1) and control (Ca-1) were 
measured immediately after using a spectrophotometer (SpectraMax Plus
384
 
Microplate Spectrophotometer, Molecular Devices, CA, USA) set at a wavelength of 
546 nm. Measurements were conducted in triplicates and a mean of the readings was 
taken for calculation. Since our samples were not strongly lipemic, icteric or 
haemolytic a sample blank value correction was not applied. The concentration of 
the NEFA (mmol/l) was determined using the following calculation: 
 
       NEFA (mg/dl)    =      Es      x   
Concstd (mg/dl)    
Estd 
 
Where [NEFA] is the concentration of free NEFAs in mg/dl which was then 
converted to mmol/l (conversion factors: mg/dl x 0.035 = mmol/l) 
 Es is [E1-Ca-1]  
Concstd  was Oleic acid (28.2 mg/dl i.e. 1.0 mmol/l) 
Estd is the absorbance of the standard at 546 nm 
Quality control of the assay was performed by measuring the within-run CVs which 
ranged from 0.90 – 5.79% (Appendix B) and the between-run CV was 4.69% 
 
 
69 
 
3.2.4b Capillary sampling  
Blood samples were taken from either the index or the middle finger of the preferred 
hand. The finger was first cleaned using a Steret alcohol wipe (Southern Syringe 
Ltd., Manchester, UK) to ensure the area was clean of any debris. The finger was 
then punctured using a BD Microtainer
®
 Genie
™
 blade lancet (2.00 mm x 1.50 mm, 
Blue) (Becton, Dickinson & Co., Plymouth, UK) and the first drop of blood wiped 
off to ensure any remaining alcohol did not affect the sample. A 5 µl sample was 
taken for measurement of whole blood lactate (study 1 and 2) and a further 5 µl 
sample was taken for measurement of blood glucose (study 1 and 2). A 300 µl 
sample was collected in a Microvette
®
 CB300 tube (Sarstedt Ltd., Leicester, UK). It 
was mixed thoroughly and immediately centrifuged (Micro Centaur, MSE Ltd. 
London, UK) at 10,000 rpm for 6 min and the supernatant was frozen at -80°C until 
further analysis for total plasma calcium, triacylglycerides, glucose and NEFA. 
 
i. Whole blood lactate  
 
Whole blood lactate was measured using a lactate test meter (Lactate Pro, Akray, 
Kyoto, Japan). This is a hand-held portable analyser capable of measuring whole-
blood lactate in the field. Capillary blood was drawn as explained above and then 
applied to a reagent strip (lactate Pro Test Strip, Akray, Kyoto, Japan).  Lactate in 
the sample reacts with potassium ferricyanide and lactate oxidase to form potassium 
ferrocyanide and pyruvate. Upon the application of a given voltage, ferrocyanide is 
oxidised, releasing electrons and creating a current. This current is measured 
amperometrically and is directly proportional to the lactate concentration of the 
blood sample. The Lactate Pro is supplied with a Check Strip (to confirm that the 
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analyser is operating correctly) and a Calibration Strip that provides a non-
quantitative indication of instrument accuracy. This method has been previously 
validated (Mc Naughton et al., 2002, Pyne et al., 2000, Makita and Satomi, 1997). 
They have all found strong correlations between (r > 0.96) (Pyne et al., 2000),  
(r = 0.98) (Mc Naughton et al., 2002) and (r = 0.99) (Makita and Satomi, 1997)  
between the Lactate Pro and other existing analysers. The limits of agreement of less 
than 2.0 mM through the physiological range of 1.0 – 18.0 mM (Pyne et al., 2000) 
underlie the suitability of this method for our current experimental conditions as all 
tests conducted are in the submaximal range of exercise intensity, where blood 
lactate are unlikely to rise over 18.0 mM (Telford et al., 1988) 
 
ii. Total plasma calcium 
 
Total plasma calcium was measured using Dr. Lange Miniphotometer plus LP 20 
(Hach Lange GmbH, Berlin, Germany) with Dr. Lange calcium cuvette test kit 
(LKM 145). In alkaline buffer solution calcium forms a purple dye with  
o-Cresolphthalein this is measured photometrically. Contents of cuvette  
(o-Cresolphthalein complexion 0.16 mmol/l contained in LKM 145) were dissolved 
in 2.0 ml buffer solution (glycine buffer, pH 10.3: 300 mmol/l). Then 50 µl sample 
and blank (50 µl distilled water)  was pipetted into the dissolved reagent, which was 
then mixed gently and analysed against blank within 30 min at 578 nm at room 
temperature (20 to 25°C).  Total plasma calcium concentration was recorded in 
mmol/l. Quality control of the assay was performed by measuring the within-run 
CVs which ranged from 0.0 – 0.54% (Appendix B) and the between-run CV was 
2.36% 
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iii. Plasma triacylglycerides 
 
Plasma triacylglycerides was measured using Dr. Lange Miniphotometer plus LP 20 
(Hach Lange GmbH, Berlin, Germany) with Dr. Lange triglyceride cuvette test kit 
(LKM 227). This is an enzymatic colorimetric test. Plasma triglycerides are 
hydrolyzed to glycerol and free NEFAs by lipase. In the presence of ATP and 
glycerol kinase (GK), the glycerol is converted to glycerol-3-phosphate. The 
glycerol-3-phosphate is then oxidized by glycerol phosphate oxidase (GPO) to yield 
Dihydroxyacetone phosphate and hydrogen peroxide. The condensation of hydrogen 
peroxide with 2, 4 dichlorophenol and 4-aminophenazone in the presence of 
peroxidase (POD) produces a red coloured quinonimine dye which is read at 520 nm. 
The intensity of the coloured complex formed is directly proportional to the 
triacylglyceride concentration of the sample. 
10 µl sample and blank (10 µl distilled water) was pipetted into the LKM 227 
cuvette containing buffer solution (lipoprotein lipase, peroxidase and  
2, 4-Dicholorphenol) and the absorbance measured (A0) at 520 nm. The protective 
foil was then removed, the cap containing starting reagents (ATP, GPO, peroxidase 
and glycerokinase) was inverted and the reactions catalysed my mixing the contents 
thoroughly. The cuvette was then immediately inserted into the Miniphotometer and 
absorbance read (Pl-1) at 520 nm. The inbuilt software made the necessary 
adjustments from A0 and Pl-1 and displayed plasma triacylglycerides in mmol/l. 
Quality control of the assay was performed by measuring the within-run CVs which 
ranged from 0.08 – 0.25% (Appendix B) and the between-run CV was 1.30% 
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iv. Plasma glucose 
 
Plasma glucose was measured using Dr. Lange Miniphotometer plus LP 20 (Hach 
Lange GmbH, Berlin, Germany) with Dr. Lange glucose cuvette test kit (LKM 141). 
Glucose is determined after enzymatic oxidation in the presence of glucose oxidase 
(GOD). The formed H2O2 reacts under catalysis of peroxidase (POD) with  
2, 4-Dicholorphenol and 4-aminophenazone to form red quinonimine dye. The 
intensity of the colour is proportional to the glucose concentration in the sample.  
10 µl sample and blank (10 µl distilled water) were pipetted into the LKM 141 
cuvette containing colour reagent (Phosphate buffer, pH 7.8, mutarotase,  
2, 4-Dicholorphenol and 4-aminophenazone) and the absorbance measured (A0) at 
520 nm. The protective foil was then removed, the cap containing starting reagents 
(glucose oxidase and peroxidase) was inverted and the reactions catalysed my 
mixing the contents thoroughly. The cuvette was then immediately inserted into the 
Miniphotometer and absorbance read (Pl-1) at the end of two minutes at 520 nm. 
The inbuilt software made the necessary adjustments from A0 and Pl-1 and 
displayed plasma glucose in mg/dl. Quality control of the assay was performed by 
measuring the within-run CVs which ranged from 0.13 – 0.87% (Appendix B) and 
the between-run CV was 1.39% 
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3.2.5 Anthropometry  
All anthropometric measurements were made in a resting state according to 
established procedures (Eston and Reilly, 2001).  
 
3.2.5a Stature and Total body mass 
Stature was measured using a stadiometer to the nearest 0.05 m (Harpenden, Avery 
Ltd, Birmingham, UK). Total Body Mass was determined using a balance beam 
scale to the nearest 0.1 kg (Avery Type 3306, Avery Ltd, Birmingham, UK).  
 
3.2.5b Body composition 
i. Air-displacement Plethysmography 
 
Body composition and total mass (studies 2 and 3) were determined using air-
displacement plethysmography (Bod Pod Express, Life Measurement Incorporated, 
Concord, USA). The test is conducted after of a 2 point calibration. The weighing 
scale was calibrated with reference weights of 2x10 kg and the air volume in the 
empty front chamber measured against reference gas cylinder of 50 kg (Life 
Measurement Incorporated, Concord, USA). After the calibration the participant's 
mass is recorded using the same scale and volume, which is determined by sitting 
inside the Bod Pod chamber. The Bod Pod consists of two chambers. The front, or 
Test Chamber, is where the participant is asked to sit in a swimsuit and swim cap 
only. This is done in order to keep air trapped between clothing and hair to a 
minimum as that would interfere with the readings. In addition any jewellery, 
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spectacles, and any other clothing or accessories are removed prior to testing. The 
seat in the front chamber forms a common wall separating it from the rear, or 
Reference Chamber. During data collection of the volume measurement, the 
chamber door is secured by a series of electromagnets and a rubber gasket. A 
Diaphragm is mounted on the common wall, which oscillates during testing. This 
causes small changes in volume inside the chamber, of which the pressure response 
to these small volume changes is measured (Fig. 3.6). This is done by measuring the 
interior volume of the empty Bod Pod chamber, then measuring it again when the 
participant is seated inside. The participant's total body volume is obtained by 
subtraction (Life Measurement Incorporated, Concord, CA, USA). Once mass and 
volume are determined body density is calculated and the relative proportions of fat 
and fat-free mass are determined using the Siri equation (Siri, 1956). This method of 
body composition has previously been validated elsewhere (Collins et al., 1999; 
Fields et al., 2000). All measurements were taken in triplicates and the mean of the 
three readings used for all calculations. 
 
Fig. 3.6 Schematic representation of the working of the BodPod 
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3.2.6 Nutritional and Physical Activity Analysis 
3.2.6a Seven day diet diaries  
All participants were asked to provide a seven day diet diary for all studies. They 
completed the record during one typical week and one typical weekend prior to 
beginning testing. A representative page from the diary is presented in appendix H. 
Even though the seven day diet dairy has been validated as a sensitive and fairly 
accurate measure of dietary analysis (De Castro, 1994), in order to keep the 
motivation of the participants‟ reporting accuracy as high as possible a commitment 
to providing a detailed nutrient composition analysis of their reported diets was 
offered as a reward for adherence. The participants were informed that the accuracy 
of their reports is exactly linked to the accuracy of their records. To aid them in 
providing correct estimates of portion sizes, sample size pictures were provided 
along with the diary (appendix I). They used these when an accurate weight of the 
food consumed was not available. They were also instructed to report any uneaten 
food that was left on the plate. They were informed that record keeping often 
produces a change in nutrient intake (Balogh et al., 1971; Hegsted, 1975) and they 
should eat normally as their dietary composition report will only be of use to them if 
it accurately reflects their normal intake.  
Nutrient analysis was conducted using the WinDiets Research software (Robert 
Gordon University, Scotland, UK). The Nutrients included in this analysis for the 
purpose of participant reports were dietary energy, protein, total fat, saturated fat, 
monounsaturated fat, polyunsaturated fat, dietary cholesterol, carbohydrate, total 
sugars, alcohol, fibre (non-starch polysaccharides), calcium, retinol, carotene, 
thiamin, riboflavin, niacin, vitamin B6, folate, vitamin Ca-12, vitamin C, vitamin D 
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and vitamin E. However, only energy, total fat, protein, carbohydrate and calcium 
values were used in the analysis for the purpose of the project.  
During the laboratory tests no food intake was allowed, whereas fluid intake such as 
tap water was permitted ad-libitum. Sports drinks with carbohydrates and/or 
electrolytes were not permitted.  
 
3.2.6b Quantification of training 
The most valid measure for quantification of training has been recognised as a 
measure of the sum of duration multiplied by the intensity, which is proportional to 
energy expenditure (Hopkins et al., 1999). In order to achieve this all participants 
were asked to produce a training log. Heart rate was recorded for seven days (a 
typical week and a typical weekend) during the training sessions in study 1. Ideally it 
was to be the same week that was used to record food intake. In study 2 and 3, 
participants were encouraged to keep a training log for the entire four weeks of 
supplementation, although a minimum of seven days was considered essential. 
Training impulse Score (TRaining IMPulse Score) method (Banister et al., 1975) 
was  used to quantify the training of all the participants during the trials. The dose 
response relationship explored in Bannister et al. (1975) indicates a direct 
relationship between training stimulus and adaptations in humans.  
The training load can be expressed as –  
Training load = Intensity x Duration  
This helps quantify the training stimulus as a composite of external loading and 
physiological response, multiplying the training load (stress) by the training intensity 
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(strain) (Jobson et al., 2009a). Training intensity was identified using HR. Five HR 
zones based on HRpeak have been identified i.e. 50 - 60%, 60 -70%, 70 – 80%, 80 -
90%, 90 – 100% of HRpeak (Edwards, 1994, Jobson et al., 2009b, Foster et al., 2001). 
Each of these zones were given a multiplier score (50 - 60% - 1, 60 -70% - 2, 70 – 
80% - 3, 80 -90% - 4, 90 – 100% - 5 (Foster et al., 2001). An exercise for each 
session was then computed by multiplying the duration of the session by the relevant 
HR zone multiplier. Mean weekly load, monotony (daily TRIMP x SD) and strain 
(monotony x load) were then compared between the two sets of trials.  
 
3.2.7 Supplementation formulation and conditions 
3.2.7a Calcium citrate capsules 
100% Calcium citrate powder was used for all interventions (NOW Foods, Illinois, 
USA). Calcium complexed with citric acid is a white amorphous, tasteless and 
odourless powder and this product contained no sugar, salt, starch, yeast, wheat, 
gluten, corn, soy, milk, egg, shellfish or preservatives. Calcium citrate contains 
approximately 21-24% elemental calcium (Levenson and Bockman, 1994). 3 g of the 
calcium citrate contained ~700 mg of elemental calcium (23.3% elemental calcium). 
Based on this an individual dose of 4.3 g/d of calcium citrate for four weeks was 
prepared. This amounted to four capsules per participant per day (1090 x 4 = 4360 
mg). Capsules were made with vegetarian shells (uk-capsules.com) made from 
hydroxypropylmethyl cellulose (pine wood fibres). Size “00” capsules were filled 
(filled weight range 540 – 1090 mg) with a capsule filler (Cap∙M∙Quik, California, 
USA.) and Tamper (Cap∙M∙Quik, California, USA.).  
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The process was conducted by a single technician (author), to minimise the 
variations in amount of powder in each capsule. Capsules were made in room 
temperature (19 - 22°C) on a bench first cleaned with sterile solution and then wiped 
dry with tissues. Nitrile gloves were used throughout the process of handling all 
materials and equipment. The steps involved were as follows –  
Assembly:  The base of the capsule holder was placed on the bench lined with 
tissues. Spacers (Fig. 3.7a) were placed on end posts facing centre. And the holder 
was set on the four corner posts resting on spacers above base. 
 
Fig. 3.7a Assembly of the capsule making equipment 
 
Loading:  Capsule shells were manually separated and the longer halves were placed 
in the holes, making sure the top of the shells were below the surface of the holder 
(Fig. 3.7b). 
 
Fig. 3.7b Loading of the capsule making equipment 
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Filling:  The calcium citrate powder was loaded on to one side of the holder and 
spread evenly with a flat card provided with the equipment, filling all capsules to the 
maximum limit (Fig.3.7c). 
 
Fig. 3.7c Filling of the capsule making equipment 
 
Tamping: A tamper was then used to simultaneously pack the contents of the 
capsules and remove excess powder from the surrounding area on the holder  
(Fig. 3.7d). Each session was tampered and refilled twice to maintain similar packed 
volume and achieve maximum filled weight capacity.  
 
Fig. 3.7d Tamping of the capsule making equipment 
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Capping: The spacers were then turned 90°. This makes the holders fall down 
exposing the upper half of filled capsules. Top caps were then fixed manually to 
each capsule (Fig. 3.7e) and the ready capsules tapped and removed from holder and 
stored in airtight containers.  
 
Fig. 3.7e Capping of the capsules 
 
Once capsules were made, a random selection of 10 capsules from each batch was 
weighed individually on a beam balance (Adam PGL precision balance) and weight 
recorded for variance. Similarly, the variance for between batches was calculated 
and adjusted for. A total of 26 batches per intervention were made.  
 
3.2.7b Placebo capsules 
Micro crystalline cellulose (Avicel PHlOP, Honeywell and Stein, Surry, UK) was 
used as placebo. Microcrystalline cellulose is indigestible and widely used in 
research as placebo (Kalliomäki et al., 2001, Walter et al., 2000). The physical 
properties of the cellulose made it ideal as the two sets of capsules (calcium citrate 
and placebo) were indistinguishable from each other. This was „sight‟ tested on 10 
individuals prior to being used in all the interventions. The method of preparation of 
81 
 
the placebo capsules was the same as described in 3.2.7a for the calcium citrate 
capsules. the weight of the placebo capsules were participanted to the same variance 
testing as the calcium citrate capsules for within and between batch weights of 
individual capsules. Further, the variance between the placebo and the calcium 
citrate tablets was calculated for weight parity among all capsules.  
 
3.2.7c Conditions for ingestion 
All participants were asked to ingest 2 capsules (1090 mg calcium citrate [one 
capsule content] contains 259 mg of elemental calcium) x 2 times /d with water or 
fruit juice in a post prandial state of at least 20 min as there is conflicting data on 
influence of meal conditions on the absorption of calcium in the gut (Heaney et al., 
1990b, Smith et al., 1987). The load of calcium dictates absorption rates in most 
healthy individuals and a 400-500 mg load is considered as optimal for maximum 
absorption (Heaney et al., 1990a) and thus a single dose of ~518 mg was given twice 
per day. The participants were also instructed to not consume these at least 60 min 
prior to their training. This was to avoid any beneficial effect of citrate on 
performance (Potteiger et al., 1996, Oöpik et al., 2003, Kowalchuk et al., 1989).  
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3.3 Testing protocols  
3.3.1 Testing conditions 
In order to minimise within-participant variation, each participant reported for 
testing at the same time of the day for each trial after a fasting period ranging from 4 
to 12 hours. Participants were also instructed to refrain from alcohol and caffeine for 
24 hours prior to each trial and to be adequately hydrated. They also wore similar 
clothing and the same footwear on each testing occasion. The SRM ergometer was 
set in the same position in all the tests by recording the individual settings at each 
adjustment point (Fig. 3.8).  Room temperature for testing was recorded and used as 
part of calculation in spiroergometry analysis. Participants were also asked to refrain 
from training on the test days and most included the test as their training session for 
the day. This enabled maintenance of a high level of protocol adherence without 
demanding unreasonable lapses in training schedules. 
 
Fig. 3.8  Schematic representation of the cycle ergometer set-up measurements for each 
participant (Wooles et. Al., 2003). 
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3.3.2  W peak (aerobic) Test (Study 2 and 3) 
A peak min-power test according to the ramp test protocol defined by the British 
Cycling Federation (BCF) v1.6 (Wooles et al., 2003) was used in study 2. This test 
was performed on a stationary electromagnetically braked cycle ergometer (SRM 
ergometer; Schoberer Rad Messtechnik, Jülich, Germany). After a 5-15 min warm 
up at workloads selected by the participants the test was commenced.  The gear 
setting was standardised for all athletes at 9. The starting wattage was determined by 
the body mass of the athlete (BCF guidelines, Wooles et al., 2003) and ramp rate was 
set at 20 W/min until volitional exhaustion. Gas exchange data was collected 
throughout the test, in addition to the power profile and HR. All variables were 
averaged every 10 sec and Wpeak (aerobic) was determined as the average power on the 
last completed stage. 
 
3.3.3 Time Trials (TT) 
All tests were carried out with at least three days between each testing both the 
placebo and the intervention phases of the trial. The tests began with the riders 
emptying their bladder, body mass being recorded and used to determine relative 
oxygen consumption in the gas exchange data collection. Resting blood samples 
were then collected before a self selected warm up protocol was allowed for all the 
participants. There were no restrictions with respect to time and intensity of the 
warm up phase. When the participants were ready to start they assumed their riding 
position, the computer screens with all measurement displays of power output, HR, 
gas exchange and time elapsed were turned so that the riders had no view of them. In 
addition the power control monitor on the cycle ergometer was also shielded. 
84 
 
However, they were allowed to know any one of the following parameters: cadence, 
HR or time elapsed during the test. And the same one parameter was then disclosed 
to them for all the subsequent time-trials. 
The tests were performed on the „open ended‟ setting of the SRM ergometer with a 
self-selected cadence. Four TT were conducted in total - a 10 mile baseline test 
(10TTB), a 25 mile baseline test (25TTB) and these were then repeated following the 
intervention, a 10 mile post-calcium test (10TTC) and 25 mile post-calcium test 
(25TTC). Gas exchange data was collected throughout; capillary blood samples were 
taken every 5 min for the 10 TT and 20 min for the 25 TT for analysis of lactate, 
glucose, and NEFA. Data was averaged at 5 min interval for the 10 TT and 20 min 
intervals for the 25TT. Water was allowed ad libitum throughout the tests. No verbal 
or other forms of encouragement were given during any tests. 
 
Plate 3.1 Laboratory set up for study 2 and 3 
 
 
Metalyser 3B 
set up 
Computer set up 
SRM software. 
SRM ergometer 
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3.4 Justification for chosen Methodology 
3.4.1 Seven day diet diary (unweighed)  
Recorded food diaries are usually used for individual dietary data collection (Morgan 
et al., 1978). A dietary record of seven consecutive days or 20 consecutive meals has 
been reported as the least amount of time needed for an accurate report of the 
individual‟s eating habits (Leverton and Marsh, 1939). The seven day diary is 
considered to be better than other forms of recall such as 24 hour diet recall or even 
shorter periods of recorded diaries (Young, 1981). However, it has many confounded 
issues that must be highlighted in order to make a realistic judgement on the 
recordings of the participants in this study. Content validity has been fervently 
discussed in the literature on recording dietary patterns. The Hawthorne effect of 
recording food has been a particular bane for most scientists. In order to study 
“actual” intake (observed without the knowledge of the participant) against that of 
“recorded” intake, the persistent issue of ethical considerations may in effect create 
barriers in maintaining true validity. In fact Young (1981) argues that “true validity” 
cannot be measured in such scenarios. Moreover, it is imperative to remember that a 
diet record is not a true estimation of nutrient status (Young, 1981). It can however 
be assumed that if dietary intake is adequate then the person is also likely to be 
sufficient in nutrients (Bingham et al., 1997).  
Not much has been published on athlete habits of recording diet history compared to 
the general population. There are a few studies reporting the differences in nutrient 
intakes between these populations (Grandjean, 1989) but not on how they differ in 
the reporting of these intakes. Past experience of the author of working with athletes 
both elite and recreational has led to the assumption that under reporting is less of a 
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concern in this population. The key difference being that, athletes are motivated to 
understand their nutrition and are generally motivated by any aspect of their habits 
that may achieve better performance. When the participants in these studies were 
explained how the accuracy of their reporting affected the accuracy of the analysis, 
they were further motivated to provide accurate reports of their eating patterns. But 
as discussed above the limitations of a dietary recall means that the data presented in 
this thesis is likely to be inflicted by such errors.  
 
3.4.2 Quantification of training via TRIMP 
There are several methods described in the literature for quantifying training, such as 
MET equivalents (Ainsworth et al., 2000), lactate threshold zones (Janssen, 2001) 
and various other forms of multiplicative factors that identify training intensity and 
volume such as those based on RPE and HR. Physical activity logs are considered to 
be quite suitable over periods of several days and weeks over other methods such as 
observational and physiological techniques (Hopkins, 1998). Hopkins (1998) also 
warns against collecting too much detail in order to not overwhelm both the 
participant and the researcher. The most prevalent model of quantifying training in 
sports is the Fitness-Fatigue model championed by Banister et al. (1975). This model 
uses HR to quantify training (input) in order to assess performance (output). But the 
issue with the Banister et al. (1975) model is that it does not take into account 
intensity of training which may have a huge impact on performance and indeed 
recovery. Thus the HR zone multiplier suggested by Foster et al. (2001) seemed 
more appropriate in this instance where the participants were involved in a variety of 
different training protocols that may have impacted on their performance during  the 
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laboratory testing four weeks apart. But the limitation of this method is that it relies 
on HR which has been shown to have great intra-variability (Aubert et al., 2003) and 
also it has been shown that the TRIMP method may have some limitations in terms 
of quantifying weight training and other such related activities (Foster et al., 2001). 
But since most the participants at least in study 2 and 3 performed a majority of their 
training as a variant of a cycling based session this did not pose a great problem. 
Moreover, most also had HR monitors in addition some had detailed power output 
and other training date available to hand. Those who did not posses a HR monitor 
were loaned one from the laboratory facilities. Overall, for the purpose of this 
investigation, in order to log a mean training pattern of the participants and not 
interfere with any prescriptive training, the TRIMP method to quantify their training 
was deemed valid and suiTable. 
 
3.4.3 Time Trials  
To evaluate the performance ability of endurance athletes, it is necessary to use 
laboratory based tests that are reliable, valid and sensitive to small changes in the 
athlete‟s abilities to perform a particular task (Hopkins et al., 1999). This is 
particularly important when performing repeated measures and when laboratory data 
needs to be applied to the field to predict actual performance. To investigate the 
relationship between physiological variables measured during a laboratory test with 
field based cycling performance, studies have used time to complete time trials as a 
criterion measure (Coyle et al., 1991, Hawley and Noakes, 1992, Miller and 
Manfredi, 1987, Palmer et al., 1996) which has shown good correlations with actual 
performance in race times. Coyle et al. (1991) have demonstrated a close association 
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between performance during an actual 40 km time trial and one hour laboratory test, 
indicating that use of such protocols simulate actual time trials reasonably well and 
therefore these tests in the laboratory generally reflect the demands during a race 
event. This is not surprising considering that in contrast to most laboratory based 
tests; TTs present a unique experience during which the athlete‟s power output  
(i.e. exercise intensity) is freely chosen thus closely simulating race conditions. 
 
3.4.4 Gross Efficiency (GE) as a measure to study metabolic changes due to 
calcium supplementation  
One of the main variables that will be used to evaluate the ergogenic effect of 
supplemental calcium is the surrogate measure of the chemomechanical property, 
efficiency. The basic definition of gross efficiency (GE) is the ratio of work done 
during the specific activity to the total energy expended and expressed as a 
percentage (Sidossis et al., 1992). Muscular efficiency in studies 2 and 3 has been 
expressed in the form of GE from whole body measurements of V O2 during the TT. 
It is important to discuss the assumptions and the limitations of this approach.  
GE estimates were dependant on the validity of estimating energy expenditure from 
whole body V O2. Although whole body respiratory gas exchange can be measured 
very reliably, it is difficult to determine what percentage of the TEE contributes to 
actual physical work accomplished as opposed to the energy expended for other 
bodily processes including stabilization and limb movement. Grasser and Brooks 
(1975) and then later Stainbsy et al. (1980) suggested baseline subtractions to 
determine net efficiency. This is to prevent the essentially linear relationship 
between work rate and energy expenditure to make it appear that efficiency increases 
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with work rate. Therefore the main aim of baseline subtraction is to establish a 
measure that refers to the efficiency of muscle contraction in-vivo. Net efficiency 
(NE) where the baseline is the energy expended at rest and work efficiency (WE) 
where the baseline is the energy cost of unloaded cycling (typically 5 kJ/min) 
(Stainbsy et al., 1980). Ettema and Lorås (2009) argues that while this procedure 
may be relatively simple in engineering, it is not so in biology because of the many 
interactions and interdependences between physiological systems. By using baseline 
subtractions one implicitly assumes that the processes related to resting metabolism 
are independent, constant and essentially isolated from the processes of doing work 
(Moseley and Jeukendrup, 2001). It may be incorrect to assume that the energy cost 
of baseline processes is unaffected by the work rate during exercise (Ettema and 
Lorås, 2009). One can argue that is precisely why GE increases with work rate 
because of the diminishing effect of offset (baseline) metabolism. 
Another approach to quantify muscular efficiency of work rate that could be applied 
is to divide the total work rate into internal and external work (WE). Internal work is 
the work necessary to move the body segments relative to the body‟s centre of mass, 
i.e. changes in the relative kinetic and potential energy of the segments. The cost of 
body segment movement energy changes is generally measured by determining 
energy cost for zero work rate (Hintzy-Cloutier et al., 2003). By measuring energy 
cost of unloaded movement (graded work rate protocol at the same cadence in case 
of cycling), the assumption is that all internal work is dissipated into heat because 
the circumstances do not allow for external work. But studies measuring metabolic 
cost of zero work rates have shown that moving lower extremities passively, 
metabolic rate increases significantly (Nobrega et al., 1994). Other studies report that 
muscle activity in unloaded cycling is extremely low and can hardly account for the 
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total increase in metabolic rate 240-450 W at zero external work at 60-120 rpm 
(Ettema and Lorås, 2009; Siddossis et al., 1992). This may indicate that other 
processes than simply the active limb movements also affect metabolic rate. Some of 
the possible contributing factors suggested in the literature range from coordination 
challenges (Neptune and Herzog, 1999), enhanced heart and ventilation rates (Aaron 
et al., 1992) and muscle activity (Bell et al., 2003). Since the metabolic rate at 
unloaded cycling is the sum of resting metabolic rate and the metabolic rate required 
for doing internal work, and as seen from the above arguments, these measurements 
neglect the inter-dependence in the physiological system for measuring muscular 
efficiency in whole body movements. Even though it is generally agreed that GE is a 
poor measure of the efficiency of muscular work  (Moseley et al., 2004), it has been 
suggested the GE is a better measure of whole body efficiency (Ettema and Lorås, 
2009).  
Since calcium changes in the cellular compartments are closely linked to changes in 
ionic concentrations of blood calcium levels. Changes in dietary calcium may have 
an effect on various tissue concentrations of calcium such as adipose tissue (Zemel, 
1998), muscle tissue (Russell et al., 1984) and metabolic changes in both these 
tissues may affect performance and efficiency via changes in physiological 
environment that regulates homeostasis. So if any efficiency gains are achieved 
through the “non-performance” related changes in efficiency of use of substrates or 
changes in flux of metabolites in the muscle cells may be better detected via 
measurements of GE. Especially as variation of GE is half that of DE, suggesting 
that smaller changes in efficiency may be better detected in GE than DE (Moseley 
and Jeukendrup, 2001). Although, Coyle et al. (1991) has suggested that delta 
efficiency (reciprocal slope of the linear relationship between energy expenditure 
91 
 
and work rate) as a more valid estimate of muscular efficiency, another study 
(Moseley and Jeukendrup, 2001) has showed this to be less reliable than GE. 
Therefore the use GE can be used as a close surrogate measure in quantifying the 
various systems that may have been involved in the metabolic processes that could 
be affected by the interaction of supplementary calcium and the ensuing metabolic 
changes. In addition, measures have been taken to further accommodate the 
reliability of the data by studying closely matched well-trained participants.  
GE was calculated by dividing the external power output by the metabolic power 
output (Cooke, 2004), where –  
External Power output (W) =  Force (N) X Distance (m) / Time (s) and  
Metabolic work-rate (W) =  (V

O2 l/min) X 348.8 
Thus % of GE =      [(Force X Distance) / Time]    X 100
 
V O2 (l/min) X 348.8 
 
3.4.5 Validity of substrate oxidation rates calculated from RER measurements. 
Estimation of energy expenditure by indirect calorimetry is based on the assumption 
that heat production within the body occurs by aerobic processes. Since the products 
of anaerobic metabolism have to be oxidised after a few seconds (e.g. lactate) this 
assumption is not invalid. During exercise however, some assumptions on heat 
production need to applied in the light that all energy produced by oxidation of 
substrates might not be released as heat due to some storage as potential energy in 
order for external work to be maintained (Frayn and Macdonald, 1997). Also energy 
expenditure calculated as a measure of constant rate of energy release per litre of 
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oxygen consumption has a larger proportion of error compared to energy production 
calculated as a sum of different substrates used. Rate of energy release from different 
macronutrients is different. For example protein is 19.48 kJ/l of O2 and  
21.12 kJ/l of O2 for carbohydrates. Therefore an intermediate value of 20.3 kJ/l of O2 
can produce an error up to 4% (Frayn and Macdonald, 1997). Thus, calculations 
based on energy equivalents of the oxygen consumed to the carbon dioxide produced 
for macronutrients seem more appropriate. The smaller variation calculated in 
energy released during the oxidation of the same substrates such as glucose (20.84 
kJ/l of O2) than of starch or glycogen (21.12 kJ/l of O2) leads to an error of ≤ 1% 
(Frayn and Macdonald, 1997). Frayn (1983) has provided stoichiometric equations 
for calculations of net substrate oxidation rates from gas exchange measurements. 
These are -  
CHO oxidation = 4.55 V CO2 – 3.21 V O2 – 2.87 n 
Fat oxidation = 1.67 V O2 – 1.67 V CO2 – 1.92 n 
Where n = grams of urinary nitrogen per min  
This method has several limitations that should be considered in the interpretation of 
the data. First the gas exchange measurements are a reflection of the different 
simultaneous biochemical processes which may have offsetting results on the 
calculation of substrate oxidation rates. For example, both gluconeogenesis from 
amino acids and ketogenesis produce a respiratory quotient below 0.7 (Frayn, 1983). 
These circumstances will result in the underestimation of carbohydrate oxidation. 
Second, urinary nitrogen excretion during exercise is probably not an accurate 
reflection of protein oxidation because exercise alters renal perfusion. This may 
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change the renal clearance rate of urea. However because the contribution of protein 
oxidation to total energy metabolism is small in exercise, an error in the 
quantification of protein oxidation will not significantly affect the calculation of 
carbohydrate and fat oxidation. The substrate oxidation rates were calculated 
assuming that nitrogen excretion would remain constant during rest and exercise 
(Carraro et al., 1990). As suggested in the literature the values of nitrogen excretion 
for the purpose of calculations was assumed to be maintained at 135 µg/kg/min 
(Romijn et al., 2000). 
Third, indirect calorimetry relies on the assumption that pulmonary gas exchange 
reflects the rate of oxygen consumption and carbon dioxide production at the tissue 
level (Jansson, 1982). This is probably true for oxygen consumption because there 
are no large stores of oxygen in the body. However carbon dioxide production as 
measured by analysis of expired air is a reliable estimate of tissue carbon dioxide 
production only if the large bicarbonate pool is stable (Sutton et al., 1981). But 
exercise above the ventilatory and blood lactate thresholds result in a compensatory 
depletion of the bicarbonate pool the extent of which depends on the intensity and 
duration of exercise in that case carbon dioxide production as estimated by 
measurements of expired air is composed of both tissue carbon dioxide production 
and carbon dioxide derived from the bicarbonate pool (Lamb and Gisolfi, 1988). 
This will result in erroneously higher values of carbohydrate oxidation as calculated 
by indirect calorimetry. Even at exercise levels below the lactate threshold 
bicarbonate kinetics are markedly altered (Heigenhauser and Jones 1991, Sutton et 
al., 1981). The margin of error would be higher at higher exercise intensities of 
exercise.  
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And thus even though it is not possible to prove conclusively the share of each 
substrate in energy production during rest and exercise using respiratory gas 
exchange measurements, studies using stable isotopes have provided some validity 
on the reliability of this method (Romijn et al., 2000, Phillips et al., 1996, Schoeller, 
1988).  
 
3.5 Statistical analysis 
Descriptive data and all related analysis of significance were generated using PASW 
(Predictive Analytics SoftWare) Statistics Version 17 (SPSS Inc., Illinois, USA). 
Significance level was set at 95% confidence intervals (CI) (p < 0.05).  
Data are represented as measures of centrality and spread (mean ± standard deviation 
(SD)). Uncertainty in the estimates of effects is expressed as 90% confidence 
intervals (CI). 
Mean differences were compared using paired t-tests and differences of means 
between trials and within trials were analysed using factorial repeated measures 
design. Mauchly‟s sphericity test was conducted to determine if the assumption for 
sphericity of the data was met. If this was violated (p < 0.05) the F value was 
corrected by reporting significance of the Greenhouse-Geisser test.  Main effect for 
time, main effect for trials and interaction between trials*time was used to detect 
statistical significance at each time point and across each trial respectively. The 
Bonferroni post-hoc test was used to report where these statistical differences were 
observed. Where appropriate, Pearson‟s correlation (r) was performed to compare 
the relationships between variables. Magnitudes of inferences were calculated using 
Cohen‟s d and where appropriate reported along with p values.  
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The degree of heteroscedasticity of the incremental test data was determined by 
calculating Pearson‟s product moment correlation coefficients (R2) between the 
difference and the average value of the physiological variables in the incremental 
tests. 
Bland-Altman plots were produced to determine the repeatability of gas exchange 
and power output data. The reporting of the Limits of Agreement (LoA) is 
represented by systematic bias (mean difference of two measurements) and random 
error (standard deviations of the mean difference). LoA were calculated and plots 
produced with 95% CI (1.96 x SD) only if the data satisfied conditions that the test-
retest differences among participants were normally distributed, and if the test and 
retest means were not significantly different and if there was no significant 
relationship between test-retest differences and test-retest means (Lamb, 1998).  
All reliability statistics are presented as %CV and/or change in mean, typical error 
(TE) and Pearson‟s product moment correlation coefficient with 95%LoA where 
appropriate. 
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CHAPTER 4 
EFFECTS OF CALCIUM SUPPLEMENTATION ON SUBSTRATE METABOLISM 
DURING SUBMAXIMAL EXERCISE 
 
4.1 Introduction 
Epidemiological data suggests a positive relationship between increased calcium 
intake and decreased fat and total body mass in healthy people (Barr, 2003; Davies et 
al., 2000). High calcium diets have shown to markedly inhibits lipogenesis (Jones et 
al., 1998; Kim et al., 1996; Xue et al., 1998), accelerate lipolysis (Zemel et al., 
2000), increase thermogenesis and suppress fat accretion and weight gain in identical 
caloric intakes (Shi et al., 2001a; Zemel et al., 2000).  
Recent data from various studies revealed that increased PTH resulting from low 
dietary calcium is associated with increased fat mass in healthy young women 
(Gunther et al., 2006; Gunther et al., 2005). Xue et al. (1998) reported the link 
between increased i[Ca
2+
] and lipogenesis in rat adipose tissue. They suggested that 
the anti-lipolytic effect of i[Ca
2+
] may be mediated by the activation of 
phosphodiesterase 3B (PDE) leading to a decrease in cAMP and hormone sensitive 
lipase (HSL) phosphorylation and consequently inhibition of lipolysis (Xue et al., 
2001). 
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This mechanism is well established in-vitro, although the influence of calcium on 
lipolysis during exercise in humans is yet to be investigated. A positive correlation 
between plasma calcium levels and NEFA oxidation in endurance-trained athletes 
has been reported (Men'shikov, 2004). There are no studies on the effects of long-
term calcium supplementation on substrate metabolism during sub-maximal long 
duration exercise. This first study aims to identify if the in-vitro model can be 
applied in the free living population with co-relatable inferences such as changes in 
body composition. In order to explore the effects of calcium supplementation during 
exercise in humans, it is important to study these effects on a heterogeneous athletic 
population first.  
Therefore, the aim of this experimental trial was to investigate the effects of calcium 
supplementation on substrate metabolism during sub-maximal exercise. These 
investigations were conducted on a mixed gender population of varying training 
status. The study also aims to investigate the effect of calcium supplementation on 
body composition changes of the athletes.  
 
4.1.1 Hypotheses 
i. It is hypothesised that calcium supplementation of 1000 mg/d for four weeks 
results in increased fat oxidation during sub-maximal exercise. 
ii. It is also hypothesised that calcium supplementation of 1000 mg/d for four 
weeks reduces body fat mass of recreationally trained individuals. 
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4.2 Methods  
4. 2.1 Participants  
Nine moderately trained (trained for 1-2 hours/day for 4-6 days/week) participants 
were recruited in this study. Inclusion criteria as described in section 3.1 were met. 
These were recruited from a cohort of sports science students and staff at the 
University of Central Lancashire. All participants were physically active and were 
trained at recreational level. The mean (± SD) physical characteristics of the 
participants are given in table 4.1. 
 
Table 4.1  Mean (± SD) physical characteristics of participants (n = 9) in study 1 
 Age 
(years) 
Weight 
(Kg) 
Height 
(cm) 
V O2peak 
(l/min) 
V O2peak 
(ml/kg/min) 
Wpeak(aerobic) 
(W) 
Mean 
(SD) 
40.56  
± 9.51 
71.33  
± 10.81 
171.8 
± 7.50 
3.17 
± 1.35 
48.10 
± 14.44 
314 
± 94 
 
 
4.2.2 Equipment (not described in Chapter 3) 
 
4.2.2a Lode Excalibur Sport cycle ergometer 
 
A stationary electromagnetically braked cycle ergometer (Lode Excalibur Sport; 
Lode Medical Technology, Groningen, The Netherlands) was used. The ergometer is 
controlled by an external unit allowing for adjustments of work load, rpm, time and 
distance (plate 4.1). The workload can be controlled in isokinetic, hyperbolic and 
linear modes. It uses the same strain gauge principle as described in section 3.2.1a 
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Plate 4.1 The Lode setup 
 
4.2.2b Skinfold measurements and body composition estimation  
 
Skinfold thickness was measured to the nearest 0.5 mm with a calibrated skinfold 
calliper (Harpenden, Body care, Kenilworth, UK) at seven anatomical sites by the 
same trained technician (author). The calliper exerts a constant pressure at varying 
openings of the jaws. The width of the opening is read off on a scale incorporated in 
the apparatus. The seven sites measured were pectoral, mid-axilla, abdominal, 
suprailium, subscapular, triceps and mid-thigh. All measurements were taken on the 
participant‟s right side. Percentage body fat (%fat) values were estimated by two 
different methods.  The seven skinfold site measurements were used to estimate 
body density (Jackson and Pollock, 1978; Jackson et al., 1980), and %fat 
Metalyser 3B  
Lode ergometer 
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subsequently calculated by the Siri equation (Siri, 1956). Muscle mass was estimated 
using the skinfold-circumference model from in-vivo derived equations in Lee et al. 
(2000). 
Reliability of the measurements was established by conducting 3 trials on the seven 
sites mentioned above (n = 11) on consecutive days. Inter-test reliability results are 
presented in table 4.2 by calculating the difference of mean between trial 1 and  
trial 2. 
 
 
Table 4.2  Change in mean, typical error and correlation coefficient of skinfold   measurement. 
Units ± SD (95% CI upper to lower limits)  
  
Change in mean 
 
Typical error 
Correlation 
coefficient 
Pearson‟s (R2) 
PECTORAL 0.26 ± 0.95 (-0.38 to 0.9) 0.69 (0.48 to 1.21) 0.99 (0.97 to 1.00) 
AXILLA 0.64 ± 1.68 (-0.49 to 1.76) 1.21 (0.85 to 2.13) 0.98 (0.93 to 1.00) 
ABDOMINAL 0.23 ± 2.66 (-1.56 to 2.02) 1.93 (1.35 to 3.39) 0.98 (0.94 to 1.00) 
SUPRAILIUM -0.53 ± 1.61 (-1.61 to 0.55) 1.17 (0.81 to 2.26) 0.99  (0.94 to 1.00) 
SUBSCAPULAR 0.73 ± 2.29 (-0.81 to 2.26) 1.66 (1.16 to 2.91) 0.95 (0.82 to 0.99) 
TRICEPS -0.20 ± 1.18 (-0.99 to 0.59)  0.85 (0.60 to 1.50) 0.98 (0.94 to 1.00) 
MIDTHIGH -0.26± 1.20 (-1.07 to 0.54) 0.87 (0.61 to 1.53) 0.99 (0.96 to 1.00) 
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4.2.3 Experimental design  
The study was designed as a randomised, double blind, placebo controlled crossover 
intervention. Participants were assigned to either a placebo (Pl) or calcium 
intervention (Ca) group at the start of the study, with a subsequent crossover 
following a four week 'wash out' period. Randomisation was achieved by placing the 
first participant enrolled in the trial A group as first order, followed by the second 
participant in the trial B group as first order. This was repeated until optimal 
recruitment number was achieved. The researcher (author) was not privy to the 
randomisation. This allowed for even number recruitment in each group from the 
start of the experiment and enrolment to the trial was on a continuous rolling basis.  
The formulation procedure for both the calcium and the placebo capsules is 
described in section 3.2.7. The timeline of the supplementation schedule is depicted 
in fig 4.1. Each phase of the intervention lasted for four weeks, with baseline 
measurements and testing performed at the start and finish of both phases of the 
intervention. 
 
 
Fig. 4.1 Schematic representation of the experimental design in study 1 
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4.2.4 Testing protocols 
 
4.2.4a Wpeak (aerobic) test 
All participants underwent a Wpeak (aerobic) test one at a time. Participants reported to 
the laboratory in a post prandial state of at least one meal consumed about 60 to 90 
min prior to testing. An incremental continuous protocol was used to elicit the peak 
volume of oxygen uptake (V O2peak) and peak aerobic power production (W peak 
(aerobic)). After a 5-10 min warm up on a self-selected load and cadence the 
participants performed a continuous incremental test on a cycle ergometer (Lode 
Excalibur Sport; Lode Medical Technology, Groningen, The Netherlands) starting at 
a 180 W and increasing by 5 W every 10 sec until volitional exhaustion. The 
participants pedalled at a consistent self-selected cadence (55-110 rpm). The seat 
height and handlebar position were adjusted to each participant‟s personal 
preference. This particular protocol was chosen in study 1 as the participant 
demographics varied widely (table 4.1). Even though it did not allow for steady state 
measurements of gas exchange at every submaximal stage it was better suited to 
those who were not used to maximal tests and/or very high intensity protocols as it 
allowed for valid determination of peak oxygen uptake values (Astrand and Rodahl, 
1986). Gas exchange data was recorded throughout using the Cortex Metalyzer 3B 
laboratory Breath-by-Breath spiroergometry System and blood indices for lactate 
concentrations was measured as per section 3.2.4b at rest, beginning of the 
incremental test, end of every 2 min and the last measurement at test termination.  
V O2peak was accepted as the highest observed value provided that there was ≤ 2 ml 
/kg/min increase in V O2 uptake with increasing workload or the participant 
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volitionally terminated the test. All gas exchange data was averaged for a 10 sec time 
period which was then used to calculate V O2peak and end wattage (Wpeak) at the last 
completed min was averaged and recorded. The POpeak determined at the last 
completed stage before accepting the V O2peak values was then used to set the 50% 
maximal intensity load.  
 
4.2.4b Steady state 50% Wpeak (aerobic) protocol 
A 60 min 50% Wpeak protocol was used to study substrate metabolism during a sub-
maximal exercise. This protocol was selected to elicit maximum fat oxidation rates 
(Achten et al., 2002). Participants adhered to conditions described in section 3.3.1 
before commencing the test on a cycle ergometer (Lode Excalibur Sport; Lode 
Medical Technology, Groningen, The Netherlands). The set-up of the ergometer was 
kept same with regards to saddle height and handlebar angles as in the incremental 
test. A 5 min warm up was allowed before commencing the actual test. The cycle 
ergometer was set at a wattage that corresponded to 50% Wpeak values from the 
incremental test. HR was monitored throughout to ensure that the required intensity 
was maintained by cross referencing those values with that of the incremental tests 
and predicted HR values. 
Gas exchange (Cortex Metalyzer 3B laboratory Breath-by-Breath spiroergometry 
System Cortex Biophysik GMBH, Version ML3B 2.1) data was collected 
throughout. All data was averaged at 60 sec intervals for analysis. One venous blood 
sample as described in section 3.2.4a was taken prior to the start of the test for 
analysis of iPTH and capillary blood samples taken as described in section 3.2.4b for 
analysis of lactate, total plasma calcium, plasma triacylglycerides, plasma glucose 
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and NEFA every 20 min just before recording an RPE score till test termination. 
Water was allowed ad-libitum throughout the tests. No verbal or other forms of 
encouragement were given during the tests. 
 
4.2.4c Dietary and physical activity records 
All participants were asked to keep a seven day diet diary and physical activity log 
as described in section 3.2.6a during any typical week of the intervention and were 
asked to repeat the same in the following intervention. The timeline for testing 
variables are represented in a schematic diagram in fig 4.2. 
 
Fig. 4.2 Schematic representation of the experimental protocol within each intervention 
 
4.2.4d Statistical analysis 
All data was analysed and statistical analysis conducted as described in section 3.5. 
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4.3 Results  
4.3.1 Anthropometry 
Mean change in anthropometric values from the placebo trial are presented in  
table 4.3. There was no statistically significant change in total body mass (p = 0.12), 
lean mass (p = 0.33) or fat mass (p = 0.10) after the Pl2. 
 
Table 4.3 Mean (± SD) anthropometric changes in participants (n = 9) of study 1 in the 
placebo trial before (Pl1) and after (Pl2) four weeks 
n = 9 
Pl1 
(mean ± SD) 
Pl2 
(mean ± SD) 
Difference; 
± 90%CI 
(d) 
Total Mass (kg) 71.74 ± 10.8 71.50 ± 11.35 -0.24; ± 0.33 -0.02 
BMI (kg/m
2
) 24.25 ± 2.43 24.17 ± 2.40 -0.08; ± 0.03 -0.01 
Fat Mass (kg) 18.00 ± 5.90 18.10 ± 5.02 0.10; ± 0.91 0.02 
Lean Mass (kg) 53.74 ± 9.84 53.40 ± 9.87 -0.34; ± 0.03 -0.03 
 
 
 
Mean anthropomentric changes after the calcium intervention are presented in  
table 4.4. After the Ca2 trial there was a statistically significant decrease in fat mass 
(p = 0.02). There was a statistically non-significant loss of mean total body mass  
(p = 0.09) and a statistically non-significant increase in lean mass (p = 0.08) after 
four weeks of calcium supplementation.  
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Table 4.4 Mean (± SD) anthropometric changes in participants of study 1 in the calcium 
trial before (Ca1) and after (Ca2) four weeks 
n = 9 
Ca1 
(mean ± SD) 
Ca2 
(mean ± SD) 
Difference; 
± 90%CI 
(d) 
Total Mass (kg) 73.72 ± 11.3 73.40 ± 10.60 -0.32; ± 0.75† -0.02 
BMI (kg/m
2
) 24.92 ± 2.38 24.81 ± 2.13 -0.11; ± 0.21 -0.05 
Fat Mass (kg) 18.59 ± 4.80 18.00 ± 5.21 -0.59; ± 0.42* -0.20 
Lean Mass (kg) 55.13 ± 8.84 55.40 ± 9.87 0.27; ± 1.07† 0.04 
*significant at p < 0.05 †approaching significance at p ≤ 0.10 
 
Further analysis revealed that the changes in anthropometric values showed different 
trends in recreationally trained (n = 4) sub-group compared to the well-trained  
(n = 5). The mean anthropometric changes during the placebo trial in recreational 
participants are presented in table 4.5. Total mass (p = 0.07) and fat mass (p = 0.08) 
increased during the four weeks; however these changes were not statistically 
significant.    
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Table 4.5 Mean (± SD) anthropometric changes in recreationally trained participants of 
study 1 before (Pl1) and after (Pl2) placebo intervention for four weeks 
n = 4 
Pl1 
(mean ± SD) 
Pl2 
(mean ± SD) 
Difference; 
± 90%CI 
(d) 
Total Mass (kg) 64.34 ± 8.03 65.37 ± 7.41 1.03; ± 0.62† 0.13 
BMI (kg/m
2
) 23.35 ± 2.33 23.72 ± 2.08 0.37; ± 0.25 0.08 
Fat Mass (kg) 20.17 ± 4.05 21.44 ± 4.76 1.27; ± 0.71† 0.23 
Lean Mass (kg) 44.17 ± 5.44 43.93 ± 2.63 -0.24; ± 2.82 0.03 
†approaching significance at p ≤ 0.10 
 
The mean changes in anthropometric values after the calcium trial in the 
recreationally trained athletes are presented in table 4.6. Mean total mass (p = 0.27) 
and mean BMI (p = 0.17) decreased non-significantly along with lean mass  
(p = 0.08) but fat mass showed a trend to increase (p = 0.07). 
Table 4.6 Mean (± SD) anthropometric changes in recreationally trained participants of 
study 1 before (Ca1) and after (Ca2) calcium intervention for four weeks 
n = 4 
Ca1 
(mean ± SD) 
Ca2 
(mean ± SD) 
Difference; 
± 90%CI 
(d) 
Total Mass (kg) 64.01 ± 8.13 63.52 ± 8.26 -0.49; ± 0.13 -0.12 
BMI (kg/m
2
) 23.23 ± 2.18 23.05 ± 2.22 -0.18; ± 0.04 -0.10 
Fat Mass (kg) 19.41 ± 8.04 19.73 ± 6.08 0.32; ± 1.95† -0.06 
Lean Mass (kg) 44.60 ± 4.45 43.79 ± 4.29 -0.81; ± 0.16† -0.26 
†approaching significance at p ≤ 0.10 
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The mean anthropometric changes in the well trained athletes during the placebo trial 
are presented in table 4.7. There were no statistically significant changes in the body 
composition in this trial. However, mean total mass (p = 0.10) and BMI (p = 0.08) 
increased, but did not reach statistical significance. 
 
Table 4.7  Mean (± SD) anthropometric changes in well trained participants of study 1 
before (Pl1) and after (Pl2) placebo intervention for four weeks 
n = 5 
Pl1 
(mean ± SD) 
Pl2 
(mean ± SD) 
Difference; 
± 90%CI 
(d) 
Total Mass (kg) 77.20 ± 9.34 78.15 ± 9.61 0.95; ± 0.26† 0.10 
BMI (kg/m
2
) 24.92 ± 1.65 25.23 ± 2.25 0.31; ± 0.60† 0.14 
Fat Mass (kg) 16.14 ± 4.26 16.45 ± 5.20 0.31; ± 0.94 0.06 
Lean Mass (kg) 61.06 ± 5.31 61.70 ± 3.91 0.64; ± 1.41 0.14 
†approaching significance at p ≤ 0.10 
 
Body composition changed significantly after four weeks of calcium 
supplementation in the well–trained atheletes (Table 4.8).  There were statistically 
significant changes in total body mass (p = 0.03), fat mass (p = 0.02) and BMI  
(p = 0.03). 
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Table 4.8 Mean (± SD) anthropometric changes in well trained participants of study 1 
before (Ca1) and after (Ca2) calcium intervention for four weeks 
n = 5 
Ca1 
(mean ± SD) 
Ca2 
(mean ± SD) 
Difference; 
± 90%CI 
(d) 
Total Mass (kg) 75.79 ± 9.26 76.83 ± 10.02 1.04; ± 0.76* 0.11 
BMI (kg/m
2
) 24.47 ± 2.25 24.80 ± 2.01 0.33; ± 0.24* 0.18 
Fat Mass (kg) 16.20 ± 5.20 15.43 ± 4.87 -0.77; ± 0.33* -0.14 
Lean Mass (kg) 59.59 ± 3.97 61.40 ± 5.66 1.81; ± 1.69 0.31 
*significant at p < 0.05  
 
 
 
4.3.2 Nutritional intake analysis  
The mean variance in energy intake of the participants in both the trials during four 
weeks of calcium supplementation was 2.88% (Table 4.9). The mean variance in 
energy intake of the recreationally trained athletes was 2.66% (Table 4.10) and of the 
well-trained athletes was 2.65% (Table 4.11).  The contribution of the various 
macronutrients to the energy intake is presented in Fig. 4.3 as a mean of all 
participants, Fig. 4.4 for the recreationally trained participants and Fig. 4.5 for the 
well-trained participants. 
Mean calcium intake of all individual participants in the study was at least 700 mg/d 
(COMA, 1991). The variance between the calcium consumption in the two trials of 
each participant was not significant (p = 0.12) (appendix J).  
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Table 4.9  Mean (± SD) nutrient intake in participants of study 1 
 
n = 9 
Trial Pl 
Mean ± SD 
Trial Ca 
Mean ± SD 
%CV 
Energy (MJ/d) 
 
8.3 ± 1.5 
 
8.3 ± 1.3 
 
2.88 
Total carbohydrates (g/d) 259 ± 72 257 ± 68 
 
4.36 
Total fat (g/d) 59 ± 8 
 
60 ± 9 
 
3.26 
Protein (g/d) 85 ± 17 
 
84 ± 15 2.81 
Alcohol (g/d) 12  ± 9 11  ± 7 16.06 
Calcium (mg/d) 770 ± 97 
 
772 ± 114 
 
2.40 
Vitamin D (µg/d) 2.85 ± 1.34 2.80 ± 1.24 8.98 
 
 
Fig. 4.3 Mean macronutrient intake in participants of study 1 as a percentage of energy 
intake (n = 9) 
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Table 4.10  Mean (± SD) nutrient intake in recreational participants of study 1 
n = 4 
(recreational) 
Trial Pl 
Mean ± SD 
Trial Ca 
Mean ± SD 
%CV 
Energy (MJ/d) 
 
7.1 ± 0.94 
 
7.2 ± 0.97 
 
2.66 
Total carbohydrates (g/d) 196 ± 50 197 ± 49 
 
4.67 
Total fat (g/d) 61 ± 5 
 
62 ± 5 
 
4.07 
Protein (g/d) 79 ± 8 
 
79 ± 6 2.14 
Alcohol (g/d) 9 ± 6 8 ± 6 13.53 
Calcium (mg/d) 765 ± 125 
 
768 ± 163 
 
3.82 
Vitamin D (µg/d) 2.81 ± 1.78 2.73 ± 1.52 13.31 
 
 
Fig. 4.4 Mean macronutrient intake in recreational participants of study 1 as a 
percentage of energy intake (n = 4) 
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Table 4.11  Mean (± SD) nutrient intake in well-trained participants of study 1 
n = 5 
(well-trained) 
Trial Pl 
Mean ± SD 
Trial Ca 
Mean ± SD 
%CV 
Energy (MJ/d) 
 
9.3 ± 1.2 
 
9.2 ± 0.9 
 
2.65 
Total carbohydrates (g/d) 310 ± 36 305 ± 32 
 
3.89 
Total fat (g/d) 58 ± 10 
 
59 ± 12 
 
2.57 
Protein (g/d) 90 ± 22 
 
88 ± 19 3.41 
Alcohol (g/d) 15  ± 10 13  ± 7 16.54 
Calcium (mg/d) 774 ± 83 
 
776 ± 79 
 
0.99 
Vitamin D (µg/d) 2.88 ± 1.10 2.86 ± 1.15 5.35 
 
 
Fig. 4.5 Mean macronutrient intake in recreational participants of study 1 as a 
percentage of energy intake (n = 4) 
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4.3.3 Training logs analysis 
The mean TRIMP score over seven days of all the participants in both the placebo 
and calcium intervention trials are presented in Fig. 4.6. The mean daily TRIMP 
scores over the 7 day period were not significantly different (p = 0.10).  
 
 
Fig. 4.6 Mean (± SD) daily load from the seven day training log of participants in both the 
placebo (Pl) and the calcium (Ca) intervention trials (n = 9) 
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The sum load of the seven days, the mean monotony and the strain of the two sets of 
training logs were not statistically significantly different (p = 0.10) and are displayed 
in table 4.12.  
 
Table 4.12  Mean (± SD) quantification of training of the participants during the four weeks of 
supplementation in both the placebo (Pl) and the calcium (Ca) interventions 
Training quantification Trials 
 Pl Ca 
Sum weekly duration (min) 346 ± 185 340 ± 208 
Mean weekly duration (min) 49 ± 26 49 ± 30 
Monotony (mean daily TRIMP/SD) 10 ± 1 9 ± 2 
Strain (total TRIMP ∙ Monotony) 5486 ± 184 5014 ± 252 
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4.3.4 Energy expenditure  
Mean total energy expenditure was significantly higher in the Ca-2 trial compared to 
all others (p = 0.03) (Table. 4.13). 
Table 4.13  Mean (± SD) total energy expenditure of the participants in all the trials 
Total energy 
expenditure 
(kJ) 
Pl-1 Pl-2 Ca-1 Ca-2 
 (mean ± SD) 2292 ± 855 2232 ± 898 2187 ± 1003 2436 ± 1065
*
 
* Significant at p ≤ 0.05 
 
Fig.4.7 shows mean energy expenditure of all the trials over the 60 min period. 
There was no statistical difference between the trials at any time points. 
 
Fig. 4.7 Mean (± SD) energy expenditure during the 50%Wpeak 60 min cycling protocol in the 
placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-2) 
intervention trials (n = 9) 
300
400
500
600
700
800
900
1000
1100
1200
1300
20 40 60
M
ea
n
 e
n
er
g
y
 e
x
p
en
d
it
u
re
 (
k
J)
 
Time (min) 
Pl-1 Pl-2 Ca-1 Ca-2
116 
 
Fig. 4.8 shows the energy expenditure in the placebo trial with values split into 
recreational athlete (n = 4) and well-trained athlete (n = 5) data. There was no 
significant change in mean energy expenditure before and after the placebo trials 
over the 60 min exercise period.  
 
 
Fig. 4.8 Mean (± SD) energy expenditure during the 50%Wpeak 60 min cycling protocol in the 
placebo; before (Pl-1) and after (Pl-2) trial. Split into groups of recreationally trained 
(n = 4) and well-trained (n = 5) 
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Mean energy expenditure over the exercise period of 60 min in the trial after Ca-2 
was not significantly different in both recreational and the well-trained athlete  
(Fig. 4.9) but showed trends towards a higher energy expenditure after calcium 
supplementation (p = 0.08).  
 
 
 
Fig. 4.9  Mean (± SD) energy expenditure during the 50%Wpeak 60 min cycling protocol in the 
calcium; before (Ca-1) and after (Ca-2) intervention trial. Split into groups of 
recreationally trained (n = 4) and well-trained (n = 5) 
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4.3.5 Gas exchange  
4.3.5a Oxygen uptake  
There was no significant difference in the mean V O2 between all the trials 
(Fig.4.10). However, mean V O2 was higher by a mean of 2.98 ± 1.17 ml/kg/min (p = 
0.15) in the first 40 min in Ca-2 compared to all the other trials and dropped to a 
mean increase of 1.37 ± 2.56 ml/kg/min (p = 0.22) in the last 20 min of the exercise 
There was a significant main effect of time on mean V O2 values during all exercise 
time points compared to resting (start) values (p = 0.01). 
 
 
Fig. 4.10 Mean (± SD) oxygen consumption during the 50%Wpeak 60 min cycling protocol in the 
placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-2) 
intervention trials (n = 9) 
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4.3.5b Respiratory Exchange Ratio (RER)  
The RER values at the beginning and during 60 min of exercise in all the trials are 
presented in Fig. 4.11. Two participants displayed excessively high levels of carbon 
dioxide production and were thus excluded from the RER calculations. Following 
calcium supplementation, mean RER showed a downward trend throughout the 
exercise hour compared to the other trials (p = 0.11). However there was a 
significant main effect of time on RER values during exercise compared to the 
values at the start (p = 0.001). Post-Hoc analysis also revealed differences between 
time points 20 and 60 (p = 0.01) and 40 and 60 (p = 0.01) but not 20 and 40  
(p = 0.08). 
 
Fig. 4.11  Mean (± SD) respiratory exchange ratio during the 50%Wpeak 60 min cycling 
protocol in the placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) 
and after (Ca-2) intervention trials (n = 9) 
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Furthermore, when the RER data was split between the recreational and the well-
trained athletes, the downward trend in the RER values was presented by the well-
trained athletes after Ca-2 compared to all other trials (Fig. 4.12). 
 
 
Fig. 4.12 Mean (± SD) respiratory exchange ratio during the 50%Wpeak 60 min cycling protocol 
in the placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-
2) intervention trials in the well-trained participants (n = 5) 
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This downward trend observed in the well-trained athletes was not displayed in the 
recreational participants (Fig. 4.13). Here there was no effect of supplementation on 
the RER values.  
 
 
Fig. 4.13 Mean (± SD) respiratory exchange ratio during the 50%Wpeak 60 min cycling protocol 
in the placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-
2) intervention trials in recreationally trained participants (n = 4) 
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4.3.5c Substrate metabolism 
Mean total energy expenditure (TEE) and proportion of carbohydrate and fat 
oxidation of all the participants are depicted in Fig. 4.14. The difference in the total 
energy expenditure was significantly higher in Ca-2 compared to all the other trials  
(p = 0.03). The proportion of energy expenditure via fat oxidation was larger in the 
Ca-2 (58.8 ± 5.9%) compared to all the other trials (Pl-1: 30.1 ± 14.5%, Pl-2: 40.1 ± 
16.2%, Ca-1: 30.0 ± 12.5%); this was statistically significant (p = 0.02). Mean 
contribution of carbohydrate was significantly lower in the Ca-2 (41.1 ± 5.9%,  
p = 0.03) compared to all the other trials (Pl-1: 69.9 ± 14.5%, Pl-2: 60.0 ± 16.2%, 
Ca-1: 70.0 ± 12.5%). 
 
Fig. 4.14 Comparison of total mean energy expenditure and proportion of CHO (white) and fat 
(black) during the 50%Wpeak 60 min cycling protocol in the placebo and calcium 
(n=9). *significant at p ≤ 0.05 
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When the data was split into the well-trained and recreationally trained subgroups, 
the well-trained group displayed the same trend of increased fat oxidation rates in the 
Ca-2 (52.1 ± 17.9%) compared to the other trials (Pl-1: 21.9 ± 14.8%, Pl-2: 22.8 ± 
22.8%, Ca-1: 26.2 ± 24.16%) (Fig. 4.15). These results did not reach statistical 
significance (p = 0.08). The remaining percentage of energy supplied by 
carbohydrate oxidation displayed the opposite trend of decreased CHO oxidation in 
Ca-2 (47.9 ± 17.9%) compared to the other trials (Pl-1: 78.1 ± 14.8%, Pl-2: 77.1 ± 
22.8%, Ca-1: 86.9 ± 24.16%) (p = 0.07). 
 
 
Fig. 4.15 Comparison of total mean energy expenditure and proportion of CHO (white) and fat 
(black) during the 50%Wpeak 60 min cycling protocol in the placebo and calcium in 
well-trained participants (n=5) 
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There were no differences in total energy expenditure or in the proportion of CHO 
(Pl-1: 53.9 ± 15.8%, Pl-2: 34.0 ± 18.4%, Ca-1: 46.3 ± 18.9%, Ca-2: 33.3 ± 9.9%)  
(p = 0.07) and fat oxidation (Pl-1: 46.0 ± 15.8%, Pl-2: 66.0 ± 18.4%, Ca-1: 54.7 ± 
18.9%, Ca-2: 66.7 ± 9.9%) (p = 0.07) rates in any of the trials with the recreationally 
trained subgroup (Fig. 4.16). 
 
Fig. 4.16 Comparison of total mean energy expenditure and proportion of CHO (white) and fat 
(black) during the 50%Wpeak 60 min cycling protocol in the placebo and calcium in 
recreationally trained participants (n=4) 
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4.3.5d Heart Rate (HR)  
Mean HR at start of the exercise was lower in Ca-2 by 27 ± 11 bpm (p = 0.09) 
compared to the mean HR at the start of all the other trials (Fig. 4.17). Mean exercise 
HR was higher by 10 ± 2 bpm (p = 0.13) in Ca-2 as compared to all the other trials. 
However, resting HR in all trials was significantly (p = 0.001) different from their 
corresponding exercise HR. 
 
 
Fig. 4.17 Mean (± SD) heart rate during the 50%Wpeak 60 min cycling protocol in the placebo; 
before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-2) intervention 
trials (n = 9) 
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4.3.6 Haematological data 
4.3.6a Plasma iPTH  
There was a non-significant decrease in mean resting iPTH levels after Ca-2 
compared to the placebo trials (p = 0.08).  The mean (±SD) values from all the trials 
are displayed in table 4.14.  
Table 4.14 Mean (± SD) resting iPTH at baseline and end of each intervention in study 1. 
 
  Pl-1 
(pmol/l) 
  Pl-2 
(pmol/l) 
  Ca-1 
(pmol/l) 
  Ca-2 
(pmol/l) 
 
Mean ± SD 
 
2.51 ± 1.16 
 
2.77 ± 1.18 
 
2.59 ± 0.75 
 
2.24 ± 1.11 
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4.3.6b Total plasma calcium  
Mean total plasma calcium is presented in Fig. 4.18. Resting plasma calcium was 
lower at the beginning of Ca-1 (1.97 ± 0.32 mmol/l) and Ca-2 (1.95 ± 0.32 mmol/l) 
as compared to the placebo trials (Pl-1 = 2.56 ± 0.27 mmol/l, Pl-2 = 2.54 ± 0.39 
mmol/l; p = 0.10). There were no significant changes in total plasma calcium values 
among all trials and across all time points (p = 0.33). 
 
 
Fig. 4.18  Mean (± SD) total plasma calcium during the 50%Wpeak 60 min cycling protocol in the 
placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-2) 
intervention trials (n = 9) 
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4.3.6c Plasma non-esterified fatty acids (NEFA) 
There was a significant main effect of time in the mean plasma NEFA values at rest 
from those that of exercise in all trials (p = 0.02) (Fig. 4.19). Even though mean 
plasma NEFA in Ca-2 was higher compared to all the other trials throughout the 60 
min exercise (p = 0.07) this did not reach statistical significance.  
 
Fig. 4.19 Mean (± SD) plasma non-esterified NEFAs during the 50%Wpeak 60 min cycling 
protocol in the placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and 
after (Ca-2) intervention trials (n = 9) 
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4.3.6d Plasma triacylglycerols (TAG)  
Mean resting TAG values was significantly lower than exercise TAG values in all 
trials (main effect of time, p = 0.001) (Fig. 4.20). There was no significant difference 
in the plasma TAG values during exercise between all trials.  
 
 
 Fig. 4.20 Mean (± SD) plasma triacylglycerides during the 50%Wpeak 60 min cycling protocol in 
the placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-2) 
intervention trials (n = 9) 
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4.3.6e Plasma glucose  
Mean plasma glucose values did not show much variation between the trials and 
remained tightly regulated between 4.0 – 5.0 mmol/l (p = 0.44) (Fig. 4.21). Also 
mean plasma glucose did not alter from rest to exercise (p = 0.22, main effect of 
time). 
 
 
Fig. 4.21 Mean (± SD) plasma glucose during the 50%Wpeak 60 min cycling protocol in the 
placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-2) 
intervention trials (n = 9). 
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4.3.6f  Plasma lactate  
Mean resting plasma lactate values in all trials are presented in Fig. 4.22. These were 
significantly lower than their corresponding exercise values (p = 0.01, main effect of 
time). There were no significant differences between lactate values of all trials  
(p = 0.08, main effect of supplementation). However, plasma lactate values during 
Ca-2 were higher than all the other trials and increased in the first 20 min of exercise 
and did not decrease for the entire hour. All the other trials, which saw a decrease in 
lactate values at 40 min time point after the initial increase at 20 min, before 
stabilising for the rest of the hour.  
 
Fig. 4.22 Mean (± SD) plasma lactate during the 50%Wpeak 60 min cycling protocol in the 
placebo; before (Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-2) 
intervention trials (n = 9) 
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4.3.7 Rating of Perceived Exertion (RPE) 
There were no significant differences in RPE rating between any of the trials 
(Fig.4.23). Resting RPE was significantly different from all exercise values  
(p = 0.001, main effect of time), but there were no significant differences across all 
time points of exercise in RPE rating in any trials (p = 0.43). 
 
Fig. 4.23 Mean (± SD) RPE during the 50%Wpeak 60 min cycling protocol in the placebo; before 
(Pl-1) and after (Pl-2) and calcium; before (Ca-1) and after (Ca-2) intervention trials 
(n = 9) 
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4.4 Discussion 
The principle aim of this study was to determine the effects of calcium 
supplementation for four weeks on substrate metabolism during submaximal 
exercise and to determine body composition changes. The main findings suggest a 
improved but non-significant shift in substrate metabolism towards a greater fat 
oxidation rate during the 60 min cycling trial after calcium supplementation 
compared to the placebo trials. This trend was amplified in well-trained athletes and 
not the recreationally trained athletes. In addition to changes in substrate oxidation 
rates, there was a significant reduction in body fat percentage of the participants with 
a concurrent increase in lean mass during the calcium supplementation trial. On 
further analysis this trend of body composition change in the calcium 
supplementation trial was attributed to the changes in the well-trained athletes‟ body 
composition only. 
 
4.4.1 Fat metabolism 
Findings from this study showed a decrease in RER values during the entire exercise 
hour at the end of Ca-2 compared to the placebo trials. This suggests that there was a 
shift towards oxidative metabolism following calcium supplementation. Oxygen 
consumption data supports this, with V O2 values being higher in the trial at the end 
of calcium supplementation period than before. Comparing the gas analysis results 
with blood indices of metabolism there seems to be some commonality in the 
inference of higher levels of appearance of oxidative substrates in plasma such as 
NEFA and TAG during Ca-2. Men‟shikov (2004) reports a strong correlation  
(r = 0.72, p < 0.05) between plasma NEFAs, changes in blood calcium and oxygen 
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consumption during exercise in well-trained athletes. This study did not make any 
dietary or supplementary intervention and recorded the acute responses of the blood 
and gas parameters during exercise of low to moderate intensity for 90 min. The 
athletes with low plasma calcium displayed low plasma NEFA and a high oxygen 
consumption value. Moreover, the non-athletes did not display such correlations. 
NEFA following calcium supplementation continued to increase during the entire 
exercise hour as one might expect from a moderate intensity protocol. These findings 
are in agreement with Wolfe et al. (1990) where they showed that the rate of 
appearance of NEFA rises steadily throughout moderate intensity exercise  
(40%V O2max, for 2 hours). Even as the NEFA levels in all trials rose throughout the 
exercise hour, the increase was highest during the entire exercise period in trial Ca-2. 
This is a further indication of continued higher rates of lipolysis following calcium 
supplementation throughout the exercise period. 
Rate of appearance of NEFA in the blood can only be used as a surrogate measure to 
understand lipolytic activity. Previous studies by Hodgetts et al. (1991) found that 
the ratio of NEFAs to albumin in venous blood of athletes coming from 
subcutaneous adipose tissue increased from 2:1 at rest to nearly 6:1 at the end of 
exercise. Klein et al. (1994) also observed that during the first 20 min of exercise at  
45%V O2max, lipolytic rate is approximately twice the rate of NEFA oxidation. This 
is particularly the case in this study as well since the highest increase in a NEFA and 
TAG is seen in the first 20 min of exercise and the post calcium supplementation 
trial shows the largest increase in these values, especially as the resting NEFA value 
in the trial following calcium supplementation was lower than the other trials. This 
could be the effect of increased dietary calcium that may have magnified the 
lipolytic rate in this trial. Various studies looking at the relation between the rate of 
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lipolysis and the rate of fat oxidation have suggested that at low to moderate 
intensity the relationship between lipolysis and fat oxidation is more or less linear as 
delivery of NEFA to the mitochondria is not obstructed either by restricted blood 
flow (Friedlander et al., 1999, Watt et al., 2002) or by albumin binding capacity 
(Romijn et al., 1993, Klein et al., 1994, Watt et al., 2002). Therefore increased 
availability of NEFA at the start of the exercise could lead to interesting avenues of 
supporting the hypothesis of calcium in glycogen sparing action during low to 
moderate intensity exercise of long duration. This can be an avenue worth exploring 
from the perspective of developing appropriate training strategies to maximise fat 
oxidation and glycogen sparing during events where glycogen availability may 
become a limiting factor in performance.  
Increased TAG appearance in the blood could also suggest towards the increased 
demand for NEFAs. The results from this study show the increase in TAG in plasma 
during Ca-2 trial in the first 20 min of exercise is the highest among all the trials. 
This could be a strong indication of increased mobilisation of fatty substrates at the 
onset of exercise. Few studies have evaluated the contribution of plasma 
triacylglycerols to total energy production. The available data suggests that during 
the resting conditions, plasma triacylglycerols may account for 5-10% of the total fat 
oxidation (Wolfe et al., 1985, Ryan et al., 1965, Klein et al., 1994). There is also 
indirect evidence that only a small fraction of total energy produced is derived from 
plasma triacylglycerols during exercise (Turcotte et al., 1992). Even though direct 
measurement of TAG oxidation during exercise has not been reported in the 
literature in this study plasma TAG increased during the exercise hour; not in a 
dissimilar pattern to NEFA increases. However in all the trials TAG seemed to 
decrease in the last 20 min of exercise. This decrease was higher during Ca-2 as 
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compared to Ca-1. Further investigation is required if this effect of decreased plasma 
TAG levels is related to abundant supply of NEFA towards the end of the exercise 
hour and if that helps in understanding the effect of lipid substrates in the blood 
during exercise. 
 
4.4.2 Glucose metabolism 
Plasma glucose remained tightly regulated between 4.0 – 5.0 mmol/l during all the 
trials. This is in conjunction with trials conducted with a similar fed state (moderate 
carbohydrate meal 60-90 min) prior to exercise at 50%V O2max (Coyle, 1995b, 
Romijn et al., 1993). One of the reasons proposed for this is the neuroendocrine 
control of both glucose production by the liver and glucose uptake by the muscle and 
muscle glycogenolysis (Wasserman, 1995). However, as dietary calcium is 
postulated in the interaction of insulin and catecholamines (Underhill, 1916) it was 
expected that there would be some metabolic consequences as a result of increased 
dietary calcium. When calcium levels in the plasma are stable blood glucose remains 
stable; whereas with changes in plasma calcium levels these regulations are affected 
(Underhill, 1916). It is possible that at a moderate intensity (50%V O2max) where the 
role of glucose-fatty acid cycle is well regulated by the availability and requirement 
of substrates, the mechanism that may involve the calcium does not play a mitigating 
role for glucose appearance and this utilization. It has been suggested  
(Hoelzer et al., 1986) that there is a redundancy in the control systems that regulate 
glucose fluxes because deficiency of one system need not necessarily lead to 
hypoglycaemia.  
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4.4.3 Energy expenditure  
 In the trial following calcium supplementation the participants expended 
significantly more energy than all the other trials. This supports the metabolic 
inefficiency model suggested by Zemel (2002). Core body temperature was not 
measured in this study. This could have perhaps given some more information 
regarding the nature of calcium action in increasing metabolic inefficiency and in 
some way help comment on the suggested role of 1,25(OH)2D3 and its dose 
responsive inhibitory effect on UCP 2 expression and in effect core body 
temperature. However, human studies have not demonstrated this metabolic 
inefficiency proposed by in-vitro studies (Jacobsen et al., 2005, Boon et al., 2005). 
Kozyreva et al. (1983) has reported an adaptation to low temperatures is associated 
with decrease in blood calcium and an increased sensitivity of β-adrenoreceptors to 
norepinephrine. Since total energy expenditure is calculated as a function of oxygen 
consumption (Whaley et al., 2006), the energy expenditure during exercise could 
have increased as a result of change in substrate utilization with a shift towards 
higher fat oxidation rates in the trial following four weeks of calcium 
supplementation. Most studies looking at the role of calcium in energy expenditure 
have not applied an exercise protocol. It is therefore difficult to conclusively say if 
the energy expenditure increase after calcium supplementation was due to changes in 
substrate metabolism or via another mechanism/s involving resting metabolic rate 
changes such as the role of UCP in adipocytes and skeletal muscle.  
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4.4.4 iPTH and calcium metabolism 
In response to the dietary calcium supplementation resting iPTH levels decreased in 
the Ca-2 trial, but this did not reach statistical significance. Studies looking at bone 
markers in athletic populations have reported similar decreases in iPTH levels with 
calcium supplementation (Riggs et al., 1998) and/or calcium and vitamin D 
supplementation (Dawson-Hughes et al., 1997, Pfeifer et al., 2001). Guillemant et al. 
(2004) have also demonstrated a single load of calcium (1g) suppressed osteoclastic 
activity acutely induced by an endurance cycling exercise. This is perhaps the 
consequence of decreased iPTH levels due to calcium intake.  
However, a physiological response to moderate exercise on plasma iPTH levels is 
associated with a increased plasma values (Ljunghall et al., 1986a) without calcium 
supplementation. Ljunghall et al. (1988) have reported ~25% increases in plasma 
iPTH levels of the same magnitude as that of a hypocalcemic test, immediately after 
exercise. Thorsen et al. (1997) have reported an increase in plasma iPTH levels with 
concurrent decreases in plasma ionised calcium levels at 1 hour (p < 0.001) and  
72 hours (p < 0.05) and a significant increase of  iPTH at 24 hour (p < 0.01) and 72 
hours (p < 0.05) after the test. In other short term studies by the same group of 
researchers, where exercise was performed with varying intensities for periods 
between 2 min and 1 hour, normal participants did not display any consistent 
changes in plasma iPTH (Ljunghall et al., 1985, Ljunghall et al., 1984). However, 
during a 5 hour bicycle exercise study there was a small decrease in iPTH (Ljunghall 
et al., 1986b). Thus it appears that the normal response to exercise on iPTH is 
dependent on the duration of exercise. The intensity of exercise influences calcium 
levels and thus iPTH levels due to increased acidosis (Ljunghall et al., 1985). One of 
the possible explanations for decreased plasma ionised calcium levels during 
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exercise, that stimulates increases in iPTH levels could be due to increases in 
complex binding of free calcium ions as well as enhanced binding of calcium to 
albumin molecules with the increased plasma NEFA during prolonged exercise 
(Zaloga et al., 1987). The stimulation of cAMP and catecholamine levels due to 
exercise has also been implicated in the changes of plasma ionised calcium levels 
during exercise due to their effect on increased plasma NEFA during exercise. Post 
exercise iPTH levels were not measured in this study. However, it is possible that 
those may remain unchanged or even display the trend of reduction seen at resting 
levels in the trial following calcium supplementation due to the longitudinal nature 
of this study. 
 
4.4.5 Changes in body mass and composition  
There was a decrease in body mass and fatness over the four week intervention 
period following calcium supplementation. Recent findings from other studies 
support these findings. In a two year intervention study by Lin et al. (2000) 54 
normal weight women participating in an exercise intervention, the dietary calcium 
to energy intake ratio was a significant predictor of changes in both body weight and 
body fat. In one large trial of the effect of calcium supplementation on bone, in 
which elderly women were randomly assigned to either placebo or 1.2 g/d of calcium 
carbonate, Davies et al. (2000) analysed this data retrospectively for changes in body 
weight and found that the calcium supplemented group lost 0.671 ± 0.112 kg/year as 
compared to the placebo group who lost 0.325 ± 0.110 kg/year, reporting an 
estimating calcium treatment difference of 0.346 kg/year (p < 0.05). The overall 
relationship derived from this reanalysis indicates a calcium intake increase of 1 g/d 
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is associated with an 8 kg reduction in body weight (Davies et al., 2000). The body 
mass reduction seen in this study is substantially higher as compared to the  
meta-analysis of 780 women from five separate clinical trials by Davies et al. (2000). 
One possible explanation for this could be that the proposed mechanism for the 
effect of calcium intake on changes in weight and fat mass would support that 
exercisers would have increased lipolysis during training and subsequent 
physiological adaptations; thus, the effect may be greater in athletes.  
The BMI of the participants reduced by 0.19 ± 0.26, which was not a significant 
decrease but not much emphasis, will be placed on BMI data. This data should be 
viewed in light with the body composition data.  The lower fat mass generally biases 
the value towards overweight or even obese when the participants in this study in 
reality weigh more due to a higher lean tissue mass in athletes as compared to 
sedentary individuals. This is more important as changes in body composition were 
particularly pronounced in the well-trained athletes. One possible reason for this 
distinction could be due to the fact that athletes due to increased expenditure and 
better absorption rates (Zittermann et al., 2000) and traditionally higher calcium loss 
through increased sweat rates (Klesges et al., 1996, Leiper et al., 1996) may have 
benefitted from the calcium supplementation more than the recreationally trained 
athletes.  
The case for improved body composition upon calcium supplementation of people 
on a habitually low calcium intake has been made repeatedly in the literature (Davies 
et al., 2000, Heaney et al., 2002, Teegarden, 2003). No significant differences 
between habitual calcium intakes were found in both the groups in the study. The 
participants‟ habitual calcium intake was proportional to the mean total energy 
intake in both the sets of diet diaries (r = 0.65). However, other aspects of calcium 
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metabolism such as sweat losses and energy balance as a result of higher training 
volumes (and thus increased fat oxidation) may have also played a part in the change 
in body composition of the well-trained athletes over the recreationally trained. An 
interesting caveat on the differences between the well-trained and the recreationally 
trained athlete groups in this study was that due to the criteria for sub grouping  
(V O2max > 50 ml/kg/min) there was an unintentional split in gender within the same 
sub grouping (recreationally trained = female, well-trained = male). It has been 
shown in a few studies that males have responded better than females to the 
increased dietary calcium intervention with relation to body mass (Vergnaud et al., 
2008, Heaney et al., 2002) and body composition (Vergnaud et al., 2008, Loos et al., 
2004) better than women. Therefore, another possible explanation for the differences 
in the two sub groups in the study may be that the intervention had a larger effect on 
males compared to that in females.  
It is important to mention that studies that have looked at dairy calcium intake have 
reported much larger changes in body mass and composition (Azadbakht et al., 2005; 
Barr, 2003; Davies et al., 2000; Harvey-Berino et al., 2005; Lin et al., 2000; 
Lorenzen et al., 2007; Pereira et al., 2002; Teegarden et al., 2003; Zemel et al., 2005; 
Zemel et al., 2003). The Coronary artery risk development in young adults 
(CARDIA) study evaluated the associations between dairy product intake and the 
incidence of the major components of the insulin resistance syndrome, including 
obesity, in a 10 year study of 3157 black and white adults. The cumulative incidence 
of obesity in those who started the study in the overweight category was significantly 
reduced from 64.8% in those who consumed the least amount of dairy foods to 
45.1% in those who consumed the highest amount of dairy foods (Davies et al., 
2000). Pereira et al. (2002) explained these differences solely by dairy intake and not 
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altered by adjustment for dietary calcium, which probably explains the other 
beneficial substances in dairy products mentioned previously that may explain the 
increased weight loss in those studies. 
 
4.4.6 Conclusions  
The main finding from this investigation was that total energy expenditure was 
significantly higher in the trial following calcium supplementation. There was no 
statistically significant difference in the metabolites in the blood or fat oxidation 
during exercise among all the trials (thus refuting hypothesis i). Even though most of 
the results did not show statistical significance the trend clearly warrants more 
investigation with well-trained athletes since the changes seem more pronounced in 
well-trained athletes compared to recreational participants.  
Also, this study being longitudinal in nature allowed for changes in body mass and 
composition in the participants that seem to clearly support most of the data in the 
literature on calcium and its anti-obesity effects. There was a statistically significant 
difference in decrease in total body mass and fat mass of the participants after 
calcium supplementation (thus supporting hypothesis ii). Once again these changes 
in body composition were markedly pronounced in well-trained athletes compared to 
the recreational participants.  
Put together these findings present a strong case for further investigation into the  
in-vivo effects of calcium in fat metabolism, its effects on body mass and 
composition, from a view to improve performance. Thus future studies aimed at 
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highly trained participants involving performance tests, may highlight the direct 
ergogenic effects of supplementary calcium intake.  
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CHAPTER 5 
EFFECTS OF CALCIUM SUPPLEMENTATION ON PERFORMANCE OF 
A TWENTY FIVE MILE CYCLING TIME TRIAL 
 
5.1 Introduction 
Increased dietary calcium has been shown to have positive correlation with fat 
metabolism (Xue et al., 2001) and subsequently decreased body fat mass (Zemel, 
2003, Zemel et al., 2000, Gunther et al., 2006). It was demonstrated in the previous 
study that sub maximal exercise at a set intensity (50%Wpeak) increased total energy 
expenditure after four weeks of calcium supplementation compared to the placebo 
trial. Also, indices of fat metabolism indicated a positive effect of calcium 
supplementation on fat oxidation during a steady state submaximal exercise session 
lasting for 60 minutes. In addition to changes in substrate metabolism, the body 
composition of the participants in the previous study improved towards an increase 
in lean mass and a decrease in fat mass during the four weeks of supplementation. 
These changes were more pronounced in the well-trained athletes compared to the 
recreational participants. Thus the current study was designed to further establish the 
relevance of these shifts in substrate metabolism from the perspective of 
improvement in real time performance. The results obtained from the previous study 
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led to an extension of the premise of ergogenicity of calcium and the need to study 
the external validity of those results derived from controlled sub maximal tests. It has 
been argued by Atkinson and Nevill (2001) that improvements in performance based 
on relevant physiological parameters might be smaller than those exhibited by the 
physiological variables. Since calcium regulation is very tightly controlled in all the 
organs including blood, it would be interesting to see the effects of increase in 
calcium intake on direct performance related variables such as power output and 
time-to-completion via the use of time trial tests. 
Thus, the aim of this experimental trial was to study the effects of four weeks of 
calcium supplementation specifically on performance during a long duration 
endurance event (twenty five mile cycling time trial (25 TT)). The secondary aim 
was to study its effect on body composition changes during the four weeks of 
supplementation on highly trained athletes. 
 
5.1.1 Hypotheses 
iii. It is hypothesised that calcium supplementation of 1000 mg/day for four 
weeks improves performance in a 25 mile time trial. 
iv. It is also hypothesised that calcium supplementation of 1000 mg/day for four 
weeks reduces body fat mass of highly trained cyclists. 
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5.2 Methods  
5.2.1 Participants 
Ten male healthy well-trained cyclists (time trialists) were recruited from local 
cycling clubs. Inclusion criteria as described in section 3.1 were met. An exclusion 
criterion was set at 10 mile time-trial time-to-finish of ≥ 25 min in the past season. 
The mean (± SD) physical characteristics of the participants are given in  
Table 5.1. 
 
Table 5.1  Mean (± SD) physical characteristics of participants in study 2 
 Age 
(years) 
Weight 
(Kg) 
Height 
(cm) 
V O2peak 
(l/min) 
V O2peak 
(ml/kg/min) 
Wpeak(aerobic) 
(W) 
POLT 
(W) 
Mean 
(± SD) 
35.8  
± 11.3 
73.80  
± 9.31 
176.0  
± 7.10 
4.59 
 ± 0.85 
62.70 
± 6.43 
350 
± 42 
238 
±16 
 
 
5.2.2 Experimental design  
The study was designed as a randomised, single blind, test - retest intervention. 
Participants were initially assigned to a four week calcium intervention (1000 mg 
elemental calcium (citrate)/day. The following year, four out of the ten participants 
returned to perform the study without any intervention (nocebo). The study was 
designed as a single blind intervention to ensure the validity of the data was not 
compromised due to the long waiting period between data collection. Participants 
147 
 
were not informed of the single blind nature of the study and were led to believe that 
the intervention was double blind and they were randomly assigned to either a 
calcium or placebo group. The study was repeated at the same time of the year 
(October to January) to coincide with the end of the racing calendar and therefore 
matched training regimes. This allowed the changes observed in the intervention not 
to be caused primarily due to increase in training intensity or load that occurs during 
the racing season. In addition the October to January period is generally used as a 
low training period by most competitive cyclists (Sassi et al., 2008, White et al., 
1982a). Therefore any improvements observed could be attributed to a large extent 
on the intervention.  
As with the earlier intervention the capsule formulation procedure was adhered to as 
described in section 3.2.8. 
 
5.2.3 Testing protocols 
5.2.3a Wpeak (aerobic) test 
All participants underwent a Wpeak (aerobic) test one at a time in order to compare their 
time trial performance power output with their peak power output. Participants 
reported to the laboratory in a post prandial state of at least one meal consumed 
about 60 to 90 min prior to testing. After setting up of cycle ergometer and emptying 
of bladder, the test was commenced and conducted as described in section 3.3.4.  
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5.2.3b Time trials  
Participants performed two 25 TT, one at baseline before calcium supplementation 
(25TTC1) and one at the end of the four week intervention period (25TTC2). On 
each occasion the participants arrived post prandial after consumption of the same 
meal at least 60-90 min prior to testing. Upon arrival they underwent the 
anthropometry measurements as described in section 3.2.5a and 3.2.5b and resting 
blood measurements as described in section 3.2.4b for analysis of lactate, plasma 
glucose and NEFA. The tests were performed as described in described in section 
3.3.5. Water was allowed ad-libitum throughout the tests. No verbal or other forms 
of encouragement were given during the tests.  
At the same time in the following year participants (n = 4) repeated the same study 
with a nocebo intervention. They performed a baseline test (25TTP1) and repeated 
the time trial after four weeks (25TTP2). 
 
5.2.3c Dietary and physical activity records 
All participants were asked to keep a seven day diet diary and physical activity log 
as described in section 3.2.6 during any typical week of the intervention and were 
asked to repeat the same in the following year during the nocebo intervention. 
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A schematic representation of the study design is presented in Fig. 5.1.  
 
 
Fig. 5.1 Schematic representation of experimental protocol within each intervention  
 
 
5.2.3d Statistical analysis 
All data was analysed and statistical analysis conducted as described in section 3.5. 
Mean differences were analysed for intra-trial changes and not inter-trial changes. 
This was done to measure the changes due to calcium supplementation from baseline 
and after four weeks. 
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5.3 Results  
5.3.1 Anthropometry  
Mean percentage change of all anthropometric values from the calcium intervention 
are presented in table 5.2. Following calcium supplementation for four weeks mean 
total body mass of the participants increased by 0.22% (p = 0.12), However, body 
composition improved favourably by a decrease in fat mass (-0.81%, p = 0.07) with 
a concurrent increase in lean mass (0.81%, p = 0.07). These changes in body 
composition did not reach statistical significance.  
 
Table 5.2 Mean (±SD) anthropometric changes in participants of study 3 following 
calcium supplementation for four weeks 
n = 10 
25TT C1 
(mean ±SD) 
25TT C2 
(mean ± SD) 
Difference; 
± 90%CI 
d 
Total Mass (kg) 73.78 ± 9.29 73.94 ± 8.70 -0.16; ± 0.31 0.02 
BMI (kg/m
2
) 23.78 ± 2.25 23.84 ± 2.12 -0.06; ± 0.07 0.01 
Fat Mass (kg) 11.08 ± 4.64 10.50 ± 4.86 -0.58; ± -0.11 -0.12 
Lean Mass (kg) 62.75 ± 7.05 63.44 ± 6.39 0.69; ± 0.34 0.09 
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When the participants returned one year later at the same time of the season and 
repeated the measurements four weeks apart without any intervention, there were 
minimal changes in their anthropometric measurements (table 5.3).  
 
Table 5.3 Mean (± SD) anthropometric changes in participants of study 3 following 
nocebo supplementation for four weeks 
n = 4 
25TT P1 
(mean ± SD) 
25TT P2 
(mean ± SD) 
Difference; 
± 90%CI 
d 
Total Mass (kg) 72.43 ± 10.45 72.47 ± 11.05 0.03; ± 0.62 0.00 
BMI (kg/m
2
) 23.37 ± 0.88 23.37 ± 1.12 0.00; ± 0.14 -0.02 
Fat Mass (kg) 10.47 ± 4.90 10.77 ± 3.95 0.30; ± 0.18 0.09 
Lean Mass (kg) 89.53 ± 4.90 89.23 ± 3.95 -0.27; ± 0.16 -0.02 
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5.3.2 Nutrition analysis  
Mean macro and relevant micro nutrient intakes over a seven day period (one typical 
week and one typical weekend) of the participants are presented in table 5.4.  
A detailed table including the COMA (1991) recommendations is presented in 
appendix J. 
 
Table 5.4 Mean (± SD) nutrient intake in participants of study 2 
n = 10 Mean ± SD 
Energy (MJ/d) 9.6 ± 1.4 
Total carbohydrates (g/d) 334 ± 75 
Total fat (g/d) 60 ± 14 
Protein (g/d) 93 ± 23 
Alcohol (g/d) 9  ± 7 
Calcium (mg/d) 757 ± 108 
Vitamin D (µg/d) 2.92 ± 1.36 
 
Fig. 5.2 Mean macronutrient intake in participants of study 2 as a percentage of energy intakes 
23% 
16% 58% 
3% 
Fat
Protein
CHO
Alcohol
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5.3.3 Training logs 
A summary and mean training volume and intensity as a TRIMP Score of the 
participants during the four weeks of supplementation is presented in Fig. 5.3. Both 
training volume and intensity of the participants did not increase over the 
supplementation period. There was no significant difference between the four weeks 
of training of the participants (p = 0.22).  
 
Fig. 5.3 Mean (± SD) weekly training volume (min) and intensity (TRIMP score) of the 
participants during the four weeks of calcium supplementation trial (n = 10) 
 
The mean monthly monotony was calculated as 3 ± 2 and the mean monthly strain 
was calculated as 1882 ± 668. Examples of training logs are presented in appendix 
K.  
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The mean training volume and TRIMP score of the nocebo trials is presented in  
Fig. 5.4. There was no significant difference between the four weeks of the trial in 
the athletes training (p = 0.36).  
 
 
Fig. 5.4 Mean (± SD) weekly training volume (min) and intensity (TRIMP score) of the 
participants during the four weeks of nocebo trial (n = 4) 
 
 
 
 
The mean monthly monotony in the nocebo trial was 3 ± 2 and strain was  
2112 ± 517.  
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5.3.4 Performance variables  
Mean changes in the performance variables between the two trials; before and after 
calcium supplementation are presented in table 5.5. All the relevant variables are 
discussed individually in the following sections.  
 
Table 5.5 Mean (± SD) change in performance variables in participants of study 2, 
following calcium supplementation for four weeks (n = 10) 
n = 10 
 
25TTC1 
(mean ± SD) 
 
25TTC2 
(mean ± SD) 
 
% 
change 
(mean) 
 
90%CI 
 
d 
Time to 
finish (min) 
62.11 ± 2.82 60.74 ± 2.53 -2.25
*
 -1.52 to -1.22 -0.51 
Power 
output (PO) 
(W) 
236.96 ± 25.93 246.96 ± 27.66 4.05 9.1 to 10.22 0.37 
Relative PO 
(W/kg) 
3.23 ± 0.36 3.35 ± 0.27 3.58 0.07 to 0.17 0.38 
Relative PO 
(W/%FFM) 
2.79 ± 0.36 2.88 ± 0.39 3.13 0.07 to 0.11 0.24 
Gross 
efficiency 
(%) 
17.30 ± 1.72 19.46 ± 1.94 2.16
†
 2.05 to 2.27 1.17 
Gross 
economy 
(W/l) 
60.36 ± 6.00 67.88 ± 6.77 11.08
†
 7.12 to 7.92 1.17 
Energy 
expenditure 
(kJ) 
4885 ± 630 4614 ± 729 -5.87 -323 to 220 0.40 
Heart rate 
(bpm) 
164 ± 11 163 ± 11 -0.68 -1.26 to -0.94 -0.10 
Cadence 
(rpm) 
93.22 ± 5.06 89.84 ± 9.92 -3.76 0.4 to 5.6 -0.43 
*
significant at p < 0.05   
† 
significant at p < 0.001 
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Mean changes in performance variables of the participants (n = 4) in the nocebo are 
presented in table 5.6 and each relevant individual variable is discussed along with 
the main calcium trial in the following sections.  
 
Table 5.6 Mean (± SD) change in performance variables in participants of study 2, 
following nocebo supplementation for four weeks (n = 4) 
n = 4 
 
25TTP1 
(mean ± SD) 
 
25TTP2 
(mean ± SD) 
 
% 
change 
(mean) 
90%CI d 
Time to 
finish (min) 
63.55 ± 6.07 64.89 ± 5.48 2.06 0.85 to 1.83 0.23 
Power 
output (W) 
240.33 ± 54.04 230.63 ± 43.30 -4.20 -18.52 to -0.86 -0.19 
Relative PO 
(W/kg) 
3.48 ± 1.17 2.90 ± 0.41 -20 -1.3 to 0.14 0.66 
Relative PO 
(W/%FFM) 
2.74 ± 0.59 2.56 ± 0.56 -7.03 -0.21 to -0.15 0.31 
Gross 
efficiency 
(%) 
20.59 ± 2.42 18.23 ± 2.80 -2.36 -2.67 to -2.05 -0.90 
Gross 
economy 
(W/l) 
71.82 ± 8.44 63.58 ± 9.76 -12.96 -9.33 to -7.15 -0.90 
Energy 
expenditure 
(kJ) 
4301 ± 1330 4811 ± 1609 10.60 281 to 740 0.35 
Heart rate 
(bpm) 
164 ± 8 160 ± 9 -2.40 -5.12 to -2.48 -0.43 
Cadence 
(rpm) 
91.35± 3.50 89.80 ± 4.07 -1.73 -2.03 to -1.07 -0.39 
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5.3.4a Time to finish  
The time to finish the 25TT after calcium supplementation for four weeks decreased 
significantly by a mean of 1.37 ± 0.29 min (p = 0.02) (Fig. 5.5). Most athletes 
decreased their time to finish with two of them increasing the time by 0.05 min and 
0.06 min. The maximum decrease in time to finish was 3.79 min. Time to finish 
correlated with PPO significantly after calcium supplementation (r = 0.81, p = 0.03) 
but not before (r = -0.66, p = 0.08).  
 
 
Fig. 5.5 Individual time to finish during the twenty five mile time trials before and after calcium 
supplementation (n = 10)  
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The time to finish data of individual participants (n = 4) in the nocebo trial is 
presented in Fig. 5.6 with a comparative graph of the same participants‟ data from 
the calcium intervention. There was a mean increase in time to finish of 1.34 ± 0.59 
min (p = 0.08). With the exception one participant (0.06 min increase), all 
participants in the trial following calcium supplementation decreased their time to 
finish. The largest individual decrease was 3.79 min in the calcium trial as opposed 
to an increase of 0.83 min in the test in the following year.  
 
Fig. 5.6 Time to finish of the individual participants who completed both the calcium (C1 and 
C2) and nocebo (P1 and P2) trial (n = 4) 
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5.3.4b Power output  
Mean power output before and after calcium supplementation is presented in Fig. 
5.7. Mean power output throughout the 25TTC2 was higher compared to the trial 
before calcium supplementation (25TTC1) (p = 0.06). Power outputs were highest at 
the start of the exercise in both the trials and continued to decrease with time 
throughout the rest of the period (p = 0.02, main effect of time). However, during the 
last few minutes after the 60
th
 min data point there were fewer participants still 
exercising after calcium supplementation as compared to before (25TTC1; n = 7 and 
25TTC2;  
n = 5). The mean power output during these last min increased (17.48 ± 20.79 W) in 
the 25TTC1 compared to a decrease in 25TTC2 (-7.80 ± 7.65 W) (p = 0.12).  
 
Fig. 5.7 Mean (± SD) Power output during the twenty five mile time trials before (25TTC1) and 
after (25TTC2) calcium supplementation (n = 10) 
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Mean power output in the trial a year after the calcium supplementation trial is 
presented in Fig. 5.8. Similar to the calcium supplementation trial mean power 
output was the highest at the start of the time trial and continued to decrease as the 
exercise session progressed in both the trials. The participants who did not finish the 
25 mile ride within 60 min were the same in both the trials (n = 2 of 4), their data is 
averaged as the data point from 60
th
 min to finish (End). There was a greater 
decrease in power output in the 25TTP2 in this data set compared to 25TTP1 (-29.20 
± 1.83 W, p = 0.12) 
 
Fig. 5.8 Mean (± SD) Power output during the twenty five mile time trials in the nocebo trial 
before (25TTP1) and after (25TTP2) four weeks (n = 4) 
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5.3.4c Gas exchange 
i. Oxygen consumption 
Mean oxygen consumption during the trials before and after four weeks of calcium 
supplementation is presented in Fig. 5.9. There was a non-significant decrease in 
oxygen consumption after 25TTC2 (p = 0.08). Exercise values in both the trials were 
significantly higher than the values at the start of the trial (p = 0.01, main effect of 
time).  
 
Fig. 5.9 Mean (± SD) oxygen consumption during the twenty five mile time trials before 
(25TTC1) and after (25TTC2) calcium supplementation (n = 10) 
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Mean oxygen consumption in the nocebo trial showed the opposite trend in oxygen 
consumption (Fig. 5.10). Mean oxygen consumption increased in 25TTP2 compared 
to 25TTP1 (mean increase of 5.2 ± 1.0 ml/kg/min, p = 0.10) except the start of the 
trials. Mean oxygen consumption was significantly different at the start of the 
exercise than throughout the exercise session in both the trials (p = 0.01, main effect 
of time).  
 
Fig. 5.10 Mean (± SD) oxygen consumption during the twenty five mile time trials in the nocebo 
trial before (25TTP1) and after (25TTP2) four weeks (n = 4) 
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ii. Respiratory exchange ratio (RER) 
Mean RER was non-significantly higher in the trial following four weeks of calcium 
supplementation compared to before supplementation (p = 0.08) (Fig. 5.11). The 
values at the start of the exercise session were significantly higher than the rest of the 
period during the exercise session in both the trials (p = 0.03, main effect of time).  
 
 
Fig. 5.11 Mean (± SD) RER during the twenty five mile time trials before (25TTC1) and after 
(25TTC2) calcium supplementation (n = 10) 
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The RER trend was reversed in the nocebo trial (Fig. 5.12).  RER continued to fall in 
the 25TTP1 throughout the exercise session after an initial increase from the starting 
values (p = 0.02, main effect of time).  
 
 
Fig. 5.12 Mean (± SD) RER during the twenty five mile time trials in the nocebo trial before 
(25TTP1) and after (25TTP2) four weeks (n = 4) 
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5.3.4d Substrate metabolism  
Mean total energy expenditure (TEE) and the percentage carbohydrate and fat are 
depicted in Fig. 5.13. Mean TEE was marginally higher in 25TTC1 (4885 ± 630 kJ) 
compared to 25TTC2 (4614 ± 729 kJ) (p = 0.22) and the mean total contribution of 
carbohydrate was 15.11 ± 1.93 % higher in 25TTC2 compared to the trial before 
calcium supplementation. Proportionately the contribution of fat decreased in 
25TTC2 15.11 ± 1.93 % compared to 25TTC1. These results were not statistically 
significant. 
 
Fig. 5.13 Comparison of mean total energy expenditure and percentage of the energy derived 
from carbohydrates (white) and fat (black) in twenty five mile time trials  
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5.3.4e Gross efficiency 
 
Athletes produced higher power at a given rate of oxygen consumption after calcium 
supplementation (p < 0.001). This trend was observed across the range of oxygen 
consumption values during the twenty five mile time trials.  
The mean gross efficiency of the participants improved throughout the trial after 
calcium supplementation than before (p = 0.001, main effect of supplementation) 
(Fig. 5.14). Gross efficiency was highest at the start of the exercise session for both 
the trials (p = 0.01, main effect of time) and continued to decrease in the trial before 
calcium supplementation. Mean gross economy of the athletes was a mean of 60.36 
± 6.00 W/l in 25TTC1 and 67.88 ± 6.77 W/l during 25TTC2 (p = 0.001, main effect 
of supplementation).  
 
Fig. 5.14 Mean (± SD) gross efficiency during the twenty five mile time trials before (25TTC1) 
and after (25TTC2) calcium supplementation (n = 10) 
 
10
12
14
16
18
20
22
24
Start 20 40 Finish
M
ea
n
 g
ro
ss
 e
ff
ic
ie
n
cy
 (
%
) 
Time (min) 
25TTC1 25TTC2
167 
 
Mean gross efficiency in the nocebo trial is presented in Fig. 5.15. Gross efficiency 
was lower in 25TTP2 compared to the trial prior 25TTP1 (-2.36 ± 0.38, p = 0.07). 
Mean GE was higher at the start of the exercise to all other time points and was 
lowest at the end of the exercise period in both the trials. 
Gross economy of the athletes was a mean of 71.82 ± 8.44 W/l in 25TTP1 and 63.58 
± 9.76 W/l in 25TTP2 (p < 0.001, main effect of supplementation).  
 
 
Fig. 5.15 Mean (± SD) gross efficiency during the twenty five mile time trials in the nocebo trial 
before (25TTP1) and after (25TTP2) four weeks (n = 4) 
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5.3.4f Haematological variables 
i. Plasma glucose  
Mean plasma glucose in the trials before and after calcium supplementation is 
presented in Fig. 5.16. There were no significant differences between the plasma 
glucose values in both the trials (p = 0.23). 
 
Fig. 5.16 Mean (± SD) plasma glucose during the twenty five mile time trials before (25TTC1) 
and after (25TTC2) calcium supplementation (n = 10) 
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ii. Plasma lactate  
Mean plasma lactate was was not significantly different in both the trials (Fig. 5.17). 
However it was non-significantly higher in the 25TTC2 after forty min until the end 
of the exercise (p = 0.12). 
 
Fig. 5.17 Mean (± SD) plasma lactate during the twenty five mile time trials before (25TTC1) 
and after (25TTC2) calcium supplementation (n = 10) 
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iii. Plasma non-esterified fatty acids (NEFA)  
Mean plasma NEFA values from both the trials, before and after calcium 
supplementation are presented in Fig. 5.18. Mean plasma NEFA were higher 
throughout rest and exercise in the 25TTC2 trial (mean difference 0.031 ± 0.002,  
p > 0.08, main effect of supplementation). There was a significant difference in the 
values at rest and at the end of exercise in both the trials (p = 0.02, main effect of 
time).  
 
Fig. 5.18 Mean (± SD) NEFA during the twenty five mile time trials before (25TTC1) and after 
(25TTC2) calcium supplementation (n = 10) 
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5.4 Discussion 
5.4.1 Performance variables  
The principle aim of this study was to determine the effect of calcium 
supplementation of four weeks on endurance cycling performance. The main 
findings from this study indicate that increasing dietary calcium has a beneficial 
effect on cycling performance via mechanisms that are different to manimuplation of 
fat oxidation rates. Athletes completed the 25 TT in a shorter time (-1.37 ± 0.29 min) 
after calcium supplementation. This was achieved via an increased power output 
throughout the exercise period. Increased power output was maintained despite 
lower mean oxygen consumption. Thus GE values were significantly higher in 
25TTC2 compared 25TTC1 (2.16 ± 0.22 %, p < 0.001). These results can be 
considered as meaningful for an athlete because the change was more than 1% 
(Currell and Jeukendrup, 2008, Paton and Hopkins, 2001). GE has been suggested 
by Coyle et al. (1992) to be a key determinant of endurance performance. GE in 
other publications (Sassi et al., 2008, Hopker et al., 2009) are in the similar range for 
the training status and V O2peak values of the participants as this study.  
GE in cycling is reported to be influenced by numerous factors such as but not 
limited to; muscle fibre type (Coyle et al., 1992), body position (Ashe et al., 2003), 
altitude exposure (Hahn and Gore, 2001, Gore et al., 2001), years of training 
(Hopker et al., 2007, Coyle, 1999), uphill riding and standing or sitting positions 
(Millet et al., 2002), cadence and pedalling technique (Cannon et al., 2007). 
Improvements in GE have been reported as a consequence of training (Hawley and 
Stepto, 2001); with (Luttrell and Potteiger, 2003) or without (Williams et al., 2009) 
specialised equipment such as power cranks. However, apart from different training 
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regimes which may have beneficial physiological and biomechanical adaptations, not 
many other avenues to improve GE have been explored in the literature. This study 
is the first to show that calcium supplementation has a beneficial effect on GE in 
cycling.  
A small change in GE can correspond to marked improvements in performance. 
Jeukendrup et al. (2000) have estimated that for an elite cyclist with a mass of 70 kg 
and a 1 hr sustainable power of 400 W, a 1% improvement in GE equates to a 48 sec 
improvement in a 40 km time trial. During this trial the mean power sustained over 1 
hr was ~250 W (246.96 ± 27.66 W) after calcium supplementation and a reported 
increase in GE of 2.16%, which amounts to a 63 sec improvement in time to finish 
with 1% improvement in GE. This is a larger improvement than the calculations in 
Jeukendrup et al. (2000) considering the cyclists in this study sustained a lower 
power output over 1 hr, and the mean body mass of these athletes was slightly higher 
(73.8 ± 9.31 kg) than the calculations based on 70 kg body mass in  Jeukendrup et al. 
(2000). However interestingly, when these calculations were made via modelling 
software, the same authors have quoted a 63 sec improvement with a 1% 
improvement in efficiency if the rider sustains ~300 W over the 40 km (Moseley and 
Jeukendrup, 2000). They (Moseley and Jeukendrup, 2000) also state that this time 
gain would be even greater in less skilled riders. This is more consistent with the 
data from this study since all the participants were non elite but well-trained and 
competitive at the club level (mean V O2peak 62.70 ± 6.43 ml/kg/min and Wpeak (aerobic) 
350 ± 42 W).  
In addition, seasonal variations and improvement in GE during pre season time 
(Hopker et al., 2009) were controlled for in this study by conducting all the tests 
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between September and December. This corresponds with the end of the racing 
season and the beginning of low intensity moderate volume training in the winter 
months. GE during this period is reported to decrease due to drop in training 
intensity (White et al., 1982a). Concurring with their results, the subsequent trial in 
this study which was conducted at the same time the following year resulted in a 
mean decrease in GE (-2.36 ± 0.38%) in four weeks with similar training and 
nutrition status of the returning participants (n = 4). Therefore the increase in GE in 
the calcium trial could at least in part be explained as a result of increase in dietary 
calcium intakes of these athletes.  
Coyle et al. (1991) has demonstrated that actual performance of elite national class 
and good state class cyclist in a 40 km time trial highly correlates with average 
absolute power during a one hour simulated laboratory test (r = -0.88).  As argued in 
Chapter 3 these laboratory simulations reflect actual demands of such cycling events 
reasonably well. It has been reported that in elite cyclists completing a 40 km time 
trial in ~54 min, power output at LT was 311 W (Coyle et al., 1991). The mean 
power output at LT in this study was 238 ± 16 W which achieved a time to finish of 
~60+ min for a similar distance. Since the athletes in the present study were club 
level competitive riders these values concur with Coyle et al. (1999) and others 
(Moseley et al., 2004, Hopker et al., 2009).  Maintaining a comparative higher power 
output over the period of ~60 min would require in part the attenuation of 
mechanisms that may involve fatigue of the skeletal muscle. Various studies looking 
at force decrease during fatigue have reported increased myofibrillar calcium 
sensitivity and increased resting i[Ca
2+
] (Chin et al., 1997) which occur due to 
metabolic changes that may in part be related to decreased glycogen content in 
muscle at exercise intensities of 60 - 80 %V O2max. The athletes in this study rode at a 
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mean 70.88 ± 4.80 % Wpeak after calcium supplementation compared to  
67.97 ± 4.11 % Wpeak at baseline. Therefore it could be argued that calcium 
supplementation may have been responsible in this sustained increased power 
output.  
Dietary calcium intake has a profound impact on calcium homeostasis. Research has 
shown that depressed calcium intake can substantially increase i[Ca
2+
] levels in 
human adipocytes (Xue et al., 2001) and skeletal muscle (via restricted energy intake 
~400 Kcal/d) (Russell et al., 1983). Experiments conducted by Barclay (1996) using 
mouse fast twitch extensor digitorum longus (EDL) muscle and slow twitch soleus 
using fatigue protocols (thirty isometric tetani) decreased the efficiency of energy 
conversion by the crossbridges and also reduced the curvature of the force velocity 
relationship. These fatigue signals seem to be amplified in an increased i[Ca
2+
] 
environment (Cairns and Lindinger, 2008). In skeletal muscle, decreased creatine 
phosphate reduces the available energy for the calcium efflux and sequestration into 
the sarcoplasmic reticulum (Russell et al., 1984). The correlation of muscle 
relaxation with free energy of adenosine triphosphate (ATP) hydrolysis suggest that 
a decrease in relaxation rate and an increase in fatigue may result from slowing of 
pumps transferring free calcium into the sarcoplasmic reticulum (Dawson et al., 
1980), and a considerable depletion in extracellular calcium levels in the transverse 
tubules of the skeletal muscle sarcolemma may contribute to fatigue (reduced force 
output) (Cairns et al., 1998).  
These mechanisms leading to fatigue are possibly attenuated by a change in calcium 
homeostasis via increased extracellular availability of calcium during a period of 
high intake. When dietary calcium is increased, it reduces entry of calcium into the 
intracellular compartments via a calcitriol and parathyroid mediated enzymatic 
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cascade and the resulting higher extracellular calcium levels compared to the 
intracellular stores (Xue et al., 2001). It is possible that four weeks of calcium 
supplementation attenuated these fatigue mechanisms in the participants allowing 
them to ride at a higher power output with no further increase oxygen consumption 
required. However, this is only possible if the glycogen stores are well replenished 
(Romijn et al., 1993) as the increased power production would in turn require a 
higher proportion of carbohydrate availability (Sherman et al., 1991). Also, specific 
carbohydrate availability is implicated in muscular excitability (Russell et al., 1983, 
1984). For example glucose administration partially restored force during late fatigue 
in muscles stimulated in-situ (Marcil et al., 2005) and in exercising humans (Stewart 
et al., 2007). This is in part explained by the amplified effects of muscle glycogen 
depletion on potassium (K
+
) induced depolarisation to reduce excitability during 
exercise (Cairns and Lindinger, 2008). Increased extracellular calcium antagonises 
this K
+ 
depletion (Cairns and Lindinger, 2008) to further alleviate muscular fatigue 
responses during submaximal exercise.  
Another effect of increased metabolic activity in working muscle is the production of 
reactive oxygen species (ROS) (Allen et al., 2008) which may interact with a 
diminished K
+
 gradient to further impair contraction during exercise. Increased 
i[Ca
2+
] due to a decrease in dietary calcium intake increases ROS production in all 
cells (Zemel and Sun, 2008) and this coupled with exercise induced ROS detrimental 
effect on exercise performance can further contribute towards fatigue.  
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5.4.2 Body mass and composition 
One of the key physiological variables associated with cycling performance is body 
mass, which increases the energy cost of acceleration, rolling resistance and the 
projected frontal area of the cyclist (and hence air resistance) (Jeukendrup et al., 
2000). Olds et al. (1995) have estimated that an extra fat mass of 2 kg would increase 
a 4000 m individual pursuit time by 1.5 sec or a distance of ~20 m. In the one hour 
record Bassett et al. (1999) have suggested that 60% improvement in performance 
could be attributed to advances in the aerodynamics of the bike, rider position etc. 
and 40% from the ability of the rider to sustain a high power output. Indeed when 
PO was accounted for the body composition changes, the cyclists were riding at an 
average higher power output per kg FFM in the trial following calcium 
supplementation compared to baseline. FFM after calcium supplementation 
increased by 0.81 ± 0.15 % (0.69 ± 0.66 kg) and reduced fat mass by 0.58 ± 0.22 kg 
compared to the baseline measurements and therefore the decreased time to finish 
the twenty five mile time trial and the subsequent increased power output seems to 
be related to increase in fat free mass and/or the subsequent decrease in fat mass in 
our trials. The importance of contribution of optimal levels of fat free mass in 
performance over total mass has been highlighted in many studies looking at 
performance in cycling (White et al., 1982a, Housh et al., White et al., 1982b). Thus, 
even the small change in body composition during the trial could have been an 
important ergogenic aspect of the calcium intervention. 
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5.4.3 Plasma lactate 
Mean plasma lactate even though statistically non-significant, showed an increase in 
25TTC2 compared to 25TTC1. It is possible that this may have been an important 
outcome due to the supplementation. The accumulation of lactate and especially 
associated photons, both intracellular and extracellular compartments have long been 
thought to contribute to the fatigue of high intensity submaximal exercise. However, 
Robergs et al. (2004) have beautifully explained the case of how lactate production 
retards, not causes acidosis. Neilson and co workers (2001) have also demonstrated 
that extracellular lactic acid accumulation has a protective effect on muscle 
excitability (on K
+
 induced force depression and impairment of calcium release from 
the sarcoplasmic reticulum) and these effects work in conjunction with elevated 
adrenaline on stabilising membrane excitability (de Paoli et al., 2007). This study 
was performed in isolated muscle fibres and it remains unknown if these 
mechanisms that operate under controlled conditions in vitro occur to a similar 
degree in complex in-vivo systems. However, the data from this investigation 
certainly inch towards supporting the hypothesis that increased lactate production 
may indeed have a performance enhancing effect by way of maintaining and even 
increasing power output of the cycling time trial via improving membrane 
contractibility.  
In addition, it is also possible that the lactate anions provide oxidizable substrate 
during long duration exercise, this may have aided the performance of the time trial 
after calcium supplementation, as lactic acid (lactate and associated proton) 
clearance through oxidation and gluconeogenesis during exercise has been thought to 
provide a beneficial and alkalizing effect on blood pH (Brooks, 2010, Gladden, 
2004).  In addition, lactate accumulation also seems to be associated with redox 
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(oxidation – reduction) potential that may help sustain intramuscular ATP 
production and thus performance (Sahlin et al., 1987).  
One of the interesting effects of lactic acid production is its effects on ionised 
calcium fractions in blood. Hydrogen ions release calcium ions from those bound to 
protein and lactate chelates this free calcium ions (Toffaletti and Abrams, 1989). In 
the absence of any direct data from submaximal exercise, a study by (Ljunghall et 
al., 1985) reported a net reduction in plasma ionised calcium content during an 
experiment with isokenetic one legged exercise. They have attributed this decrease to 
formation of calcium – lactate complex. This concurrent decrease in plasma ionised 
calcium would normally stimulate parathyroid hormone to mobilise calcium from the 
bone. However, it is possible that calcium supplementation may have some 
protective effect in maintaining the ionised calcium levels during exercise without a 
subsequent rise in iPTH that may in turn affect the lipolytic and associated metabolic 
cascade (Zemel, 2002) to impair performance. It is not possible to comment any 
further on iPTH responses in this study as they were not measured.  
These mechanisms perhaps explain to a certain degree the performance enhancing 
effect of plasma lactate combined with calcium supplementation; however they do 
not explain why lactate production was increased after four weeks of calcium 
supplementation in the same exercise compared to the trial without supplementation. 
One way to look at the data is that since fatigue may have been attenuated in the trial 
after supplementation of calcium via multiple mechanisms, it allowed the athletes to 
perform at a relatively higher intensity (increased power output) thus displaying the 
well established linear relationship between plasma lactate values and exercise 
intensity (Coyle, 1995a). 
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5.4.4 Substrate metabolism  
There was no significant difference in the total energy expenditure between the two 
trials. This concurs with various other studies that have looked at the influence of 
dietary calcium on energy expenditure in humans (Melanson et al., 2003, Jacobsen et 
al., 2005, Teegarden et al., 2008) or mice (Papakonstantinou et al., 2003). But it is 
the reverse of what was observed in study 1, where the athletes were required to 
cycle at a fixed intensity for 60 min before and after calcium supplementation.  
In fact, metabolic energy expenditure calculated as a product of oxygen consumption 
was slightly lower (~125 kJ) in 25TTC2. Mean oxygen consumption decreased with 
a concurrent increase in RER values indicating that the intensity of exercise 
performed was higher in the trial following calcium supplementation with a 
concurrent increase in power output. The percentage contribution of fat as a substrate 
decreased in the trial after calcium supplementation by ~15%. The decreased rate of 
fat oxidation may not be a reflection on the effect of calcium supplementation, but an 
artefact of increased intensity of exercise in the 25TTC2 which the athletes were able 
to sustain perhaps via the metabolic pathways discussed earlier. Since the intensity 
of exercise did not remain the same it would not be possible to make any direct 
comparisons on the influence of dietary calcium on fat oxidation in time trials where 
exercise intensity is regulated by the athlete in order to achieve the best time-to-
completion of a set distance.  
Studies looking at specifically fat oxidation effect of calcium supplementation in non 
exercising population have reported positive correlations between calcium intakes 
and fat oxidation rates. Melanson et al. (2003) have reported positive correlations 
between acute calcium intake (over a wide range of intakes within a 24 hour period) 
and fat oxidation rates in that 24 hour period. Interestingly, this correlation 
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disappears with habitual calcium intake (dairy and total calcium). But several 
longitudinal studies have reported increases in fat oxidation rates as a result of 
increased calcium intakes. A 12 week intervention with 900 mg/d calcium 
supplementation in overweight women (75.5 ± 9.6 kg) increased fat oxidation by 1.5 
± 0.6 g/h (Teegarden et al., 2008). An even longer intervention of one year in young 
women reported an increase in fat oxidation (Gunther et al., 2005).  
However, the blood indices indicate a higher NEFA availability in blood during the 
trial after calcium supplementation, indicating an increased rate of lipolysis. It is 
therefore possible that this study did not see an increase in fat oxidation rates as the 
intensity of the exercise was not in the range of maximum fat oxidation (Horowitz 
and Klein, 2000b) and therefore the available NEFA may have either re-esterified 
(Romijn et al., 1995) or substrate oxidation rates would have altered post the 
exercise session (Romijn et al., 1993). Recovery RER or NEFA was not measured in 
this study to make further inferences on this point. However, Men'shikov (2004) 
have reported a multiple correlation between after load plasma free NEFAs, changes 
in plasma ionised calcium and oxygen consumption (r = 0.72, p < 0.05).  
It is also possible that the increased lipolytic rate may be a function of higher 
exercise intensity (Horowitz and Klein, 2000b) rather than any influence of calcium 
supplementation. Since increased lipolysis during exercise is directly correlated to 
the catecholamine response (Arner et al., 1990, Coppack et al., 1994) and increased 
dietary calcium has shown to influence an increase in catecholamine response (Izawa 
and Komabayashi, 1994). Further supporting that premise Kozyreva (1983) found 
that adaptation to low temperatures is associated with a decrease in blood calcium 
and an increased sensitivity of the β-adrenoreceptors to norepinephrine. But, there 
are conflicting reports in the literature with regards to the effect of dietary calcium 
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on lipolysis per se. Some studies have reported theoretical mechanistic (Xue et al., 
2001) and physiological observations in humans (Parikh and Yanovski, 2003, Zemel, 
2003) and animals (Shi et al., 2001a, Zemel et al., 1995) implicating a positive 
correlation with dietary calcium and increased lipolysis. Jacobsen et al. (2005) have 
reported an increase in NEFA levels in overweight (26.5 ± 2 kg/m2) male (n = 8) 
and female (n = 2) after one week of high calcium (1800 mg/d) with normal protein 
intake (15%EI) of 66 ± 212 µmol/l. In a study by Cummings et al. (2006) calcium 
intake (575 calcium citrate mg in breakfast) acutely stimulated post prandial fat 
oxidation along with a decreased suppression of NEFA independent of insulin 
action. However, Lorenzen et al. (2007) reported suppressed post prandial lipidemia 
only with a meal high in dairy calcium (793 mg) and no such effect with 
supplemental (850 mg elemental calcium from carbonate) dose. In another study five 
weeks of calcium phosphate (800 mg/d) intervention did not show an effect on fat 
metabolism or energy expenditure in resting conditions or caffeine and epinephrine 
stimulation (Bortolotti et al., 2008). It is difficult to make outright comparisons with 
the results of these studies however, because the demographics of the sample were 
mainly overweight or obese populations and these blood indices reflect a resting fat 
metabolism state rather than an intense exercise period.  
Hormonal changes such as iPTH and subsequently 1,25 (OH)2D3 has been shown to 
have immediate effects on lipolysis (Shi et al., 2001b, Zemel et al., 2000, Xue et al., 
2001). A seven day high calcium diet (1259 ± 9 mg/d) intervention has shown 
significant decrease in plasma 1,25 (OH)2D3 (175 ± 16 to 138 ± 15 pmol/l) (Boon et 
al., 2005). Subsequently, they also reported a significant decrease in adipose tissue 
NEFA synthase mRNA expression in a group of lean people consuming a diet high 
in dairy calcium, but this was only at an intake of 2500 mg/d of calcium and they so 
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no effect with a more realistic 1200 mg/d calcium intake (Boon et al., 2007). iPTH 
has been shown to increase during intense (Kristoffersson et al., 1995) and 
submaximal exercise (Ljunghall et al., 1986a, Ljunghall et al., 1988) perhaps through 
adrenergic stimuli (Rasmussen, 1971). Also, in-vitro and in-vivo experiments have 
demonstrated that an increase in NEFA causes complex binding of free calcium ions 
as well as enhanced binding of calcium to albumin (Zaloga et al., 1987). This 
reduction in the ionic calcium levels due to submaximal exercise stimulates iPTH 
release from the thyroid gland (Ljunghall et al., 1986a) which in turn may stimulate 
calcium release from the bone. Plasma ionic calcium concentrations were not 
directly measured in this study, however, Zaloga et al. (1987) have demonstrated that 
this binding of NEFA to calcium ions has a net effect of significant reduction in 
plasma ionic concentrations, but total calcium concentrations (which include 
complex and albumin bound fractions) are unchanged. However, Salvesen et al. 
(1994) and Vora et al. (1983) have reported an increase in plasma total calcium and 
ionised calcium after a treadmill exercise session of moderate intensity. Without 
directly measuring plasma calcium levels it would be speculative to infer the effects 
of supplementation on the hormones related to changes in plasma calcium 
concentrations. But it is possible that the higher NEFA levels seen after calcium 
supplementation of four weeks may have been a consequence of the changes in 
hormonal milieu due to the supplementation or may just be an effect of the increased 
intensity of cycling sustained by the athletes who may have stimulated greater 
lipolytic response or even hemoconcentration.   
There was no difference in mean plasma glucose values between the two trials in the 
first forty minutes. However, in the last 20 min of the exercise plasma glucose 
increased by 0.93 ± 0.66 mmol/l in 25TTC2 compared to 25TTC1. As the mean 
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power output was higher in the trial after calcium supplementation this increase 
could have been a result of increased metabolic activity via adrenergic stimulation 
(Exton et al., 1972). Even though calcium has been implicated in the release of 
insulin (Krahl, 1966, Clausen, 1979) and chelation of i[Ca2+]can prevent insulin from 
stimulating glucose transport and glucose oxidation  in adipocytes (Pershadsingh et 
al., 1987) and cardiac muscle (Cheng et al., 1993) . At most, speculatively it is 
possible that plasma glucose increase in the last 20 min of exercise in the trial 
following calcium supplementation could be related to a similar action of calcium 
supplementation in skeletal muscle as well.  
 
5.5 Conclusions  
The results from this study suggest that calcium is beneficial to endurance type 
events. There has been a meaningful reduction in time to complete the time trial with 
a concurrent increase in gross efficiency and economy of the riders (Thus supporting 
hypothesis iii). This was achieved via increases in power output capacity and 
perhaps an involvement of metabolic substrates that may have been altered due to 
dietary calcium. This study shows that even though calcium may improve rate of 
lipolysis in exercising humans, the oxidation of substrates is closely dictated by the 
relative intensity of the exercise (Coyle et al., 1997, Romijn et al., 1993, Romijn et 
al., 1995). This is an important point for athletes, coaches and sports nutritionists to 
consider whilst designing nutritional and training strategies to maximise adaptations 
to fat oxidation via novel approaches such as increase in intake of dietary calcium.  
With regards to the body composition of the participants, there was no statistically 
significant decrease in fat mass (thus refuting hypothesis iv). However, trends 
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certainly continue to support the hypothesis of increased calcium intake with a 
reduction in fat mass (Zemel, 2003, Zemel et al., 2008, Zemel et al., 2000).  
Nonetheless, the role of calcium in improving the athletes‟ ability to maintain higher 
power outputs over 60 min periods seem to be an avenue that has potential for 
further research. However, considering the potential effects of calcium on power 
output, it is important to test this hypothesis further with a higher exercise intensity 
protocol to study if the demands of higher power output can further augment the 
metabolic consequences that occur as a result of calcium supplementation.  
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CHAPTER 6 
EFFECTS OF CALCIUM SUPPLEMENTATION ON PERFORMANCE OF 
A TEN MILE CYCLING TIME TRIAL 
 
6.1 Introduction 
The previous study indicated that calcium supplementation improves 25TT 
performance. The main findings suggested that increased power output and the 
corresponding improvements in time-to-completion without a concurrent increase in 
oxygen uptake were the responsible factors in meaningful improvements in 
performance. The present study was conducted to quantify the range of effect of 
calcium supplementation on performance. A ten mile time trial (10TT) a standard 
race duration, is markedly different metabolic interactions of the substrates from that 
of an hour long (25TT) endurance event. Thus this study will help identify the role of 
calcium in performance where fat oxidation is not the primary source of energy.  
Increased dietary calcium seems to play a role in increasing the concentration of 
NEFA in the plasma (Zemel, 2004, Zemel, 2003, Xue et al., 1998). However the fat 
oxidation rates were not concurrently increased in the 25TT indicating other 
mechanisms of ergogenicity. Increased power output might have been one of the 
important mechanisms through which calcium exerts an ergogenic effect. A 10TT 
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would require a higher mean PO over the duration of the exercise compared to the 
25TT therefore allowing the observation of the range of this effect of calcium 
supplementation on endurance performance. Thus, if the role of calcium in 
performance enhancement is broader than just that of change in the availability of 
substrate metabolism this would be more pronounced in the 10TT. Factors such as 
attenuation of fatigue (Cairns et al., 1998) and other related effects such as changes 
in the ionic state of the extra cellular and intracellular compartments, that play a 
larger role in more intense exercise (Nummela et al., 2008, Allen et al., 2008b, 
Robergs et al., 2004) will be highlighted through improvement in performance.  
Hence, the aim of this experimental trial was to study the effects calcium 
supplementation on performance during a ten mile cycling time trial. This would be 
achieved by investigating its effects on power output and improvement in gross 
efficiency of the athletes.  
 
 6.1.1 Hypotheses  
v. It is hypothesised that calcium supplementation of 1000 mg/day for four 
weeks improves cycling performance via improvements in power output and 
gross efficiency of athletes.  
vi. It is hypothesised that calcium supplementation of 1000 mg/day for four 
weeks does not improve performance in a 10 mile time trial via changes in 
substrate availability. 
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6.2 Methods  
6. 2.1 Participants 
Ten male healthy well-trained cyclists (time trialists) were recruited from local 
cycling clubs. These were the same athletes that were recruited in study 2. Inclusion 
criteria as described in section 3.1 were met. An exclusion criterion was set at 10 
mile time-trial time-to-finish of ≥ 25 min in the past season. The mean (± SD) 
physical characteristics of the participants are given in table 5.1. 
 
6.2.2 Experimental design  
The study was designed as a randomised, single blind, placebo controlled crossover 
intervention. Participants were initially assigned to a four week calcium intervention 
(1000 mg elemental calcium (citrate)/day). And the following year, four out of the 
ten participants returned to perform the study without any intervention. The study 
was designed as a single blind intervention to ensure the collection of the 
intervention data was not compromised due to the long waiting period between the 
two points in data collection. Participants were not informed of the single blind 
nature of the study and were led to believe that the intervention was double blind and 
they were randomly assigned to either a calcium or placebo group.  
The study was repeated at the same time of the year (October to January) to coincide 
with the end of the racing calendar. This allowed the changes observed in the 
intervention not to be caused primarily due to increase in training intensity or load 
that occurs during the racing season. In addition the October to January period is 
generally used to as a low training period by most competitive cyclists (Sassi et al., 
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2008, White et al., 1982a); therefore any improvements observed could be attributed 
to a large extent on the intervention.  
As with the earlier interventions the capsule formulation procedure was adhered to as 
described in section 3.2.7. 
 
6.2.3 Testing protocols 
6.2.3a Wpeak (aerobic) test 
All participants underwent a Wpeak (aerobic) test one at a time in order to compare their 
time trial performance power output with their peak power output. This was 
performed once either before the 25TT or before 10TT depending on the 
randomisation protocol. Participants reported to the laboratory in a post prandial 
state of at least one meal consumed about 60 to 90 min prior to testing. After setting 
up of cycle ergometer and emptying of bladder, the test was commenced and 
conducted as described in section 3.3.4.  
 
6.2.3b Time trials  
Participants performed two 10 TT, one at baseline before calcium supplementation 
(10TTC1) and one at the end of the 30 day intervention period (10TTC2). On each 
occasion the participants arrived post prandial after consumption of the same meal at 
least 60-90 min prior to testing. Upon arrival they underwent the anthropometry 
measurements as described in section 3.2.5 and resting blood measurements as 
described in section 3.2.4 for analysis of lactate, plasma glucose and NEFA. The 
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tests were performed as described in described in section 3.3.5. Water was allowed 
ad-libitum throughout the tests. No verbal or other forms of encouragement were 
given during the tests. 
At the same time of the following year participants (n = 4) repeated the same study 
without a supplement intervention (nocebo). They performed a baseline test before 
the start of the intervention (10TTP1) and after 30 days (10TTP2). 
 
6.2.3c Dietary and physical activity records 
All participants were asked to keep a seven day diet diary and physical activity log 
as described in section 3.2.6 during any typical week of the intervention and were 
asked to repeat the same in the following year during the nocebo intervention. 
A schematic representation of the test protocol has been presented in Fig. 6.1. 
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Fig. 6.1 Schematic representation of experimental protocol within each intervention of study 3 
 
 
6.2.3d  Statistical analysis 
All data was analysed and statistical analysis conducted as described in section 3.5. 
Mean differences were analysed for intra-trial changes and not inter-trial changes. 
This was done to measure the changes due to calcium supplementation from baseline 
and after four weeks. 
 
191 
 
6.3 Results 
6.3.1 Performance variables  
Mean changes in performance variables between the two trials before and after 
calcium supplementation have been presented in table 6.1 along with % change, 
90%CI and effect size (d). All relevant variables are discussed individually as a 
product of the time line during the exercise period in the following sections.  
 
Table 6.1 Mean (± SD) change in performance variables in participants of study 3, 
following calcium supplementation for four weeks 
n = 10 
10TT C1 
(mean ± SD) 
10TT C2 
(mean ± SD) 
% 
change 
(mean) 
 
90%CI 
of mean 
change 
 
 d 
Time to finish 
(min) 
23.66 ± 1.18 23.45 ± 1.07 -0.86 
 
-0.26 to -0.14 0.18 
Power output 
(W) 
264.32 ± 32.56 271.54 ± 33.20 2.66
*
 
 
6.88 to 7.56 0.21 
Relative PO 
(W/kg) 
3.60 ± 0.32 3.69 ± 0.39 2.44 
 
0.05 to 0.13 0.25 
Relative PO 
(W/%FFM) 
3.11 ± 0.44 3.17 ± 0.44 1.89 
 
0.00 0.14 
Gross efficiency 
(%) 
18.59 ± 0.87 19.78 ± 1.27 1.19
†
 
 
0.98 to 1.4 1.09 
Gross economy 
(W/l) 
64.84 ± 3.00 68.99 ± 4.45 6.01
†
 
 
3.42 to 4.88 0.82 
Energy 
expenditure (kJ) 
2078 ± 231 1928 ± 250 -7.78 
 
-160 to 140 0.19 
Heart rate (bpm) 168 ± 10 168 ± 14 0.24 
 
-1.34 to 2.16 0.00 
Cadence (rpm) 94.42 ± 8.89 94.45 ± 5.88 0.03 
 
-1.54 to 1.6 0.00 
*
significant at p < 0.05   
† 
significant at p < 0.001 
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Mean changes in performance variables of the athletes (n = 4) who repeated the trial 
without any calcium supplementation a year later are presented in table 6.2. These 
are subsequently discussed individually with the calcium trial variables for 
comparative analysis.  
 
Table 6.2 Mean (± SD) change in performance variables in participants of study 3, 
following nocebo supplementation for four weeks 
n = 4 
 
10TT P1 
(mean ± SD) 
 
10TT P2 
(mean ± SD) 
 
% 
change 
(mean) 
 
 
90%CI 
of mean 
change 
d 
Time to finish 
(min) 
24.27 ± 2.04 24.28 ± 2.11 0.01 
 
-0.05 to 0.05 0.00 
Power output 
(W) 
266.13 ± 54.91 261.68 ± 53.97 -1.70 
 
-5.23 to -3.69 -0.08 
Energy 
expenditure 
(kJ) 
1795 ± 426 2087 ± 229 13.99 
 
129 to 454 0.85 
Gross 
efficiency (%) 
20.21 ± 0.12 19.10 ± 0.50 -1.11 
 
-1.42 to -0.8 -0.90 
Gross 
economy (W/l) 
70.49 ± 0.42 66.61 ± 1.75 -5.82 
 
-4.97 to -2.79 -0.90 
Heart rate 
(bpm) 
163 ± 10 168 ± 5 3.06 
 
0.89 to 9.11 -0.65 
Cadence (rpm) 92.50 ± 5.51 93.85 ± 2.55 1.44 
 
-1.08 to 3.78 -0.31 
 
 
 
 
193 
 
6.3.1a Time to finish 
There was a non-significant decrease in mean time to finish the 10 mile time trial 
after four weeks of calcium supplementation (-0.20 ± 0.11 min, p =0.08). The 
maximum decrease in finish time was -0.93 min and the minimum was an increase 
of 0.66 min. Individual time to finish after before and after calcium supplementation 
are presented in Fig. 6.2. Time to finish correlated significantly with PPO in both 
before (r = -0.91, p = 0.001) and after supplementation (r = -0.90, p = 0.001).  
There was no significant difference in time to finish after the nocebo trial  
(0.00 ± 0.06 min, p > 0.05). The time-to-completion of all participants who 
completed both the calcium and the placebo trial are presented in Fig. 6.2 (second 
graph) where all (n = 4) participants performed better in the calcium trial except one 
who‟s time-to-completion increased after calcium supplementation (0.66 min). 
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Fig. 6.2 Individual time to finish during the ten mile time trials before (10TTC1) and after 
(10TTC2) calcium supplementation (n = 10). Time to finish of the individual 
participants in the nocebo trial before (25TTP1) and after four weeks (25TTP2) (n = 4) 
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6.3.1b Power output  
Mean power output during 10TTC1 and 10TTC2 are presented in Fig. 6.3. After 
calcium supplementation mean power output was greater throughout the 10 TT  
(p = 0.09). Mean power output in all the trials was greatest in the first five minutes 
and then steadily declined over 20 min (p = 0.10). 
 
Fig. 6.3 Mean (± SD) Power output during the ten mile time trials before (10TTC1) and after 
(10TTC2) calcium supplementation (n = 10) 
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Mean power output in the nocebo trials are presented in Fig. 6.4. In both the trials 
mean power output was highest in the beginning and steadily declined over the 
exercise period. Mean power output was lower throughout the exercise session in the 
10TTP2 trial (p = 0.22). Mean power output was maintained (a mean decrease of  
0.43 ± 4.29 W) in the last few min (4.27 ± 2.04 min) in the 10TTP1 trial and mean 
power output continued to decline in the last few min (4.28 ± 2.10 min) in 10TTP2 
trial (-8.12 ± 2.01 W) (p = 0.27). 
 
Fig. 6.4 Mean (± SD) power output during the ten mile time trials in the nocebo trial before 
(10TTP1) and after (10TTP2) four weeks (n = 4) 
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6.3.1c Gas exchange 
i. Oxygen uptake  
There was no statistically significant difference in the mean oxygen consumption 
between the two trials (Fig. 6.5) (p = 0.11). There was a significant effect of time in 
mean oxygen uptake between the start values and all the exercise values (p = 0.03). 
 
 
Fig. 6.5 Mean (± SD) oxygen consumption during the ten mile time trials before (10TTC1) and 
after (10TTC2) calcium supplementation (n = 10) 
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During the nocebo trial this trend was reversed (Fig. 6.6). The mean oxygen 
consumption increased during 10TTP2 (p = 0.12) and there was no difference in the 
values at the start of both the trials. There was a significant effect of time between 
the start and the exercise values in both the trials (p = 0.02). 
 
 
Fig. 6.6 Mean (± SD) oxygen consumption output during the ten mile time trials in the nocebo 
trial before (10TTP1) and after (10TTP2) four weeks (n = 4) 
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ii. Respiratory Exchange Ratio (RER) 
 
RER at the start and during trials before and after calcium supplementation is 
presented in Fig. 6.7. RER increased in the trial after four weeks of calcium 
supplementation as compared to the trial before, but this did not reach statistical 
significance (p = 0.08). There was a significant effect of time from resting values 
compared to the exercise values in both trials (p = 0.03). 
 
 
Fig. 6.7 Mean (± SD) RER during the ten mile time trials before (10TTC1) and after (10TTC2) 
calcium supplementation (n = 10) 
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This trend was not observed in the trials after one year without calcium 
supplementation (Fig. 6.8) (p = 0.28).  
 
 
Fig. 6.8 Mean (± SD) RER output during the ten mile time trials in the nocebo trial before 
(10TTP1) and after (10TTP2) four weeks (n = 4) 
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6.3.1d Gross efficiency 
Athletes produced higher power at a given rate of oxygen consumption after calcium 
supplementation (p = 0.001). This trend was observed across the range of oxygen 
consumption values during the ten mile time trials. Gross efficiency was 
significantly higher throughout the exercise session after the calcium 
supplementation throughout the trial (Fig. 6.9) (p = 0.001) compared to baseline.  
 
 
Fig. 6.9 Mean (± SD) gross efficiency during the ten mile time trials before (10TTC1) and after 
(10TTC2) calcium supplementation (n = 10) 
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However, this trend was reversed in 10TTP (Fig. 6.10), but did not reach statistical 
significance (p = 0.09).  
 
 
Fig. 6.10 Mean (± SD) gross efficiency output during the ten mile time trials in the nocebo trial 
before (10TTP1) and after (10TTP2) four weeks (n = 4) 
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6.3.1e. Haematological variables 
i. Plasma lactate 
 
Mean plasma lactate in 10TTC1 and 10TTC2 are presented in the Fig. 6.11. There 
was no difference in the plasma lactate values at rest between the two trials  
(p = 0.18).  
 
Fig. 6.11 Mean (± SD) plasma lactate during the ten mile time trials before (10TTC1) and after 
(10TTC2) calcium supplementation (n = 10) 
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ii. Plasma glucose 
 
There was no statistically significant difference in the mean plasma glucose between 
the two trials (p = 0.10) (Fig. 6.12). Mean exercise plasma glucose decreased in the 
first five min in both trials but remained higher in the 10TTC2 throughout the rest of 
the time trial. There was no statistically significant difference (condition and time) in 
the values between the two trials but the trend indicated that exercise plasma glucose 
was higher throughout 10TTP2. 
 
Fig. 6.12 Mean (± SD) plasma glucose during the ten mile time trials before (10TTC1) and after 
(10TTC2) calcium supplementation (n = 10) 
 
 
 
 
3.0
3.5
4.0
4.5
5.0
5.5
6.0
6.5
7.0
7.5
Rest Start 5 10 15 20 Finish
M
ea
n
 p
la
sm
a 
g
lu
co
se
 
 (
m
m
o
l/
l)
 
Time (min) 
10TTC1 10TTC2
205 
 
iii. Plasma NEFA  
 
Mean plasma NEFA was non-significantly higher at rest and during exercise 
following four weeks of calcium supplementation as compared to before 
supplementation (p = 0.07) (Fig. 6.13). Resting values were significantly lower than 
the NEFA values towards the end of the exercise period (time points 20 min and 
finish time) in both the trials (p = 0.01, main effect of time). 
 
 
Fig. 6.13 Mean (± SD) plasma NEFA during the ten mile time trials before (10TTC1) and after 
(10TTC2) calcium supplementation (n = 10) 
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6.4 Discussion  
6.4.1 Performance enhancement via attenuation of muscular fatigue 
The principle aim of this study was to continue to quantify the effect of calcium 
supplementation on cycling performance. This study aimed to outline the effects of 
the supplementation on a more intense and relatively higher contribution of the 
anaerobic fraction of energy supply (~75-80% PPO) during exercise. The main 
findings indicate that calcium seems to improve cycling performance even at a 
higher intensity but the magnitude of benefit seems to diminish. The cyclists in this 
study (10 mile time trial) were 0.86% faster to finish after four weeks of calcium 
supplementation than baseline measurements. Time to finish the trial in this study 
correlated significantly with the PPO of the riders in both trials, baseline and after 
supplementation and this concurs with Hawley and Noakes (1992) who looked at 
PPO and 20 km TT correlations (r = -0.91) but not Balmer et al. (2000) who reported 
high correlations with PPO and mean PO of 16.1 Km TT (r = 0.99) but not with time 
to finish (r = 0.46). This result is not as clinically significant as the performance 
enhancement achieved in the 25 TT (change in time to finish = 2.25%).  
 
Bentley et al. (2001) have shown a strong correlation on a 90 min TT performance 
with Wpeak but not that of 20 min TT. Even though these relationships have been 
criticised in the literature (Bentley et al., 2001) for differences in the protocols used 
to elicit Wpeak, it does indicate that the mechanisms that are involved in improvement 
of submaximal exercise due to increased dietary intake of calcium also play a part at 
higher intensities. Increased mean PO (7.22 ± 0.65 W) in this study lends to the 
explanation, that the fatigue attenuating mechanisms have a strong role to play in the 
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effect that calcium seems to exert as an ergogenic aid. It has also led to a higher GE 
and economy in the riders and as discussed earlier, Coyle (1992) has eluded towards 
GE being a key determinant of endurance performance. Once again the riders were 
riding at a higher given power output with a decreased oxygen consumption level for 
that intensity after four weeks of calcium supplementation compared to the baseline 
measurements. GE values in other 10 mile (16.1 km) TT are in the similar range 
(Balmer et al., 2000).  
Coyle (1999) highlights that performance V O2 is determined mainly via maximal 
oxygen uptake and the corresponding oxygen consumption at lactate threshold. The 
model further indicates that lactate threshold power is a function of lactate threshold 
V O2 and GE. Indeed this study shows that power output was higher in the trial 
following calcium supplementation at lactate threshold (mean increase of 3.11 ± 
0.33%). However this increase in sustainability of increased power output at the 
lactate threshold was not a function of increased V O2, therefore one has to assume 
that the relationship could have been uncoupled due to the influence of calcium, 
perhaps in lactate clearance or in the total ionic shift per se from intra to extracellular 
space. The evidence to support this explanation can be found in the difference in the 
pattern of appearance of lactate in the blood between the two trials. The 10TT 
calcium intervention did not see an increase in lactate values above that noted at 
baseline after the first 5 min of exercise whereas, in the 25TT the mean plasma 
lactate values were higher than baseline throughout the exercise period. In contrast to 
the 25TT where the lactate and the power output values followed the same pattern, 
this was not the case in the short, more intense 10TT despite similar increases in 
power output after calcium supplementation. The increase in dietary calcium causing 
a change in the intracellular environment of the muscle could have made it possible 
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for a higher lactate level to be sustained in the muscle cells upon increased power 
output before an increase in blood lactate levels which were observed during the 20 
min and beyond measurements in the submaximal tests. Therefore it is possible to 
see the mean lactate values in the blood to increase above that observed during 
baseline measurements in the 25 TT but not in the short duration ~20 min of 10TT 
where the muscles could still sustain the higher levels of lactate build up. Studies by 
Wasserman et al. (1986) show that mechanisms for lactate increase in blood during 
exercise is inconsistent with mechanisms depending simply on an increase in 
glycolysis without an accompanying change in the redox state. Bentley et al. (2001) 
have calculated that only 45% of the variation in the power output during a 20 mile 
TT could be explained by the relationship between power outputs at lactate 
threshold. This seems to indicate that other factors aside from the ability of the 
athletes to delay lactate accumulation in blood may explain the difference in the time 
trial performance of the two trials.  
Various studies looking at the skeletal muscle damage have alluded to the increases 
in resting i[Ca
2+
] levels in fatigued muscles compared to the un-fatigued muscle 
fibres (Bruton et al., 1998, Cairns and Lindinger, 2008, Chin et al., 1997, Westerblad 
and Allen, 1996). A pivotal role for i[Ca
2+
] in modifying ec-coupling was first 
suggested by the finding that in skinned fibres exposed to millimolar concentrations 
of calcium, ec-coupling was completely abolished (Fitts and Balog, 1996). This in 
conjunction with the results from other studies (Zhao et al., 2005, Germinario et al., 
2008) showing increased availability of extracellular calcium entry pathways into the 
cells, attenuate fatigue and lowers extracellular calcium exacerbates fatigue during 
repeated tetani may imply a role of increased calcium intake in these fatigue 
attenuating mechanisms. The exact mechanism however seems seeped in limitations 
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of measurements, an in-depth understanding of ionic shifts during high intensity and 
submaximal exercise  and the application of different exercise protocols to study 
fatigue and performance. An intriguing question, which has been addressed in many 
studies, is whether cycling efficiency can be increased either by training (Faria et al., 
2005, Hawley and Stepto, 2001, Joyner and Coyle, 2008) or any other mechanisms. 
If calcium did play a part in improvement of GE in the 10 TT then the involvement 
of cardiac output and pedalling rate were not major players as shown in this trial. 
Interestingly, Gaesser and Brooks (1975) have implicated pedalling frequency as an 
important determinant of GE. In this study, it has been shown that an increase in PO 
with a concurrent reduced oxygen uptake, allowing the athletes to maintain this 
higher intensity this was achieved with no difference in the pedalling rate or change 
in oxygen cost. One of the reasons for a decreased oxygen consumption and thus 
improved GE could be attenuation of fatigue via changes in metabolic costs to 
sustain the exercise including but not limited to changes glucose metabolism.  
 
6.4.2 Substrate metabolism 
During the 10TT glucose concentration in the plasma increased after calcium 
supplementation after the first five min of exercise compared to the baseline 
measurements. Studies looking at the relationship of dietary calcium to glycolysis 
indicate the role of increased i[Ca
2+
] and a corresponding increase in glucose 
transport in the skeletal muscle cells (Sørensen et al., 1980). Persechini and Cronk, 
(1999) demonstrated that in skeletal muscle fibres entry of external calcium could 
activate calmodulin associated in the mobilisation of hexokinase and 
phosphofructokinase. Calmodulin activation also increases translocation of GLUT-4 
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containing vesicles to the sarcolemma (Bruton et al., 2001) subsequently increasing 
glucose transport in the cells. High intensity (70-80% V O2max) exercise stimulates 
glycolysis (Romijn et al., 1993) and it is possible that increase in dietary calcium 
reducing the i[Ca
2+
] rise may reduce or inhibit the glucose uptake facilitated by the 
activation of calmodulin. This mechanism has been shown to work in insulin 
stimulated glucose transport into the sarcolemma (Bruton et al., 2001) as well. This 
in turn could lead to a decreased uptake of glucose in the muscle cells and a potential 
rise in plasma glucose due to increased glycolytic activity during high intensity 
exercise. There is also some evidence that growth hormone increases i[Ca
2+
] and 
blocks the blocks the insulin like response of cells in the uptake of glucose (Gaur et 
al., 1998), however the mechanisms still remain unclear. For example the correlation 
between exercise induced GH release and its effect on i[Ca
2+
] levels in skeletal 
muscles and whether these influence insulin sensitivity during exercise remains 
unclear. Therefore even though GH has been shown to affect i[Ca
2+
] levels 
(Schwartz et al., 1992) , its role in glucose metabolism during exercise is unclear. 
Since high intensity exercise stimulates GH and consequently increases blood 
glucose levels via increased liver output (Pruett, 1971), if increased dietary calcium 
did influence GH this could be an important mechanistic pathway for the increased 
blood glucose levels seen in the trial after four weeks of calcium supplementation. 
Also, increased adrenergic stimulation of glycolytic activity simply as a function of 
increased intensity of exercise cannot be ruled out. This can be seen even in the 
increase of NEFA in the blood after calcium supplementation compared to baseline 
measurements. Lipolytic activity seems to have been enhanced due to increase in 
calcium intake. This is evident from both the 10TT and 25 TT data and there is 
evidence in the literature to suggest that increase in metabolites in the plasma may be 
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due to the role calcium plays in energy and substrate metabolism in addition to its 
role in attenuating fatigue and thus enabling the athletes to maintain higher power 
outputs.  
 
6.4.3 Other possible avenues in performance enhancement via calcium 
Blood flow depends on vascular tone, which is greatly influenced by the sympathetic 
nervous system through adrenoceptor stimulation and ultimately by the intracellular 
free calcium (Kuriyama et al., 1982). Jolma et al. (2000) have shown that increased 
dietary calcium in hypertensive people reduced vasoconstriction via increased 
sensitivity to nitric oxide and decreased vascular production of superoxide and 
vasoconstrictor prostanoids. The participants in this study maintained a higher power 
output without a concurrent increase in oxygen consumption, which allowed them to 
be more efficient after four weeks of calcium supplementation. It is possible that 
improved vasodilatation due to increased dietary calcium, led to improved blood 
transport and thus oxygen to the muscle cells, thus improving GE.   
 
6.4.4 Conclusions  
The findings from this study further support the role of calcium in endurance 
performance. As with the previous study the more intense 10TT also elicited higher 
PO and concurrent faster time to completion. In addition the similar trend of 
increased GE of the riders was seen as in the longer duration event of 25TT (thus 
supporting hypothesis v). As suggested by the literature (Romijn et al., 1993, 
Horowitz and Klein, 2000) the 10TT relied mainly on non lipid substrates for energy 
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production. The appearance of FFA continued to rise throughout the exercise 
however the RER data suggests that fat metabolism played a minor role in the 
performance of this event (thus supporting hypothesis vi).   
Thus despite the role of fat metabolism being limited in an event of 10TT, calcium 
positively influenced performance of the riders. This indicates that beneficial role of 
calcium in performance enhancement is broader than just its effects on substrate 
metabolism.  
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CHAPTER 7 
SYNTHESIS OF FINDINGS 
 
This thesis set out to investigate the role of supplemental calcium in substrate 
metabolism, body composition and thus endurance performance. In order to study 
these effects, a series of investigations were designed. First, was to explore the 
changes in substrate metabolism, particularly increased fat oxidation during exercise. 
These changes were then cumulated along with the effect of calcium 
supplementation on body composition changes over four weeks. Lastly, based on the 
findings of this exploratory study, sample population to study the effects on calcium 
directly on performance enhancement was identified and studied. 
The first intervention of moderate intensity exercise, on a heterogeneous mixed 
population, was designed to explore changes in substrate metabolism due to calcium 
supplementation. Based on the suggested in-vitro data (Xue et al., 2001, Zemel, 
1998, Zemel, 2001) and epidemiological studies (Teegarden et al., 2008, Teegarden 
and Zemel, 2003, Zemel et al., 2008, Zemel et al., 2000), the initial model derived 
from the literature (Fig. 2.17) suggests an inverse relationship between low dietary 
intakes of calcium and decreased lipolysis in intact adipose tissue (Xue et al., 2001), 
which was also related to changes in iPTH levels.  Therefore, the first stage in the 
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creation of a detailed model, to identify the role of calcium supplementation in sports 
performance, was to identify if calcium supplementation had an effect on calcium 
metabolism. Results from the first study revealed that calcium supplementation did 
not significantly change any markers of calcium metabolism in the non-deficient 
healthy people. Plasma iPTH did show a small non-significant reduction in the 
calcium supplementation trial, similar to the findings of several other studies 
(Feldman, 1999, Schrager, 2005, Theobald, 2005b).  
Secondly, it was important to study the impact of calcium supplementation in the 
diet on markers of lipolysis as suggested by Xue et al. (2001). This may help 
changes in substrate oxidation rates during endurance type activities. Indicators of 
lipolysis such as appearance of NEFA in the plasma showed a non-significant 
increase in the calcium supplementation trial, along with increased fat oxidation 
during the exercise session. Even though the markers of calcium metabolism in the 
plasma saw no changes due to increased calcium, plasma NEFA did show a trend 
towards increased lipolytic activity. This is shown within the preliminary model 
outlined in Fig.7.1. 
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Fig. 7.1  Schematic representation of changes in blood metabolites aftercalciumsupplementation    
(stage1). Non-significant changes (NSC) 
 
 
This increased availability of NEFA could potentially increase fat oxidation rates. 
Fat oxidation at rest has been shown to increase modestly in healthy population as an 
effect of increasing calcium (Jacobson, et al., 2005) and dairy (Boon et al., 2005) in 
the diet. This has not been studied in exercising population prior to this investigation. 
Indeed, the results from the first study, allied to those existing in the literature, 
showed that fat oxidation rates, at moderate intensities of exercise, were significantly 
higher after four weeks of calcium supplementation. The second stage of creating a 
model to explain calcium supplementation and performance consisted of studying 
the impact of these substrate oxidation changes over a four week period on body 
composition.  
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Favourable changes in body composition due to increase in dietary calcium have 
been reported elsewhere (Pereira et al., 2002, Zemel, 2004, Zemel et al., 2005) in 
obese, over-weight non-athletic populations. The current study is the first of its kind 
studying athletic populations. The results from study one showed that the 
participants lost significant amounts of body fat after calcium supplementation. 
However, these results, when analysed according to training status, showed that this 
was the case only with the well-trained participants. The recreationally trained 
participants displayed increases in body fat, and decreases in lean mass. These 
findings are expressed within the model at Fig. 7.2.  
 
         
        (a)                                     (b) 
Fig. 7.2 Schematic representation of the changes in body composition of well-trained (a) and     
recreationally trained (b) participants in study 1(stage 2) 
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The difference in the change in body composition, between the two sub groups, was 
not related to TEE. Mean TEE in the entire group was significantly higher, though 
this was not the case when the data was analysed for well-trained athletes (Fig. 4.15). 
Unlike animal model observations, the well-trained athletic sample did not display 
the energy inefficiency model described in Zemel et al. (2000). This model alluded 
to the down regulation of UCP2 and 3 as a result of higher circulating calcitriol 
levels (Fig. 2.17) during exercise. However, if this were to be true only in regulating 
RMR as suggested (Sun et al., 2004, Zemel et al., 2000) then the decreases in body 
fat levels of the well-trained participants, despite no increase in TEE during exercise, 
could be explained. Irrespective, these changes in body composition could have an 
indirect effect on performance enhancement in endurance sport, especially in events 
that require the athletes to maintain a power to weight ratio advantage over a period 
of time (Coyle et al., 1991).  
When further building the model, the changes in body composition, with calcium 
supplementation, are now embedded at Fig. 7.3 This model consolidates the findings 
from the initial exploratory study, on where calcium supplementation may play an 
important role on improved lipolysis and ensuing fat oxidation, and its effects on 
changes in body fat levels.   
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Fig.7.3 Schematic representation (derived from the mean of the entire group in study 1) of the 
effect of calcium supplementation on fat metabolism and body composition changes in 
four weeks of supplementation. Non-significant changes (NSC) 
 
The final stage of the model creation required identification of the impact of the 
changes mentioned above on athletic performance enhancement. In order to identify 
the direct effect of calcium supplementation on performance, studies two and three 
were performed on well-trained, time trial cyclists. Stratification of performance, 
based on preliminary time trial efforts, was used to ensure as homogenous a 
population as possible were used. Measures of energy and fat metabolism, body 
composition changes were also measured to corroborate the findings from the 
previous study, and to further support the structure of the newer model outlined in 
Fig. 7.3. Body composition changes followed the same trend as in study one, again 
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justifying their inclusion as a key component within the model. The effect of calcium 
supplementation on lipolysis too concurred with the earlier study, as seen by the 
increased availability of NEFA after four weeks of supplementation. These results 
further consolidated the role of calcium in affecting energy and substrate metabolism 
in highly trained athletes, and justify their inclusion within the performance-related 
model. 
However, the novel finding in these studies was that this increased availability of 
NEFA did not influence the rate of carbohydrate oxidation during a time trial. This 
confirms that fat oxidation rates are tightly regulated as a function of intensity of 
work (Romijn et al., 1993) which may rise during competition to override the 
lipolytic drive and increase reliance on glycolysis. Despite calcium supplementation 
being non-glycogen sparing it aided in decreasing time to finish the trials; both 
25TTC and 10TTC. One explanation for this can be seen in the improved gross 
efficiency of the participants after the calcium intervention. Despite a mean decrease 
in consumption of oxygen during the time trials the PO increased (~4% increment in 
power output during the 25 TT and ~2.7% improvement in the power output in 10 
TT) decreasing time to finish as a consequence.  
The role of calcium in the increased PO in the time trials could be attributed to its 
effect on attenuating fatigue via increased in extra cellular calcium levels. Cairns and 
Lindinger, (2008) reported attenuation of muscular fatigue with increased extra 
cellular calcium levels. Westerblad and Allen (1991) showed that in exercise that 
lasted longer than 20 min muscles did not display marked acidosis during fatigue but 
increased i[Ca
2+
]. Calcium supplementation attenuates increases in i[Ca
2+
] (Zemel, 
2002). It is therefore plausible that the higher intensity of exercise sustained by the 
athletes, post calcium supplementation, was a result of fatigue attenuation via the 
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above mentioned mechanisms. This response has been embedded within a further 
update to the model, seen in figure 7.4. Thus, the increased plasma lactate in the 
25TTC2, compared to that in 25TTC1, is potentially a function of increased PO (Fig. 
5.16). In addition, the reduction in oxygen uptake which contributed to the improved 
gross efficiency has potential associations with improved vascular tension due to 
increased intake of calcium, as highlighted by the research carried out with 
hypertensive patients (Zemel, 2001, Azadbakht et al., 2005, Pereira et al., 2002, 
Fujiwara et al., 1991, Stern et al., 1984). This may allow for increased distribution of 
oxygen to the muscles whilst exercising reducing the gross uptake of oxygen. These 
influences are now embedded in the revised model at Fig. 7.4. 
 
Fig.7.4. Schematic representation of the role of calcium in performance enhancement via its 
effect on PO, GE 
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The identification of the possible mechanistic routes in which calcium may have had 
an influence on performance in addition to its effect on body composition changes 
demonstrate that calcium supplementation has a dual effect in improving 
performance. Thus, the final stage in understanding the model, in which calcium 
may function as an ergogenic aid, is presented in Fig. 7.5. This model incorporates 
the findings from this series of hierarchical investigations, where the role of fat 
metabolism and oxidation having been explored in a heterogeneous population, led 
to performance tests conducted on well-trained athletes. In particular, the role of 
body composition, performance, hormonal influences and vascular factors are 
outlined. 
 
Fig.7.6. Schematic representation of the consolidated role of calcium in performance 
enhancement via its effect on PO, GE and changes in body composition. Non-
significant changes (NSC) 
222 
 
Results from the final studies revealed that time to completion of the endurance trials 
decreased uniformly. The milieu of possible avenues is described in Fig. 7.5, though 
further investigation is needed to confirm the existence of these pathways more fully. 
However, what the completed model does not show was that performance 
enhancement in endurance exercise may have occurred via glycogen sparing. The 
role of increased mobilisation of fatty acids into the plasma has an important 
function in the overall effect it may have on changes on body composition. During a 
moderate to high intensity performance trial, this increased availability of fatty 
substrates is still over ridden by the preferential use of carbohydrate sources (Brooks, 
1997).  
Since all the interventions were four weeks long it has only been possible to study 
short term effects of these metabolic shifts proposed by Zemel and co-workers. They 
proposed that calcium‟s down regulation of calcitriol synthesis is primarily 
responsible for its beneficial impact on body weight (Zemel et al., 2000). This view 
is based on in-vitro studies in which treatment of adipocytes with supraphysiological 
(nanomolar) levels of free calcitriol produces a rapid influx of calcium. Such an 
effect is observed almost immediately and is not mediated by the interaction with the 
nuclear vitamin D receptor (Shi et al., 2001b). The translation of these in-vitro 
observations to human studies will take time in gathering a critical mass. But more 
importantly these observations need to be made specifically on athletes per se as 
physiological adaptations in energy and substrate metabolism are rather different in 
trained and untrained people (Sidossis et al., 1998). This was highlighted by the 
difference in the body composition results in the two sub-groups in study 1. Such 
factors including the lack of statistically significant results in certain metabolic 
variables suggest that these observations need to be made on a larger sample of 
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athletes with different training status. In addition, there are a few limitations that 
were encountered as a process of this investigation which have been highlighted 
below.  
 
7.1 Limitations of the study  
7.1.1 Implications of nocebo interventions  
Since there was no placebo treatment in Chapters 5 and 6, the sensitivity of the 
magnitude of the findings may be compromised. The main reason for not having a 
cross-over design was to ensure that the intervention period was short enough to not 
include any change in normal training volume of the athletes due to the racing 
calendar. The four week period of the intervention during the months of October to 
January for all the 10 athletes allowed maintanence of this homogeneity. Based on 
the study one (Chapter 4) logistics, a cross over design incorporating a four week 
intervention period would transcend this low volume training period. This would 
lead to a bigger loss of sensitivity of the findings compared to the exclusion of a 
placebo. In order to minimize the potential negative effects of this single blind test, 
retest design, two things were ensured; firstly that the athletes were told that the 
design was a two group intervention where they could either be in the placebo or the 
intervention group; and secondly, the time trials were conducted again at the same 
time of the following year with a smaller proportion of the same participants (n = 4) 
who could participate again and this allowed for reporting the changes in 
performance that would normally occur at that time of the year when no calcium 
supplementation was taken. The limitation of this trial in the following year was that 
the sample size was less than that of the original calcium supplementation trial 
224 
 
(40%) and thus compromising an exact like for like findings. However, a strength of 
this designed was that participants acted as their own controls, thus enabling a 
comparison of an individual‟s data with and without calcium supplementation. Even 
though, this did not reach statistical significance, meaningful individual differences 
have been observed in the outcome between the nocebo and the calcium 
supplementation trials. 
 
7.1.2 Sample size 
Another limitation of all the studies has been the limited sample size. It has been 
reported that a sample size of 10 participants with 3 trials would not meet the 95% 
confidence to study within participant variations (Hopkins et al., 1999). However, 
externally valid test protocols such as time trials (Atkinson et al., 1999) have allowed 
for the demonstration that the changes in performance indicators such as power 
output and time-to-completion to show meaningful changes in performance of the 
participants. As discussed by Batterham and Atkinson (2005) the sample size matters 
only if the statistical significance is not reached. It has been shown that GE and time-
to-completion in at least 25 TT and GE and mean power output in 10TT are 
statistically significant results. In conjunction with the statistical significance and the 
90% CI data one can confidently say that the sample size was adequate to reduce the 
probability of a type I error. Batterham and Atkinson (2005) argues that a low 
sample size makes it more difficult to arrive at statistical significance because the 
associated low degrees of freedom make it more difficult for a given test statistic to 
be greater than the critical value. Lastly, sample sizes in sports science studies have 
traditionally been smaller in number compared to other medical and clinical trials. 
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One reason for this is the homogeneity of the sample required to test the effect of a 
certain intervention. This invariably will reduce the transferability of the results to a 
wider population base and therefore any conclusive evidence of the ergogenicity of 
calcium in the wider sporting areas needs further research.  
 
7.1.3 Normal variance of cycling performance 
One disadvantage of the studies on 25 and 10 mile TT was that the coefficient of 
variance of the cyclists‟ performance on time trials was not measured without any 
intervention in general. (Hopkins et al., 2001) suggests the importance of a practice 
trial as more evident in studies conducting more than two trials. (Hopkins et al., 
2001) have reported the CV between the first 2 trials as 1.3 times the CV between 
subsequent trials; performance was also reported to have improved by 1.2% between 
the first 2 trials but by only 0.2% between subsequent trials. However, they found no 
clear-cut effect of time between trials (Hopkins et al., 2001). All the performance 
variables (time-to-completion and mean PO) however have improved by more than 
1.2% with the exception of time to finish in the 10TT (-0.86%) and the trend being 
reversed in the trial that followed at the same time after one year without any 
intervention indicates that the ergogenic effects seen in the trials as a consequence of 
the calcium intervention is not a type I error. 
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7.1.4 Ergogenic effects of citrate 
The form of calcium supplements used in all the studies was calcium citrate. This 
was chosen as calcium citrate has been shown to have improved bioavailability in 
humans compared to other oral forms (Hanzlik et al., 2005, Heaney et al., 2001, 
Sheikh et al., 1987, Pak et al., 1987). However, citrate supplementation has been 
studied in sports as a potential ergogenic aid (Oöpik et al., 2003, Potteiger et al., 
1996, Kowalchuk et al., 1989, Parry-Billings and MacLaren, 1986). One of the main 
biochemical arguments in the case of the ergogenicity of citrate is the increase in 
extracellular pH which may create a favourable pH gradient for the removal of 
intracellular lactate and hydrogen ions (Requena et al., 2005). In most studies this 
was achieved via an acute load of calcium citrate given 30 mins (Hooker et al., 1987) 
ranging to 3 hours (George and MacLaren, 1988) prior to the exercise session. A 
majority of the positive outcomes reported have been with studies looking at high 
intensity, near maximal (Mc Naughton and Cedaro, 1992) to supra maximal 
(McNaughton, 1990, Linossier et al., 1997) with a few studies reporting some 
beneficial effect of citrate in endurance events (Potteiger et al., 1996, Oöpik et al., 
2003) but not others (Schabort et al., 2000). In order to minimize any effect of citrate 
on performance the participants were asked to consume their capsules at least 60 to 
90 min prior to their training sessions during the four weeks of calcium 
supplementation. The laboratory tests in all the studies were performed after the end 
of the supplementation period, so no capsule was consumed on those days. There are 
no known interventions looking at any longitudinal effects of citrate on performance 
since citrate associated buffering capacity does not lend to these effects on  long term 
accumulation of these ions.  
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7.1.5 Other physiological variables 
In terms of physiological parameters studied, there are a few shortcomings in 
variables measured the author would like to highlight. It would have been very 
interesting to study the effects of changes in resting metabolic rate and core body 
temperature measurements of the participants due to calcium supplementation. It has 
been shown that increasing dietary calcium increases lipolysis (Xue et al., 1998, Xue 
et al., 2001) and decreases lipogenesis (Xue and Zemel, 2000). Also UCP 2 in 
adipocytes and UCP 3 expression in skeletal muscle have been shown to be 
significantly up regulated in high calcium diet interventions (Sun and Zemel, 2004). 
These proteins are able to uncouple ATP production from mitochondrial respiration, 
thereby dissipating energy as heat and affecting energy metabolism efficiency 
(Schrauwen and Hesselink, 2002). Thus, the changes observed in body composition 
in all the studies in this trial may have had a stronger explanation and perhaps a 
direct mechanistic link if resting metabolic rate and core body temperature 
observations were made.  
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CHAPTER 8 
CONCLUSIONS AND FUTURE DIRECTIONS  
 
8.1  Overall conclusions 
The aims of this investigation were to explore the in-vitro mechanisms of the role of 
calcium on substrate metabolism, energy expenditure and body composition. In 
addition, if calcium did influence these factors during long duration exercise, then its 
impact on endurance performance would be quantified.  
From the first exploratory study of heterogeneous mixed athletic sample it was 
shown that calcium supplementation increased total energy expenditure but did not 
have a statistically significant impact on fat metabolism. Plasma NEFA exhibited 
trends of increased appearance in the plasma with a concurrent trend in increased fat 
oxidation during a 60 min steady state (50% O2peak) protocol (aim 1). In addition 
the body composition of the participants changed favourably with a reduction in fat 
mass and an increase in lean mass (aim 2). This was exhibited by the well-trained 
participants but this trend was reversed in the recreationally trained participants.  
Thus the further 2 studies investigating the role of calcium on endurance 
performance were conducted on two varying durations, twenty five mile and ten mile 
V
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time trials. These tests were conducted on highly trained athletes based on the results 
from study 1. The results from these studies indicate that calcium supplementation 
improved power output and GE of the riders (aim 3) reducing the time to complete 
the trials. This improvement was however, more pronounced in the 25TT than in the 
10TT. In addition the body composition of the participants showed a small but 
statistically non-significant decrease in body fat over a four week period.  
Thus the involvement of calcium in performance enhancement warrants further 
investigation. Also, the mechanistic route or routes in which calcium intake is 
helpful to athletes in improving performance remains to be elucidated. As explored 
earlier, this may be due to various factors including attenuation of fatigue, improved 
lipolysis and vascular tone in addition to favourable changes in body composition. 
Thus, future studies designed to understand these mechanisms will be important to 
enhance our understanding of the role of calcium in energy metabolism. On the 
whole, benefits of understanding the complex role of calcium in energy metabolism 
range from amelioration of the spread of obesity, hypertension, diabetes and other 
areas of the metabolic syndrome to potential ergogenic effects on performance. 
 
8.2 Future directions  
From the original tap-water “incidence” in Sydney Ringer‟s laboratory (Ringer, 
1883, Ringer, 1882) to the identification of the far reaching effects of changes to 
cellular ion handling in the development of hypertension, obesity, diabetes, 
cardiovascular abnormalities, the research in the area of the role of calcium ion in 
metabolism has come a long way. But, in many ways this is only scratching the 
surface. This investigation began with a simple hypothesis based on the negative 
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correlation between dietary calcium and body mass/fat; but the journey has been 
daunting in the sheer complexity and delicacy of the interactions between various 
cellular fractions and indeed entire systems within the body. The results of these 
studies demand further investigations in various aspects of the role of calcium 
metabolism; from lipolysis in the adipocytes (perhaps with direct measurements on 
rate of glycerol appearance) and IMTG in the skeletal muscle, insulin action on 
glucose transport and utilization, fatigue attenuation mechanisms, vascular tone, core 
body temperature via changes in UCP regulation, production of ROS and indeed 
changes in gross energy balance over time. Specifically UCP3 expressed in skeletal 
muscle that may have an involvement in regulation of ROS, in mitochondrial NEFA 
transport and in regulation of glucose metabolism in skeletal muscle, in addition to 
the role they play in energy regulation (Schrauwen and Hesselink, 2002). Also, 
recently, it has been shown that cycling efficiency is inversely proportional to the 
UCP3 content in skeletal muscle (Mogensen et al., 2006). With the involvement of 
calcium in the regulation of UCP content in both adipocyte and skeletal muscle (Sun 
and Zemel, 2004) this is a promising avenue to explore with regard to calcium an its 
role in energy partitioning and this body composition.  
Some of the immediate and pertinent questions that arise from this investigation are 
perhaps the specific issue of the use of calcium as an ergogenic aid in sport. There is 
a need to tease out the mechanistic links between the increased power output and the 
relationship with improved GE and indeed performance. This investigation has only 
revealed a possible link between calcium and such factors such as increased power 
output with a few suggestive ideas on the underlying mechanisms. There needs to be 
specific studies designed to identify them in isolation. In addition, optimum dosage, 
timing, length of supplementation, differing levels of total energy intake along with 
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different macro nutrient combinations, interaction of other dietary micro nutrients 
aiding calcium or hindering its effect as an ergogenic aid, effects of long term 
habitual calcium intake on a short term high calcium supplementation program, 
different protocols with acute calcium loading and perhaps numerous as such need to 
be addressed before we can conclusively and confidently say more about the place of 
calcium on the sport nutrition podium.  
Another interesting line of investigation would be the interaction of calcium used as 
an ergogenic aid with other well established ergogenic aids, for example caffeine. 
Caffeine is known to cause an increase in urinary excretion of calcium (Heaney and 
Recker, 1982), this as discussed in Chapter 2 has far reaching effects on the athletes, 
including increased peripheral vascular resistance and increased secretion of 
calcitropic hormones that may in turn cause the metabolic shift in substrate 
oxidation. However, when studying the ergogenic effects of caffeine per se, its role 
in CNS stimulation (Nehlig et al., 1992) which may involve changes in i[Ca
2+
] levels 
(Allen and Westerblad, 1995), inhibition of phosphodiesterases (Nehlig and Debry, 
1994) and blocking of cAMP (Nehlig and Debry, 1994, Nehlig et al., 1992) all of 
which may in turn influence or at least impact the effect calcium may have on 
performance. Caffeine has also shown to directly affect force production and raise 
i[Ca
2+
] levels in mouse skeletal muscle (Allen and Westerblad, 1995Allen and 
Westerblad, 1995). Thus, such interactions will need closer inspection considering 
the wide spread use of substances such as caffeine in sport.  
Also, the studies on fat metabolism, fat excretion and energy balance all need further 
investigation with the specific sporting populations, as there is increasing data on 
sedentary population but knowing the changes in physiological adaptations that 
occur in trained individuals these questions that have gained recognition in the 
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metabolically disturbed population need to be revisited within sporting populations.  
Finally, these questions will undoubtedly need to be readdressed with advances in 
technology and instrumentation design and thus create avenues that have not even 
been conceived of by the author.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
233 
 
REFERENCES 
 
 
Aaron, E., Seow, K., Johnson, B. & Dempsey, J. (1992) Oxygen cost of exercise 
hyperpnea: Implications for performance. Journal of Applied Physiology,  
72: 1818-1825. 
 
Abe, M. & Sherwood, L. (1972) Regulation of parathyroid hormone secretion by 
adenyl cyclase. Biochemical and Biophysical Research Communications, 48: 
396-401. 
Achten, J., Gleeson, M. & Jeukendrup, A. E. (2002) Determination of the exercise 
intensity that elicits maximal fat oxidation. Medicine & Science in Sports & 
Exercise, 34: 92-97. 
 
Achten, J. & Jeukendrup, A. (2004) Optimizing fat oxidation through exercise and 
diet. Nutrition, 20: 716-727. 
Ainsworth, B. E., Haskell, W. L., Whitt, M. C., Irwin, M. L., Swartz, A. M., Strath, 
S. J., O'Brien, W. L., Bassett Jr, D. R., Schmitz, K. H. & Emplaincourt, P. O. 
(2000) Compendium of physical activities: An update of activity codes and 
met intensities. Medicine and Science in Sports and Exercise,  
32(9): S498-S516. 
 
Alberts, B., Bray, D., Johnson, A., Lewis, J., Raff, M., Roberts, K., Walter, P. & 
Campbell, A. (2004) Essential cell biology, New York: Garland Science. 
Allen, D. G., Lamb, G. D. & Westerblad, H. (2008) Skeletal muscle fatigue: Cellular 
mechanisms. Physiological Reviews, 88: 287-332. 
Allen, D. G., Lee, J. A. & Westerblad, H. (1989) Intracellular calcium and tension 
during fatigue in isolated single muscle fibres from xenopus laevis. The 
Journal of Physiology, 415: 433-458. 
Allen, D. & Westerblad, H. (1995) The effects of caffeine on intracellular calcium, 
force and the rate of relaxation of mouse skeletal muscle. The Journal of 
Physiology, 487: 331-342. 
Allen, D. G. & Westerblad, H. (2001) Role of phosphate and calcium stores in 
muscle fatigue. The Journal of Physiology, 536: 657-665. 
Andersson, U., Filipsson, K., Abbott, C. R., Woods, A., Smith, K., Bloom, S. R., 
Carling, D. & Small, C. J. (2004) AMP-activated protein kinase plays a role 
in control of food intake. Journal of Biological Chemistry, 279 (13): 12005-
12008. 
Arner, P., Kriegholm, E., Engfeldt, P. & Bolinder, J. (1990) Adrenergic regulation of 
lipolysis in situ at rest and during exercise. Journal of Clinical Investigation,  
85: 893-898. 
234 
 
Ashe, M., Scroop, G. C., Frisken, P., Amery, C., Wilkins, M. & Khan, K. (2003) 
Body position affects performance in untrained cyclists. British Journal of 
Sports Medicine, 37: 441-444. 
Astrand, P. O. & Rodahl, K. (Ed) (1986) Textbook of work physiology. New York: 
Mc Graw Hill. 
Atkinson, G., Nevill, A. & Edwards, B. (1999) What is an acceptable amount of 
measurement error? The application of meaningful „analytical goals‟ to the 
reliability of sports science measurements made on a ratio scale. [abstract] 
Journal of Sports Sciences, 17(1): 18.  
Atkinson, G. & Nevill, A. (2001) Selected issues in the design and analysis of sport 
performance research. Journal of Sports Sciences, 19: 811-827. 
Aubert, A. E., Seps, B. & Beckers, F. (2003) Heart rate variability in athletes. Sports 
Medicine, 33: 889-919.Azadbakht, L., Mirmiran, P., Esmaillzadeh, A. & 
Azizi, F. (2005) Dairy consumption is inversely associated with the 
prevalence of the metabolic syndrome in tehranian adults. American Journal 
of Clinical Nutrition, 82: 523-530. 
Azadbakht, L., Mirmiran, P., Esmaillzadeh, A. & Azizi, F. (2005) Dairy 
consumption is inversely associated with the prevalence of the metabolic 
syndrome in tehranian adults. American Journal of Clinical Nutrition,  
82: 523-530. 
Balmer, J., Davison, R. C. R. & Bird, S. R. (2000) Peak power predicts performance 
power during an outdoor 16.1-km cycling time trial. Medicine & Science in 
Sports & Exercise, 32: 1485-1490. 
 
Banister, E., Calvert, T., Savage, M. & Bach, T. (1975) A systems model of training 
for athletic performance. Australian Journal of Sports Medicine, 7: 57-61. 
 
Barger-Lux, M. J., Heaney, R. P., Packard, P. T., Lappe, J. M. & Recker, R. R. 
(1992) Nutritional correlates to low calcium intakes. Clinical Applied 
Nutrition, 2: 39-44. 
Barclay, C. (1996) Mechanical efficiency and fatigue of fast and slow muscles of the 
mouse. The Journal of Physiology, 497: 781-794. 
 
Barr, S. I. (2003) Increased dairy product or calcium intake: Is body weight or 
composition affected in humans? Journal of Nutrition, 133: 245S-248. 
Bassett Jr, D. R., Kyle, C. R., Passfield, L., Broker, J. P. & Burke, E. R. (1999) 
Comparing cycling world hour records, 1967-1996: Modeling with empirical 
data. Medicine & Science in Sports & Exercise, 31: 1665-1676. 
 
Batterham, A. & Atkinson, G. (2005) How big does my sample need to be? A primer 
on the murky world of sample size estimation. Physical Therapy in Sport,  
6: 153-163. 
235 
 
Batterham, A. & Hopkins, W. (2006) Making meaningful inferences about 
magnitudes. International Journal of Sports Physiology and Performance,  
1: 50-57. 
Bell, H. J., Ramsaroop, D. M. & Duffin, J. (2003) The respiratory effects of two 
modes of passive exercise. European Journal of Applied Physiology,  
88: 544-552. 
Bentley, D., McNaughton, L., Thompson, D., Vleck, V. & Batterham, A. (2001) 
Peak power output, the lactate threshold, and time trial performance in 
cyclists. Medicine & Science in Sports & Exercise, 33: 2077-2081. 
Berchtold, M. W., Brinkmeier, H. & Müntener, M. (2000). Calcium ion in skeletal 
muscle: Its crucial role for muscle function, plasticity, and disease. 
Physiological Reviews, 80: 1215-1265. 
 
Bergman, B. C. & Brooks, G. A. (1999) Respiratory gas-exchange ratios during 
graded exercise in fed and fasted trained and untrained men. Journal of 
Applied Physiology, 86: 479-487. 
Berridge, M., Lipp, P. & Bootman, M. (2000) The versatility and universality of 
calcium signalling. Nature Reviews Molecular Cell Biology, 1: 11-21. 
Bianchi, C. & Shanes, A. (1959) Calcium influx in skeletal muscle at rest, during 
activity, and during potassium contracture. The Journal of General 
Physiology, 42: 803-815. 
Bigland-Ritchie, B. & Woods, J. (1984) Changes in muscle contractile properties 
and neural control during human muscular fatigue. Muscle & nerve,  
7: 691-699. 
Bingham, S. A., Gill, C., Welch, A., Cassidy, A., Runswick, S. A., Oakes, S., Lubin, 
R., Thurnham, D. I., Key, T. & Roe, L. (1997) Validation of dietary 
assessment methods in the uk arm of epic using weighed records, and 24-
hour urinary nitrogen and potassium and plasma vitamin c and carotenoids as 
biomarkers. International Journal of Epidemiology, 26: S137-S151. 
 
Blaustein, M. (1974) The interrelationship between sodium and calcium fluxes 
across cell membranes. Reviews of Physiology, Biochemistry and 
Pharmacology, 70: 33-82. 
Bloom, S., Johnson, R., Park, D., Rennie, M. & Sulaiman, W. (1976) Differences in 
the metabolic and hormonal response to exercise between racing cyclists and 
untrained individuals. The Journal of Physiology, 258(1): 1-18. 
Boon, N., Hul, G. B. J., Sicard, A., Kole, E., Van Den Berg, E. R., Viguerie, N., 
Langin, D. & Saris, W. H. M. (2006) The effects of increasing plasma 
calcitriol on energy and fat metabolism and gene expression. Obesity,  
14: 1739-1746. 
 
236 
 
Boon, N., Hul, G. B. J., Stegen, J. H. C. H., Sluijsmans, W. E. M., Valle, C., Langin, 
D., Viguerie, N. & Saris, W. H. M. (2007) An intervention study of the 
effects of calcium intake on faecal fat excretion, energy metabolism and 
adipose tissue mrna expression of lipid-metabolism related proteins. 
International Journal of Obesity, 31: 1704-1712. 
Boon, N., Hul, G. B. J., Viguerie, N., Sicard, A., Langin, D. & Saris, W. H. M. 
(2005) Effects of 3 diets with various calcium contents on 24-h energy 
expenditure, fat oxidation, and adipose tissue message rna expression of lipid 
metabolism-related proteins. American Journal of Clinical Nutrition,  
82: 1244-1252. 
Borer, K. (2003) Exercise endocrinology, Champaign: Human Kinetics Publishers. 
Borg, G. (1973) Perceived exertion: A note on" History" And methods. Medicine 
and Science in Sports, 5(2): 90-93. 
Bortolotti, M., Rudelle, S., Schneiter, P., Vidal, H., Loizon, E., Tappy, L. & 
Acheson, K. J. (2008) Dairy calcium supplementation in overweight or obese 
persons: Its effect on markers of fat metabolism. American Journal of 
Clinical Nutrition, 88: 877-885. 
Bowers Jr, G. & Rains, T. (1988) Measurement of total calcium in biological fluids: 
Flame atomic absorption spectrometry. Methods in enzymology,  
158: 302-319. 
Brooks, G. (1997) Importance of the „crossover‟concept in exercise metabolism. 
Clinical and Experimental Pharmacology and Physiology, 24: 889-895. 
Brooks, G. A. (2010) What does glycolysis make and why is it important? Journal of 
Applied Physiology, 108: 1450-1451. 
 
Bruton, J., Katz, A. & Westerblad, H. (2001) The role of Ca
2+
 and calmodulin in 
insulin signalling in mammalian skeletal muscle. Acta Physiologica 
Scandinavica, 171: 259-265. 
Bruton, J. D., Lannergren, J. & Westerblad, H. (1998) Mechanisms underlying the 
slow recovery of force after fatigue: Importance of intracellular calcium. Acta 
Physiologica Scandinavica, 162: 285-293. 
Burke, E. R. (2005) Nutritional ergogenic aids. IN Berning, J. R. & Steen, S. N. 
(Ed.) Nutrition for sport and exercise (2nd Edition). London: Jones & 
Bartlett Publishers Inc. 
Bülow, J. & Madsen, J. (1976). Adipose tissue blood flow during prolonged, heavy 
exercise. Pflügers Archiv European Journal of Physiology, 363: 231-234. 
 
Cairns, S., Hing, W., Slack, J., Mills, R. & Loiselle, D. (1998) Role of extracellular 
Ca
2+
 in fatigue of isolated mammalian skeletal muscle. Journal of Applied 
Physiology, 84: 1395-1406. 
237 
 
Cairns, S., Knicker, A., Thompson, M. & Sjøgaard, G. (2005) Evaluation of models 
used to study neuromuscular fatigue. Exercise and sport sciences reviews, 
 33: 9-16. 
Cairns, S. & Lindinger, M. I. (2008) Do multiple ionic interactions contribute to 
skeletal muscle fatigue? The Journal of Physiology, 586: 4039-4054. 
Carraro, F., Stuart, C. A., Hartl, W. H., Rosenblatt, J. & Wolfe, R. R. (1990). Effect 
of exercise and recovery on muscle protein synthesis in human subjects. 
American Journal of Physiology - Endocrinology And Metabolism,  
259: E470-E476. 
Cammisotto, P. G. & Bukowiecki, L. J. (2004) Role of calcium in the secretion of 
leptin from white adipocytes. AJP - Regulatory, Integrative and Comparative 
Physiology, 287: R1380-R1386. 
Cannon, D. T., Kolkhorst, F. W. & Cipriani, D. J. (2007) Effect of pedaling 
technique on muscle activity and cycling efficiency. European Journal of 
Applied Physiology, 99: 659-664. 
 
Carafoli, E. & Brini, M. (2000) Calcium pumps: Structural basis for and mechanism 
of calcium transmembrane transport. Current Opinion in Chemical Biology, 
4: 152-161. 
Cheng, H., Lederer, W. & Cannell, M. (1993) Calcium sparks: Elementary events 
underlying excitation-contraction coupling in heart muscle. Science,  
262: 740-744. 
Chin, E. R., Balnave, C. D. & Allen, D. G. (1997) Role of intracellular calcium and 
metabolites in low-frequency fatigue of mouse skeletal muscle. American 
Journal of Physiology - Cell Physiology, 272: C550-C559. 
Clapham, D. (2007) Calcium signaling. Cell, 131: 1047-1058. 
Clausen, T., Dahl-Hansen, A. & Elbrink, J. (1979) The effect of hyperosmolarity and 
insulin on resting tension and calcium fluxes in rat soleus muscle.  
The Journal of Physiology, 292: 505-526. 
 
Collins, M. A., Millard-Stafford, M. L., Sparling, P. B., Snow, T. K., Rosskopf, L. 
B., Webb, S. A. & Omer, J. (1999) Evaluation of the bod pod (r) for 
assessing body fat in collegiate football players. Medicine & Science in 
Sports & Exercise, 31(9): 1350-1356. 
Committee on Medical Aspects of Food Policy (COMA) (1991) Dietary reference 
values for food energy and nutrients for the United Kingdom. London: The 
Stationary Office. 
Cooke, C.B. (2004). Maximal oxygen uptake, Economy and efficiency. IN Eston, R. 
& Reilly, T. (Eds.) Kinanthropometry and exercise physiology laboratory 
manual, Vol. 2: Exercise Phyiology. London: Routledge. 
 
Coppack, S., Jensen, M. & Miles, J. (1994) In vivo regulation of lipolysis in humans. 
The Journal of Lipid Research, 35: 177-193. 
238 
 
Coppack, S., Persson, M., Judd, R. & Miles, J. (1999) Glycerol and nonesterified 
fatty acid metabolism in human muscle and adipose tissue in vivo. American 
Journal of Physiology- Endocrinology And Metabolism, 276: E233-E240. 
Coyle, E. (1995) Substrate utilization during exercise in active people. American 
Journal of Clinical Nutrition, 61: 968S-979S. 
Coyle, E. (1999) Physiological determinants of endurance exercise performance. 
Journal of Science and Medicine in Sport, 2: 181-189. 
Coyle, E. (1995) Integration of the physiological factors determining endurance 
performance ability. IN Holloszy, J. O. (Ed.) Exercise and sports science 
reviews. Baltimore: Williams and Wilkins. 
Coyle, E., Feltner, M., Kautz, S., Hamilton, M., Montain, S., Baylor, A., Abraham, 
L. & Petrek, G. (1991) Physiological and biomechanical factors associated 
with elite endurance cycling performance. Medicine & Science in Sports & 
Exercise, 23(1): 93-107. 
 
Coyle, E., Jeukendrup, A., Wagenmakers, A. & Saris, W. (1997) Fatty acid 
oxidation is directly regulated by carbohydrate metabolism during exercise. 
American Journal of Physiology- Endocrinology And Metabolism, 273: 
E268-E275. 
Coyle, E. F., Sidossis, L. S., Horowitz, J. F. & Beltz, J. D. (1992) Cycling efficiency 
is related to the percentage of type i muscle fibers. Medicine & Science in 
Sports & Exercise, 24: 782-788. 
Cummings, N. K., James, A. P. & Soares, M. J. (2006) The acute effects of different 
sources of dietary calcium on postprandial energy metabolism. British 
Journal of Nutrition, 96: 138-144. 
Currell, K. & Jeukendrup, A. (2008) Validity, reliability and sensitivity of measures 
of sporting performance. Sports Medicine, 38: 297-316. 
Curry, D., Bennett, L. & Grodsky, G. (1968) Requirement for calcium ion in insulin 
secretion by the perfused rat pancreas. American Journal of Physiology,  
214: 174-178. 
Davies, K. M., Heaney, R. P., Recker, R. R., Lappe, J. M., Barger-Lux, M. J., 
Rafferty, K. & Hinders, S. (2000) Calcium intake and body weight. Journal 
of Clinical Endocrinology Metabolism, 85: 4635-4638. 
Dawson-Hughes, B., Harris, S., Krall, E. & Dallal, G. (1997) Effect of calcium and 
vitamin d supplementation on bone density in men and women 65 years of 
age or older. New England Journal of Medicine, 337: 670-676. 
Dawson, M., Gadian, D. & Wilkie, D. (1980) Mechanical relaxation rate and 
metabolism studied in fatiguing muscle by phosphorus nuclear magnetic 
resonance. The Journal of Physiology, 299: 465-484. 
 
239 
 
Denke, M. A., Fox, M. M. & Schulte, M. C. (1993) Short-term dietary calcium 
fortification increases fecal saturated fat content and reduces plasma lipids in 
men. Journal of Nutrition, 123: 1047-1057. 
De Paoli, F. V., Overgaard, K., Pedersen, T. H. & Nielsen, O. B. (2007) Additive 
protective effects of the addition of lactic acid and adrenaline on excitability 
and force in isolated rat skeletal muscle depressed by elevated extracellular 
K
+
. The Journal of Physiology, 581: 829-839. 
 
Dickerson, J. & Morgan, J. B. (2003) Growth, development and the chemical 
composition of the body. Nutrition in Early Life. Chichester: John Wiley and 
Sons Ltd. 
Draznin, B., Sussman, K., Kao, M., Lewis, D. & Sherman, N. (1987) The existence 
of an optimal range of cytosolic free calcium for insulin stimulated glucose 
transport in rat adipocytes. Journal of Biological Chemistry. 262: 14385-
14388. 
Dyck, D., Putman, C., Heigenhauser, G., Hultman, E. & Spriet, L. (1993) Regulation 
of fat-carbohydrate interaction in skeletal muscle during intense aerobic 
cycling. American Journal of Physiology- Endocrinology And Metabolism, 
265: E852-E859. 
Eaton, S. B. & Nelson, D. A. (1991) Calcium in evolutionary perspective. American 
Journal of Clinical Nutrition, 54: 281S-287. 
Edwards, S. (1994) The heart rate monitor book. New York: Polar CIC Inc. 
 
Edwards, R., Hill, D. & Jones, D. (1975). Metabolic changes associated with the 
slowing of relaxation in fatigued mouse muscle. The Journal of Physiology, 
251: 287-294. 
 
Ettema, G. & Lorås, H. (2009) Efficiency in cycling: A review. European Journal of 
Applied Physiology, 106: 1-14. 
 
Exton, J. H., Friedmann, N., Wong, E. H.-A., Brineaux, J. P., Corbin, J. D. & Park, 
C. R. (1972) Interaction of glucocorticoids with glucagon and epinephrine in 
the control of gluconeogenesis and glycogenolysis in liver and of lipolysis in 
adipose tissue. Journal of Biological Chemistry, 247: 3579-3588. 
Faria, E. W., Parker, D. L. & Faria, I. E. (2005) The science of cycling: Physiology 
and training-part 1. Sports Medicine, 35: 285-312. 
Frayn, K. (1983). Calculation of substrate oxidation rates in vivo from gaseous 
exchange. Journal of Applied Physiology, 55: 628. 
Frayn, K. N. & Macdonald, I. A. (1997). Assessment of substrate and energy 
metabolism in vivo. In: Draznin, B. & Rizza, R. (Eds.) Clinical research in 
diabetes and obesity , methods, assessment and metabolic regulation. New 
Jersey: Humana Press. 
 
240 
 
Feldman, D. (1999). Vitamin d, parathyroid hormone, and calcium: A complex 
regulatory network. The American Journal of Medicine, 107: 637-639. 
 
Fields, D. A., Goran, M. I. & McCrory, M. A. (2002) Body-composition assessment 
via air-displacement plethysmography in adults and children: A review. 
American Journal of Clinical Nutrition, 75: 453-467. 
Finch, S., Britain, G., Unit, M. R. C. D. N., Social, Research, C. P., Epidemiology, 
U. o. L. D. o. & health, P. (1998) National diet and nutrition survey: People 
aged 65 years and over. Report of the diet and nutrition survey. London: The 
Stationery Office. 
Fitts, R. H. & Balog, E. M. (1996) Effect of intracellular and extracellular ion 
changes on e–c coupling and skeletal muscle fatigue. Acta Physiologica 
Scandinavica, 156: 169-181. 
Foster, C., Florhaug, J., Franklin, J., Gottschall, L., Hrovatin, L., Parker, S., 
Doleshal, P. & Dodge, C. (2001) A new approach to monitoring exercise 
training. Journal of Strength and Conditioning Research, 15: 109-115. 
 
Friedlander, A. L., Casazza, G. A., Horning, M. A., Usaj, A. & Brooks, G. A. (1999) 
Endurance training increases fatty acid turnover, but not fat oxidation, in 
young men. Journal of Applied Physiology, 86: 2097-2105. 
Friedman, P., Coutermarsh, B., Kennedy, S. & Gesek, F. (1996) Parathyroid 
hormone stimulation of calcium transport is mediated by dual signaling 
mechanisms involving protein kinase a and protein kinase c. Endocrinology, 
137: 13. 
Fry, A., Schilling, B., Chiu, L., Weiss, L., Kreider, R. & Rasmussen, C. (2003) 
Muscle fiber and performance adaptations to resistance exercise with 
myovive, colostrum or casein and whey supplementation. Research in Sports 
Medicine, 11: 109-128. 
Food Standards Agency (FSA) (2008) Manual of Nutrition, 11
th
ed., London: The 
Stationery Office. 
Fujiwara, S., Arita, M., Ueno, Y., Shiotani, M., Nakatsu, C., Nakamura, Y., Hano, 
T., Nishio, I. & Masuyama, Y. (1991) Effects of calcium antagonist, 
angiotensin-converting enzyme inhibitors and beta-blocker on hemodynamic 
and sympathetic nerve responses to exercise in essential hypertension. 
Journal of Cardiology, 21: 115-124. 
Gaesser, G. A. & Brooks, G. A. (1975) Muscular efficiency during steady-rate 
exercise: Effects of speed and work rate. Journal of Applied Physiology,  
38: 1132-1139. 
 
Galbo, H., Holst, J. & Christensen, N. (1975) Glucagon and plasma catecholamine 
responses to graded and prolonged exercise in man. Journal of Applied 
Physiology, 38: 70-76. 
 
241 
 
Gaur, S., Schwartz, Y., Tai, L. R., Frick, G. P. & Goodman, H. M. (1998) Insulin 
produces a growth hormone-like increase in intracellular free calcium 
concentration in okadaic acid-treated adipocytes. Endocrinology,  
139: 4953-4961. 
George, K. & MacLaren, D. (1988) The effect of induced alkalosis and acidosis on 
endurance running at an intensity corresponding to 4 mm blood lactate. 
Ergonomics, 31: 1639-1645. 
Germinario, E., Esposito, A., Midrio, M., Peron, S., Palade, P., Betto, R. & Danieli-
Betto, D. (2008) High-frequency fatigue of skeletal muscle: Role of 
extracellular [Ca
2+
]. European Journal of Applied Physiology, 104: 445-453. 
Gettys, T. W., Harkness, P. J., & Watson, P. M. (1996) The beta 3-adrenergic 
receptor inhibits insulin stimulated leptin secretion from isolated rat 
adipocytes. Endocrinology 137: 4054-4067. 
Gladden, L. B. (2004) Lactate metabolism: A new paradigm for the third 
millennium. The Journal of Physiology, 558: 5-30. 
 
Gollnick, P., Pernow, B., Essen, B., Jansson, E. & Saltin, B. (1981) Availability of 
glycogen and plasma ffa for substrate utilization in leg muscle of man during 
exercise. Clinical physiology and functional imaging, 1: 27-42. 
Gore, C., Hahn, A., Aughey, R., Martin, D., Ashenden, M., Clark, S., Garnham, A., 
Roberts, A., Slater, G. & McKenna, M. (2001) Live high: Train low increases 
muscle buffer capacity and submaximal cycling efficiency. Acta 
Physiologica Scandinavica, 173: 275-286. 
 
Grandjean, A. C. (1989) Macronutrient intake of us athletes compared with the 
general population and recommendations made for athletes. American 
Journal of Clinical Nutrition, 49: 1070-1076. 
 
Greenberg, D. (1997) Calcium channels in neurological disease. Annals of 
neurology, 42: 275-282. 
Gruchow, H., Sobocinski, K. & Barboriak, J. (1988) Calcium intake and the 
relationship of dietary sodium and potassium to blood pressure. American 
Journal of Clinical Nutrition, 48: 1463-1470. 
Guillemant, J., Accarie, C., Peres, G. & Guillemant, S. (2004) Acute effects of an 
oral calcium load on markers of bone metabolism during endurance cycling 
exercise in male athletes. Calcified Tissue International, 74: 407-414. 
Gunther, C. W., Legowski, P. A., Lyle, R. M., Weaver, C. M., McCabe, L. D., 
McCabe, G. P., Peacock, M. & Teegarden, D. (2006) Parathyroid hormone is 
associated with decreased fat mass in young healthy women. International 
Journal of Obesity, 30: 94-99. 
 
 
242 
 
Gunther, C. W., Lyle, R. M., Legowski, P. A., James, J. M., McCabe, L. D., 
McCabe, G. P., Peacock, M. & Teegarden, D. (2005) Fat oxidation and its 
relation to plasma parathyroid hormone in young women enrolled in a 1-y 
dairy calcium intervention. American Journal of Clinical Nutrition,  
82: 1228-1234. 
Hahn, A. G. & Gore, C. J. (2001) The effect of altitude on cycling performance: A 
challenge to traditional concepts. Sports Medicine, 31: 533-557. 
 
Hales, C. & Milner, R. (1968) Cations and the secretion of insulin from rabbit 
pancreas in vitro. The Journal of Physiology, 199(1): 177-187. 
Hanzlik, R. P., Fowler, S. C. & Fisher, D. H. (2005) Relative bioavailability of 
calcium from calcium formate, calcium citrate, and calcium carbonate. 
Journal of Pharmacology And Experimental Therapeutics, 313: 1217-1222. 
Harvey-Berino, J., Gold, B. C., Lauber, R. & Starinski, A. (2005) The impact of 
calcium and dairy product consumption on weight loss. Obesity Research, 
13: 1720-1726. 
Hauser, H. & Dawson, R. (1968) The displacement of calcium ions from 
phospholipid monolayers by pharmacologically active and other organic 
bases. Biochemical Journal, 109: 909-916. 
Hawley, J. (2002) Effect of increased fat availability on metabolism and exercise 
capacity. Medicine & Science in Sports & Exercise, 34: 1485-1491. 
Hawley, J., Burke, L., Angus, D., Fallon, K., Martin, D. & Febbraio, M. (2000) 
Effect of altering substrate availability on metabolism and performance 
during intense exercise. British Journal of Nutrition, 84: 829-838. 
Hawley, J. & Noakes, T. (1992) Peak power output predicts maximal oxygen uptake 
and performance time in trained cyclists. European Journal of Applied 
Physiology and Occupational Physiology, 65: 79-83. 
Hawley, J. A. & Stepto, N. K. (2001) Adaptations to training in endurance cyclists: 
Implications for performance. Sports Medicine, 31: 511-520. 
Heaney, R. P., Davies, K. M. & Barger-Lux, M. J. (2002) Calcium and weight: 
Clinical studies. Journal of the American College of Nutrition,  
21: 152S-155S. 
Heaney, R. P., Dowell, M. S., Bierman, J., Hale, C. A. & Bendich, A. (2001) 
Absorbability and cost effectiveness in calcium supplementation. Journal of 
the American College of Nutrition, 20: 239-246. 
Heaney, R. & Recker, R. (1982) Effects of nitrogen, phosphorus, and caffeine on 
calcium balance in women. The Journal of laboratory and clinical medicine, 
99: 46-55. 
Heaney, R. P., Recker, R. R. & Weaver, C. M. (1990a) Absorbability of calcium 
sources: The limited role of solubility. Calcified Tissue International,  
46: 300-304. 
243 
 
Heaney, R. P., Weaver, C. M. & Fitzsimmons, M. L. (1990b) Influence of calcium 
load on absorption fraction. J Bone Miner Res, 5: 1135-1138. 
Heigenhauser, G. J., and N. L. Jones. (1991) Bicarbonate loading. Perspectives in 
exercise science and sports medicine. IN Lamb, D. R. & Williams, M. H. 
(Eds.) (Vol. 4) Ergogenics, Enhancement of performance in exercise and 
sport. Traverse City: Cooper Pub. Group. Ltd. 
 
Henderson, L., Gregory, J., Swan, G., Britain, G., Research, M. R. C. H. N. & 
Agency, F. S. (2003) The national diet & nutrition survey: Adults aged 19 to 
64 years, London: The Stationery Office. 
Hintzy-Cloutier, F., Zameziati, K. & Belli, A. (2003) Influence of the base-line 
determination on work efficiency during submaximal cycling. Journal of 
sports medicine and physical fitness, 43: 51-56. 
Hodgetts, V., Coppack, S. W., Frayn, K. N. & Hockaday, T. D. (1991) Factors 
controlling fat mobilization from human subcutaneous adipose tissue during 
exercise. Journal of Applied Physiology, 71: 445-451. 
Hoelzer, D., Dalsky, G., Clutter, W., Shah, S., Holloszy, J. & Cryer, P. (1986) 
Glucoregulation during exercise: Hypoglycemia is prevented by redundant 
glucoregulatory systems, sympathochromaffin activation, and changes in islet 
hormone secretion. Journal of Clinical Investigation, 77: 212-221. 
Holloszy, J. O. & Booth, F. W. (1976) Biochemical adaptations to endurance 
exercise in muscle. Annual Review of Physiology, 38: 273-291. 
Holloszy, J. O. & Coyle, E. F. (1984) Adaptations of skeletal muscle to endurance 
exercise and their metabolic consequenses. Journal of Applied Physiology, 
56(4): 831-838 
Holloszy, J. O. & Narahara, H. T. (1967) Enhanced permeability to sugar associated 
with muscle contraction: Studies of the role of Ca
2+
. The Journal of General 
Physiology, 50: 551-562. 
Hooker, S., Morgan, C. & Wells, C. (1987) Effect of sodium bicarbonate ingestion 
on time to exhaustion and blood lactate of 10 km runners. Medicine & 
Science in Sports & Exercise, 19: S67. 
Hopker, J., Coleman, D. & Passfield, L. (2009) Changes in cycling efficiency during 
a competitive season. Medicine & Science in Sports & Exercise, 41: 912-919. 
Hopker, J. G., Coleman, D. A. & Wiles, J. D. (2007) Differences in efficiency 
between trained and recreational cyclists. Applied Physiology, Nutrition, and 
Metabolism, 32: 1036-1042. 
Hopkins, W. G. (1998) Measurement of training in competitive sports. Sportscience, 
2. 
 
Hopkins, W. G., Hawley, J. A. & Burke, L. M. (1999) Design and analysis of 
research on sport performance enhancement. Medicine and Science in Sports 
and Exercise, 31: 472-485. 
244 
 
Hopkins, W., Schabort, E. & Hawley, J. (2001) Reliability of power in physical 
performance tests. Sports Medicine, 31: 211-234. 
Horowitz, J. F. & Klein, S. (2000) Lipid metabolism during endurance exercise. 
American Journal of Clinical Nutrition, 72: 558S-563S. 
Housh, T., Thorland, W., Johnson, G., Tharp, G., Cisar, C. & Refsell, M. Col.(1984). 
Body composition variables as discriminators of sports participation of elite 
adolescent female athletes. Research Quarterly for Exercise and Sport, 55: 
302-304. 
Hue, L. & Taegtmeyer, H. (2009). The randle cycle revisited: A new head for an old 
hat. American Journal of Physiology-Endocrinology and Metabolism, 297: 
E578-E5791. 
Huxley, A. (2007) Biological actions of calcium IN Ebashi, S. & Otituski, I. (Eds.) 
Regulatory Mechanisms of Striated Muscle Contraction. Japan: Springer. 
 
Izawa, T. & Komabayashi, T. (1994) Ca
2+
 and lipolysis in adipocytes from exercise-
trained rats. Journal of Applied Physiology, 77: 2618-2624. 
Jackson, A. & Pollock, M. (1978) Generalized equations for predicting body density 
of men. British Journal of Nutrition, 40: 497-504. 
Jackson, A. & Pollock, M. (1980) Generalized equations for predicting body density 
of women. Med. Sci. Sports Exerc, 12: 175-182. 
Jacobsen, R., Lorenzen, J. K., Toubro, S., Krog-Mikkelsen, I. & Astrup, A. (2005) 
Effect of short-term high dietary calcium intake on 24-h energy expenditure, 
fat oxidation, and fecal fat excretion. International Journal of Obesity 
Related Metabolic Disorders, 29: 292-301. 
Jansson, E. (1982) On the significance of the respiratory exchange ratio after 
different diets during exercise in man. Acta Physiologica Scandinavica,  
114: 103-110. 
Janssen, P. G. (2001) Lactate threshold training, Champaign: Human Kinetics 
Publishers. 
 
Jeukendrup, A. E., Craig, N. P. & Hawley, J. A. (2000) The bioenergetics of world 
class cycling. Journal of Science and Medicine in Sport, 3: 414-433. 
Jobson, S., Passfield, L., Atkinson, G., Barton, G. & Scarf, P. (2009) The analysis 
and utilization of cycling training data. Sports Medicine, 39: 833-844. 
 
Jolma, P., Kalliovalkama, J., Tolvanen, J.-P., KÃÃbi, P., KÃhÃnen, M., 
HutriKÃhÃnen, N., Wu, X. & PÃrsti, I. (2000) High-calcium diet enhances 
vasorelaxation in nitric oxide-deficient hypertension. American Journal of 
Physiology - Heart and Circulatory Physiology, 279: H1036-H1043. 
Jones, G., Strugnell, S. & DeLUCA, H. (1998) Current understanding of the 
molecular actions of vitamin d. Physiological Reviews, 78: 1193-1231. 
245 
 
Joyner, M. J. & Coyle, E. F. (2008) Endurance exercise performance: The 
physiology of champions. The Journal of Physiology, 586: 35-44. 
Kahn, B. B., Alquier, T., Carling, D. & Hardie, D. G. (2005) Amp-activated protein 
kinase: Ancient energy gauge provides clues to modern understanding of 
metabolism. Cell metabolism, 1: 15-25. 
Kalliomäki, M., Salminen, S., Arvilommi, H., Kero, P., Koskinen, P. & Isolauri, E. 
(2001) Probiotics in primary prevention of atopic disease: A randomised 
placebo-controlled trial. The Lancet, 357: 1076-1079. 
Keeton, R. B. & Binder-Macleod, S. A. (2006) Low-frequency fatigue. Physical 
Therapy, 86: 1146-1150. 
 
Kim, J., Mynatt, R., Moore, J., Woychik, R., Moustaid, N. & Zemel, M. (1996) The 
effects of calcium channel blockade on agouti-induced obesity. The FASEB 
Journal, 10: 1646-1652. 
Klein, S., Coyle, E. F. & Wolfe, R. R. (1994) Fat metabolism during low-intensity 
exercise in endurance-trained and untrained men. American Journal of 
Physiology - Endocrinology and Metabolism, 267: E934-E940. 
Klein, S., Weber, J., Coyle, E. & Wolfe, R. (1996) Effect of endurance training on 
glycerol kinetics during strenuous exercise in humans. Metabolism,  
45: 357-361. 
Klesges, R. C., Ward, K. D., Shelton, M. L., Applegate, W. B., Cantler, E. D., 
Palmieri, G. M. A., Harmon, K. & Davis, J. (1996) Changes in bone mineral 
content in male athletes. JAMA: The Journal of the American Medical 
Association, 276: 226-230. 
Kowalchuk, J., Maltais, S., Yamaji, K. & Hughson, R. (1989) The effect of citrate 
loading on exercise performance, acid-base balance and metabolism. 
European Journal of Applied Physiology and Occupational Physiology,  
58: 858-864. 
Kozyreva, T. (1983) The effect of calcium ions on the temperature sensitivity of 
humans. Fiziologiia Cheloveka, 9: 671-762. IN Men'shikov, I. V. (2004) Free 
fatty acids and Ca
2+
 in blood plasma of endurance-trained athletes after 
prolonged physical exercise. Human Physiology, 30: 485-489. 
Krahl, M. (1966) Insulinlike and anti-insulin effects of chelating agents on adipose 
tissue. Federation proceedings, 25(3):832-834. 
 
Kristoffersson, A., Hultdin, J., Holmlund, I., Thorsen, K. & Lorentzon, R. (1995) 
Effects of short-term maximal work on plasma calcium, parathyroid 
hormone, osteocalcin and biochemical markers of collagen metabolism. 
International Journal of Sports Medicine, 16: 145-149. 
Kunstel, K. (2005) Calcium requirements for the athlete. Current Sports Medicine 
Reports, 4: 203-206. 
246 
 
Kuriyama, H., Ito, Y., Suzuki, H., Kitamura, K. & Itoh, T. (1982) Factors modifying 
contraction-relaxation cycle in vascular smooth muscles. American Journal 
of Physiology- Heart and Circulatory Physiology, 243(5): H641-H662. 
Kurth, E. J., Hirshman, M. F., Goodyear, J. J. & Winder, W. W. (1999) 5'amp 
activated protein kinase activation causes glut4 translocationin skeletal 
muscle. Diabetes. 48:1-5 
Lamb, K. (1998) Test-retest reliability in quantitative physical education research:  
A commentary. European Physical Education Review, 4: 145-152. 
Lee, R. C., Wang, Z. M., Heo, M., Ross, R., Janssen, I. & Heymsfield, S. B. (2000) 
Total-body skeletal muscle mass: Development and cross-validation of 
anthropometric prediction models. American Journal of Clinical Nutrition, 
72: 796-803. 
Levenson, D. I. & Bockman, R. S. (1994) A review of calcium preparations. 
Nutrition reviews, 52: 221-232. 
Leverton, R. & Marsh, A. (1939) Comparison of food intakes for weekdays and for 
saturday and sunday. Journal of Home Economics, 31: 111-114. 
 
Leiper, J., Carnie, A. & Maughan, R. (1996) Water turnover rates in sedentary and 
exercising middle aged men. British Journal of Sports Medicine, 30: 24-26. 
Linossier, M., Dormois, D., Bregere, P., Geyssant, A. & Denis, C. (1997) Effect of 
sodium citrate on performance and metabolism of human skeletal muscle 
during supramaximal cycling exercise. European Journal of Applied 
Physiology and Occupational Physiology, 76: 48-54. 
Lin, Y. C., Lyle, R. M., McCabe, L. D., McCabe, G. P., Weaver, C. M. & 
Teegarden, D. (2000) Dairy calcium is related to changes in body 
composition during a two-year exercise intervention in young women. 
Journal of the American College of Nutrition, 19: 754-760. 
Ljunghall, S., Joborn, H., Benson, L., FellstrÖM, B., Wide, L. & ÅKerstrom, G. 
(1984) Effects of physical exercise on plasma calcium and parathyroid 
hormone. European Journal of Clinical Investigations. 14(6): 469-73. 
Ljunghall, S., Joborn, H., Lundin, L., Rastad, J., Wide, L. & ÄKerstrÖM, G. (1985) 
Regional and systemic effects of short-term intense muscular work on plasma 
concentration and content of total and ionized calcium. European Journal of 
Clinical Investigations. 15(5):248-52. 
Ljunghall, S., Joborn, H., Roxin, L. E., Rastad, J., Wide, L. & Akerstrom, G. (1986) 
Prolonged low-intensity exerciseraises the plasma paprthyroid levels. 
Clinical Endocrinology, 25: 535-542. 
Ljunghall, S., Joborn, H., Roxin, L., Skarfors, E., Wide, L. & Lithell, H. (1988) 
Increase in plasma parathyroid hormone levels after prolonged physical 
exercise. Medicine & Science in Sports & Exercise, 20: 122-125. 
247 
 
Loos, R., Rankinen, T., Leon, A., Skinner, J., Wilmore, J., Rao, D. & Bouchard, C. 
(2004) Calcium intake is associated with adiposity in black and white men 
and white women of the heritage family study. Journal of Nutrition,  
134(7): 1772-1778.Abe, M. & Sherwood, L. (1972). Regulation of 
parathyroid hormone secretion by adenyl cyclase. Biochemical and 
Biophysical Research Communications, 48: 396-401. 
 
Lorenzen, J., Molgaard, C., Michaelsen, K. & Astrup, A. (2006) Calcium 
supplementation for 1 y does not reduce body weight or fat mass in young 
girls. American Journal of Clinical Nutrition, 83: 18-23. 
Lorenzen, J. K., Nielsen, S., Holst, J. J., Tetens, I., Rehfeld, J. F. & Astrup, A. 
(2007) Effect of dairy calcium or supplementary calcium intake on 
postprandial fat metabolism, appetite, and subsequent energy intake. 
American Journal of Clinical Nutrition, 85: 678-687. 
Lunde, P., Verburg, E., Vøllestad, N. & Sejersted, O. (1998). Skeletal muscle fatigue 
in normal subjects and heart failure patients. Is there a common mechanism? 
Acta Physiologica Scandinavica, 162: 215-228. 
Makita, S. & Satomi, J. (1997) Reliability of simplified blood lactate test meter 
(lactate pro). Journal of Clinical Sports Medicine, 14: 1-7. 
 
Marcil, M., Karelis, A. D., Péronnet, F. & Gardiner, P. F. (2005) Glucose infusion 
attenuates fatigue without sparing glycogen in rat soleus muscle during 
prolonged electrical stimulation in situ. European Journal of Applied 
Physiology, 93: 569-574. 
 Marino, F. E., Gard, M. & Drinkwater, E. J. (2009) The limits to exercise 
performance and the future of fatigue research. British Journal of Sports 
Medicine. doi:10.1136/bjsm.2009.067611 
Maughan, R. (1999) Nutritional ergogenic aids and exercise performance. Nutrition 
research reviews, 12: 255-280. 
McCarron, D., Morris, C. & Cole, C. (1982) Dietary calcium in human hypertension. 
Science, 217: 267-269. 
McCarron, D., Morris, C., Henry, H. & Stanton, J. (1984) Blood pressure and 
nutrient intake in the united states. Science, 224: 1392-1398. 
McGarry, J. D., Mannaerts, G. P. & Foster, D. W. (1977) A possible role for 
malonyl-CoA in the regulation of hepatic fatty acid oxidation and 
ketogenesis. Journal of Clinical Invesitigations, 60(1): 265-270. 
McKenna, M. J., Harmer, A. R., Fraser, S. F. & Li, J. L. (1996) Effects of training on 
potassium, calcium and hydrogen ion regulation in skeletal muscle and blood 
during exercise. Acta Physiologica Scandinavica, 156: 335-346. 
McNaughton, L. (1990) Sodium citrate and anaerobic performance: Implications of 
dosage. European Journal of Applied Physiology and Occupational 
Physiology, 61: 392-397. 
248 
 
McNaughton, L. & Cedaro, R. (1992) Sodium citrate ingestion and its effects on 
maximal anaerobic exercise of different durations. European Journal of 
Applied Physiology and Occupational Physiology, 64: 36-41. 
McNaughton, L., Thompson, D., Philips, G., Backx, K. & Crickmore, L. (2002) A 
comparison of the lactate pro, accusport, analox gm7 and Kodak ektachem 
lactate analysers in normal, hot and humid conditions. International Journal 
of Sports Medicine, 23: 130-135. 
 
Melanson, E. L., Donahoo, W. T., Dong, F., Ida, T. & Zemel, M. B. (2005) Effect of 
low- and high-calcium dairy-based diets on macronutrient oxidation in 
humans. Obesity, 13: 2102-2112. 
Melanson, E. L., Sharp, T. A., Schneider, J., Donahoo, W. T., Grunwald, G. K. & 
Hill, J. O. (2003) Relation between calcium intake and fat oxidation in adult 
humans. International Journal of Obesity Related Metabolism Disorders,  
27: 196-203. 
Men'shikov, I. V. (2004) Free fatty acids and Ca
2+
 in blood plasma of endurance-
trained athletes after prolonged physical exercise. Human Physiology,  
30: 485-489. 
Miller, F. & Manfredi, T. (1987) Physiological and anthropometrical predictors of 
15-kilometer time trial cycling performance time. Research Quarterly for 
Exercise and Sport, 58: 150-154. 
 
Millet, G. P., Tronche, C., Fuster, N. & Candau, R. (2002) Level ground and uphill 
cycling efficiency in seated and standing positions. Medicine & Science in 
Sports & Exercise, 34: 1645-1652. 
 
Mogensen, M., Bagger, M., Pedersen, P., Fernström, M. & Sahlin, K. (2006) Cycling 
efficiency in humans is related to low ucp3 content and to type i fibres but 
not to mitochondrial efficiency. The Journal of Physiology, 571: 669-681. 
Morgan, R., Jain, M., Miller, A., Choi, N., Matthews, V., Munan, L., Burch, J., 
Feather, J., Howe, G. & Kelly, A. (1978) A comparison of dietary methods in 
epidemiologic studies. American Journal of Epidemiology, 107: 488-498. 
 
Moseley, L., Achten, J., Martin, J. C. & Jeukendrup, A. E. (2004) No differences in 
cycling efficiency between world-class and recreational cyclists. 
International Journal of Sports Medicine, 25: 374-379. 
 
Moseley, L. & Jeukendrup, A. E. (2001) The reliability of cycling efficiency. 
Medicine & Science in Sports & Exercise, 33: 621-627. 
 
Nehlig, A., Daval, J.-L. & Debry, G. (1992) Caffeine and the central nervous system: 
Mechanisms of action, biochemical, metabolic and psychostimulant effects. 
Brain Research Reviews, 17: 139-170. 
Nehlig, A. & Debry, G. (1994) Caffeine and sports activity: A review. International 
Journal of Sports Medicine, 15: 215-223. 
249 
 
Nielsen, O. B., Paoli, F. & Overgaard, K. (2001) Protective effects of lactic acid on 
force production in rat skeletal muscle. The Journal of Physiology,  
536: 161-166. 
Neptune, R. & Herzog, W. (1999) The association between negative muscle work 
and pedaling rate. Journal of biomechanics, 32: 1021-1026. 
 
Nichols, A. W. (2007) Probiotics and athletic performance: A systematic review. 
Current Sports Medicine Reports, 6: 269-273. 
Noakes, T. (2000) Physiological models to understand exercise fatigue and the 
adaptations that predict or enhance athletic performance. Scandinavian 
journal of medicine & science in sports, 10: 123-145. 
Nobrega, A. C. L., Williamson, J. O. N. W., Friedman, D. B., Araujo, C. G. S. & 
Mitchell, J. H. (1994) Cardiovascular responses to active and passive cycling 
movements. Medicine & Science in Sports & Exercise, 26: 709-714. 
 
Nummela, A. T., Heath, K. A., Paavolainen, L. M., Lambert, M. I., St Clair Gibson, 
A., Rusko, H. K. & Noakes, T. D. (2008) Fatigue during a 5-km running time 
trial. International Journal of Sports Medicine, 29: 738-745. 
Odland, L., Howlett, R., Heigenhauser, G., Hultman, E. & Spriet, L. (1998) Skeletal 
muscle malonyl-coa content at the onset of exercise at varying power outputs 
in humans. American Journal of Physiology- Endocrinology and Metabolism, 
274: E1080-E1085. 
Olds, T. S., Norton, K. I., Lowe, E., Olive, S., Reay, F. & Ly, S. (1995) Modeling 
road-cycling performance. Journal of Applied Physiology, 78: 1596-1611. 
 
Oöpik, V., Saaremets, I., Medijainen, L., Karelson, K., Janson, T. & Timpmann, S. 
(2003) Effects of sodium citrate ingestion before exercise on endurance 
performance in well-trained college runners. British Medical Journal,  
37: 485-489. 
 
Pak, C. Y., Harvey, J. A. & Hsu, M. C. (1987) Enhanced calcium bioavailability 
from a solubilized form of calcium citrate. Journal of Clinical Endocrinology 
Metabolism, 65: 801-805. 
Palmer, G., Dennis, S., Noakes, T. & Hawley, J. (1996) Assessment of the 
reproducibility of performance testing on an air-braked cycle ergometer. 
International Journal of Sports Medicine, 17: 293-298. 
 
Papakonstantinou, E., Flatt, W. P., Huth, P. J. & Harris, R. B. S. (2003) High dietary 
calcium reduces body fat content, digestibility of fat, and plasma vitamin d in 
rats. Obesity Research, 11: 387-394. 
Parikh, S. J. & Yanovski, J. A. (2003) Calcium intake and adiposity. American 
Journal of Clinical Nutrition, 77: 281-287. 
 
250 
 
Parry-Billings, M. & MacLaren, D. (1986) The effect of sodium bicarbonate and 
sodium citrate ingestion on anaerobic power during intermittent exercise. 
European Journal of Applied Physiology and Occupational Physiology,  
55: 524-529. 
Paton, C. & Hopkins, W. (2001) Tests of cycling performance. Sports Medicine,  
31: 489-496. 
Pereira, M. A., Jacobs, D. R., Jr., Van Horn, L., Slattery, M. L., Kartashov, A. I. & 
Ludwig, D. S. (2002) Dairy consumption, obesity, and the insulin resistance 
syndrome in young adults: The cardia study. JAMA: The Journal of the 
American Medical Association, 287: 2081-2089. 
Persechini, A. & Cronk, B. (1999) The relationship between the free concentrations 
of Ca
2+
 and Ca
2+
-calmodulin in intact cells. Journal of Biological Chemistry, 
274: 6827-6830. 
Pershadsingh, H. A., Shade, D. L., Delfert, D. M. & McDonald, J. M. (1987) 
Chelation of intracellular calcium blocks insulin action in the adipocyte. 
Proceedings of the National Academy of Science of United States of America, 
84(4): 1025-1029. 
Petrie, H., Stover, E. & Horswill, C. (2004) Nutritional concerns for the child and 
adolescent competitor. Nutrition, 20: 620-631. 
Pfeifer, M., Begerow, B., Minne, H. W., Nachtigall, D. & Hansen, C. (2001) Effects 
of a short-term vitamin D3 and calcium supplementation on blood pressure 
and parathyroid hormone levels in elderly women. Journal of Clinical 
Endocrinology and Metabolism, 86: 1633-1637. 
Phillips, S., Green, H., Tarnopolsky, M., Heigenhauser, G., Hill, R. & Grant, S. 
(1996) Effects of training duration on substrate turnover and oxidation during 
exercise. Journal of Applied Physiology, 81: 2182-2196. 
Potteiger, J., Nickel, G., Webster, M., Haub, M. & Palmer, R. (1996) Sodium citrate 
ingestion enhances 30 km cycling performance. International Journal of 
Sports Medicine, 17: 7-11. 
Pruett, E. (1971) Fat and carbohydrate metabolism in exercise and recovery, and its 
dependence upon work load severity. IN Shephard, R. J. & Åstrand, P (2000) 
Endurance in sport, IOC Medical Commission, International Federation of 
Sports Medicine. Malden: Blackwell Science Publishing Ltd. 
Pyne, D., Boston, T., Martin, D. & Logan, A. (2000) Evaluation of the lactate pro 
blood lactate analyser. European Journal of Applied Physiology,  
82: 112-116. 
 
Rajpathak, S., Rimm, E., Rosner, B., Willett, W. & Hu, F. (2006) Calcium and dairy 
intakes in relation to long-term weight gain in us men. American Journal of 
Clinical Nutrition, 83: 559-566. 
Ranallo, R. & Rhodes, E. (1998) Lipid metabolism during exercise. Sports Medicine,  
26: 29-42. 
251 
 
Randle, P., Garland, P., Hales, C. & Newsholme, E. (1963) The glucose fatty-acid 
cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes 
mellitus. Lancet, 1: 785-789. 
Rasmussen, H. (1971) Ionic and hormonal control of calcium homeostasis.  
The American Journal of Medicine, 50: 567-588. 
Requena, B., Zabala, M., Padial, P. & Feriche, B. (2005) Sodium bicarbonate and 
sodium citrate: Ergogenic aids? The Journal of Strength & Conditioning 
Research, 19: 213-224. 
Resnick, L. (1992) Cellular ions in hypertension, insulin resistance, obesity, and 
diabetes: A unifying theme. Journal of the American Society of Nephrology, 
3: S78-S85. 
Resnick, L. (1999) The cellular ionic basis of hypertension and allied clinical 
conditions. Progress in cardiovascular diseases, 42: 1-22. 
Richter, E. & Ruderman, N. (2009) Ampk and the biochemistry of exercise: 
Implications for human health and disease. The Biochemical journal,  
418: 261-275. 
Riggs, B. L., O'Fallon, W. M., Muhs, J., O'Connor, M. K., Kumar, R. & Melton, L. 
J. (1998) Long-term effects of calcium supplementation on plasma 
parathyroid hormone level, bone turnover, and bone loss in elderly women. 
Journal of Bone and Mineral Research, 13(2): 168–174. 
Ringer, S. (1882) Concerning the influence exerted by each of the constituents of the 
blood on the contraction of the ventricle. The Journal of Physiology,  
3: 380-393. 
Ringer, S. (1883) A further contribution regarding the influence of the different 
constituents of the blood on the contraction of the heart. The Journal of 
Physiology, 4: 29-42. 
Robergs, R. A., Ghiasvand, F. & Parker, D. (2004) Biochemistry of exercise-induced 
metabolic acidosis. American Journal of Physiology - Regulatory, Integrative 
and Comparative Physiology, 287: R502-R516. 
Robertson, W. G., Marshall, R. W. & Bowers, G. N. (1981) Ionized calcium in body 
fluids. Critical Reviews in Clinical Laboratory Sciences, 15: 85-125. 
Romijn, J. A., Coyle, E. F., Sidossis, L. S., Gastaldelli, A., Horowitz, J. F., Endert, 
E. & Wolfe, R. R. (1993) Regulation of endogenous fat and carbohydrate 
metabolism in relation to exercise intensity and duration. American Journal 
of Physiology - Endocrinology and Metabolism, 265: E380-E391. 
Romijn, J. A., Coyle, E. F., Sidossis, L. S., Zhang, X. J. & Wolfe, R. R. (1995) 
Relationship between fatty acid delivery and fatty acid oxidation during 
strenuous exercise. Journal of Applied Physiology, 79: 1939-1945. 
Rose, A. J. & Richter, E. A. (2005) Skeletal muscle glucose uptake during exercise: 
How is it regulated? Physiology, 20: 260-270. 
252 
 
Ross, A. C., Manson, J. E., Abrams, S. A., Aloia, J. F., Brannon, P. M., Clinton, S. 
K., Durazo-Arvizu, R. A., Gallagher, J. C., Gallo, R. L., Jones, G., Kovacs, 
C. S., Mayne, S. T., Rosen, C. J. & Shapses, S. A. (2010) The 2011 report on 
dietary reference intakes for calcium and vitamin d from the institute of 
medicine: What clinicians need to know. Journal of Clinical Endocrinology 
and Metabolism, 96: 53-58. 
Ruderman, N., Saha, A. & Kraegen, E. (2003) Minireview: Malonyl coa, amp-
activated protein kinase, and adiposity. Endocrinology, 144: 5166-5171. 
Russell, D., Walker, P., Leiter, L., Sima, A., Tanner, W., Mickle, D., Whitwell, J., 
Marliss, E. & Jeejeebhoy, K. (1984) Metabolic and structural changes in 
skeletal muscle during hypocaloric dieting. The American Journal of Clinical 
Nutrition, 39: 503-513. 
 
Ryan, W. G. & Schwartz, T. B. (1965) Dynamics of plasma triglyceride turnover in 
man. Metabolism. Metabolism, 14(12): 1243-1254. 
Sahlin, K., Katz, A. & Broberg, S. (1990) Tricarboxylic acid cycle intermediates in 
human muscle during prolonged exercise. American Journal of Physiology- 
Cell Physiology, 259: C834-C841. 
Sahlin, K., Katz, A. & Henriksson, J. (1987) Redox state and lactate accumulation in 
human skeletal muscle during dynamic exercise. Biochemical Journal,  
245(2): 551-556. 
Salvesen, H., Johansson, A., Foxdal, P., Wide, L., Piehl-Aulin, K. & Ljunghall, S. 
(1994) Intact plasma parathyroid hormone levels increase during running 
exercise in well-trained men. Calcified Tissue International, 54: 256-261. 
 
Sassi, A., Impellizzeri, F., Morelli, A., Menaspa, P. & Rampinini, E. (2008) Seasonal 
changes in aerobic fitness indices in elite cyclists. Applied Physiology, 
Nutrition, and Metabolism, 33: 735-742. 
Schabort, E., Wilson, G. & Noakes, T. (2000) Dose-related elevations in venous ph 
with citrate ingestion do not alter 40-km cycling time-trial performance. 
European Journal of Applied Physiology, 83: 320-327. 
Schoeller, D. A. (1988) Measurement of energy expenditure in free-living humans 
by using doubly labeled water. The Journal of Nutrition, 118: 1278-1291. 
Schrager, S. (2005) Dietary calcium intake and obesity. The Journal of the American 
Board of Family Practice, 18: 205-210. 
 
Schrauwen, P. & Hesselink, M. (2002) UCP2 and UCP3 in muscle controlling body 
metabolism. Journal of Experimental Biology, 205: 2275-2285. 
Schudt, C., Gaertner, U. & Pette, D. (1976) Insulin action on glucose transport and 
calcium fluxes in developing muscle cells in vitro. European Journal of 
Biochemistry, 68: 103-111. 
253 
 
Schulkin, J. (2001) Calcium hunger: Behavioral and biological regulation, 
Cambridge University Press: Cambridge. 
Schwartz, Y., Yamaguchi, H. & Goodman, H. M. (1992) Growth hormone increases 
intracellular free calcium in rat adipocytes: Correlation with actions on 
carbohydrate metabolism. Endocrinology, 131: 772-778. 
Shapses, S. & Riedt, C. (2006) Bone, body weight, and weight reduction: What are 
the concerns? Journal of Nutrition, 136: 14531456. 
Sheikh, M. S., Santa Ana, C. A., Nicar, M. J., Schiller, L. R. & Fordtran, J. S. (1987) 
Gastrointestinal absorption of calcium from milk and calcium salts. The New 
England Journal of Medicine, 317: 532-536. 
Sherman, W., Peden, M. & Wright, D. (1991) Carbohydrate feedings 1 h before 
exercise improves cycling performance. The American Journal of Clinical 
Nutrition, 54: 866-870. 
Shi, H., DiRienzo, D. & Zemel, M. B. (2001a) Effects of dietary calcium on 
adipocyte lipid metabolism and body weight regulation in energy restricted 
ap2-agouti transgenic mice. FASEB J, 15(2): 291-293. 
Shi, H., Halvorsen, Y. D., Ellis, P. N., Wilkison, W. O. & Zemel, M. B. (2000) Role 
of intracellular calcium in human adipocyte differentiation. Physiological 
Genomics, 3: 75-82. 
Shi, H., Norman, A. W., Okamura, W. H., Sen, A. & Zemel, M. B. (2001b)  
1a,25-dihydroxyvitamin D3 modulates human adipocyte metabolism via 
nongenomic action. The FASEB Journal, 15 (14): 2751-2753. 
Sidossis, L., Gastaldelli, A., Klein, S. & Wolfe, R. (1997) Regulation of plasma fatty 
acid oxidation during low-and high-intensity exercise. American Journal of 
Physiology- Endocrinology and Metabolism, 272: E1065-E1070. 
Sidossis, L. S., Horowitz, J. F. & Coyle, E. F. (1992) Load and velocity of 
contraction influence gross and delta mechanical efficiency. International 
Journal of Sports Medicine 13: 407-411. 
 
Sidossis, L. S., Wolfe, R. R. & Coggan, A. R. (1998) Regulation of fatty acid 
oxidation in untrained vs. Trained men during exercise. American Journal of 
Physiology - Endocrinology and Metabolism, 274: E510-E515. 
Siri, W. (1956) The gross composition of the body. IN Lawrence, J. H. & Tobias, C. 
A. (Eds.) Advances in biological and medical physics, Vol. 4. New York: 
Academic Press. 
Smith, K. T., Heaney, R. P., Flora, L. & Hinders, S. M. (1987) Calcium absorption 
from a new calcium delivery system (ccm). Calcified Tissue International, 
41: 351-352. 
Smithers, G., Gregory, J., Bates, C., Prentice, A., Jackson, L. & Wenlock, R. (2000) 
The national diet and nutrition survey: Young people aged 4–18 years. 
Nutrition Bulletin, 25: 105-111. 
254 
 
Soares, M., Binns, C. & Lester, L. (2004) Higher intakes of calcium are associated 
with lower bmi and waist circumference in australian adults: An examination 
of the 1995 national nutrition survey. Asia Pacific Journal of Clinical 
Nutrition, 28(13): S85-S90. 
Sørensen, S., Christensen, F. & Clausen, T. (1980) The relationship between the 
transport of glucose and cations across cell membranes in isolated tissues. X. 
Effect of glucose transport stimuli on the efflux of isotopically labelled 
calcium and 3-o-methylglucose from soleus muscles and epididymal fat pads 
of the rat. Biochimica et Biophysica Acta (BBA)-Biomembranes,  
602: 433-445. 
Stainbsy, W. N., Gladden, L. B., Barclay, J. K. & Wilson, B. A. (1980) Exercise 
efficiency: Validity of base-line subtractions. Journal of Applied Physiology, 
48: 518-522. 
 
Stern, N., Lee, D. B., Silis, V., Beck, F. W., Deftos, L., Manolagas, S. C. & Sowers, 
J. R. (1984) Effects of high calcium intake on blood pressure and calcium 
metabolism in young shr. hypertension, 6: 639-646. 
Stewart, R., Duhamel, T., Foley, K., Ouyang, J., Smith, I. & Green, H. (2007) 
Protection of muscle membrane excitability during prolonged cycle exercise 
with glucose supplementation. Journal of Applied Physiology, 103: 331-339. 
 
Stricker, P. R. (1998) Other ergogenic agents. Clinics in sports medicine,  
17(2): 283-297. 
Sun, X. & Zemel, M. B. (2004) Calcium and dairy products inhibit weight and fat 
regain during ad libitum consumption following energy restriction in ap2-
agouti transgenic mice. Journal of Nutrition, 134: 3054-3060. 
Sutton, J., Jones, N. & Toews, C. (1981) Effect of ph on muscle glycolysis during 
exercise. Clinical science, 61: 331-338. 
 
Teegarden, D. (2003) Calcium intake and reduction in weight or fat mass. The 
Journal of Nutrition, 133: 249S-251S. 
Teegarden, D., White, K. M., Lyle, R. M., Zemel, M. B., Van Loan, M. D., 
Matkovic, V., Craig, B. A. & Schoeller, D. A. (2008) Calcium and dairy 
product modulation of lipid utilization and energy expenditure. Obesity,  
16: 1566-1572. 
Teegarden, D. & Zemel, M. B. (2003). Dairy product components and weight 
regulation: Symposium overview. Journal of Nutrition, 133: 243S-244S. 
 
Telford, R., Hahn, A., Catchpole, E., Parker, A. & Sweetenham, W. (1988) 
Postcompetition blood lactate concentration in highly ranked australian 
swimmers. Swimming science V. Human Kinetics, Champaign, 101: 277-284. 
 
Theobald, H. (2005) Dietary calcium and health. Nutrition Bulletin, 30: 237-277. 
255 
 
Thompson, W., Holdman, N., Janzow, D., Slezak, J., Morris, K. & Zemel, M. (2005) 
Effect of energy-reduced diets high in dairy products and fiber on weight loss 
in obese adults. Obesity, 13: 1344-1353. 
Thorsen, K., Kristoffersson, A., Hultdin, J. & Lorentzon, R. (1997) Effects of 
moderate endurance exercise on calcium, parathyroid hormone, and markers 
of bone metabolism in young women. Calcified Tissue International,  
60: 16-20. 
Toffaletti, J. & Abrams, B. (1989) Effects of in vivo and in vitro production of lactic 
acid on ionized, protein-bound, and complex-bound calcium in blood. 
Clinical Chemistry, 35: 935-938. 
Tordoff, M. G. (2001) Calcium: Taste, intake, and appetite. Physiological Reviews,  
81: 1567-1597. 
Tordoff, M. G., Hughes, R. L. & Pilchak, D. M. (1998) Calcium intake by rats: 
Influence of parathyroid hormone, calcitonin, and 1,25-dihydroxyvitamin D. 
American Journal of Physiology - Regulatory, Integrative and Comparative 
Physiology, 274: R214-R231. 
Trowman, R., Dumville, J. C., Hahn, S. & Torgerson, D. J. (2006) A systematic 
review of the effects of calcium supplementation on body weight. British 
Journal of Nutrition, 95: 1033-1038. 
Turcotte, L. P., Richter, E. A. & Kiens, B. (1992) Increased plasma ffa uptake and 
oxidation during prolonged exercise in trained vs. Untrained humans. 
American Journal of Physiology - Endocrinology and Metabolism,  
262: E791-E799. 
Underhill, F. P. (1916) Studies in carbohydrate metabolism. Xi. The role of calcium 
in the regulation of blood sugar content. Journal of Biological Chemistry,  
25: 447-461. 
van Loon, L. J. C. (2004) Use of intramuscular triacylglycerol as a substrate source 
during exercise in humans. Journal of Applied Physiology, 97: 1170-1187. 
Vaskonen, T. (2003) Dietary minerals and modification of cardiovascular risk 
factors. The Journal of Nutritional Biochemistry, 14: 492-506. 
Vavvas, D., Apazidis, A., Saha, A. K., Gamble, J., Patel, A., Kemp, B. E., Witters, 
L. A. & Ruderman, N. B. (1997). Contraction-induced changes in acetyl-coa 
carboxylase and 5 -amp-activated kinase in skeletal muscle. Journal of 
Biological Chemistry, 272: 13255-62. 
Venti, C., Tataranni, P. & Salbe, A. (2005) Lack of relationship between calcium 
intake and body size in an obesity-prone population. Journal of the American 
Dietetic Association, 105: 1401-1407. 
Vergnaud, A., Peneau, S., Chat-Yung, S., Kesse, E., Czernichow, S., Galan, P., 
Hercberg, S. & Bertrais, S. (2008) Dairy consumption and 6-y changes in 
body weight and waist circumference in middle-aged french adults. American 
Journal of Clinical Nutrition, 88: 1248-1255. 
256 
 
Vora, N. M., Kukreja, S. C., York, P. A. J., Bowser, E. N., Hargis, G. K. & 
Williams, G. A. (1983) Effect of exercise on plasma calcium and parathyroid 
hormone. Journal of Clinical Endocrinology and Metabolism,  
57: 1067-1069. 
Walter, M., Lochmuller, H., Reilich, P., Klopstock, T., Huber, R., Hartard, M., 
Hennig, M., Pongratz, D. & Muller-Felber, W. (2000) Creatine monohydrate 
in muscular dystrophies: A double-blind, placebo-controlled clinical study. 
Neurology, 54: 1848-1850. 
 
Wasserman, D. H. (1995) Regulation of glucose fluxes during exercise in the 
postabsorptive state. Annual Review of Physiology, 57: 191-218. 
Wasserman, K., Beaver, W. & Whipp, B. (1986) Mechanisms and patterns of blood 
lactate increase during exercise in man. Medicine & Science in Sports & 
Exercise, 18: 344-352. 
Watson, R. T. & Pessin, J. E. (2001) Intracellular organization of insulin signaling 
and GLUT4 translocation. Recent Progress in Hormone Research,  
56: 175-194. 
Watt, M. J., Heigenhauser, G. J. F., Dyck, D. J. & Spriet, L. L. (2002) Intramuscular 
triacylglycerol, glycogen and acetyl group metabolism during 4 h of 
moderate exercise in man. The Journal of Physiology Online, 541: 969-978. 
Welberg, J. W., monkelban, J. F. & de Vries, E. G. (1994) Effects of supplemental 
dietary calcium on quantitative and qualitative fecal fat excretion in man. 
Annals of Nutrition and Metabolism. 38(4): 185-1891. 
Westerblad, H. & Allen, D. G. (1991) Changes of myoplasmic calcium concentration 
during fatigue in single mouse muscle fibers. The Journal of General 
Physiology, 98: 615-635. 
Westerblad, H. & Allen, D. G. (1993) The contribution of i[Ca
2+
] to the slowing of 
relaxation in fatigued single fibres from mouse skeletal muscle. The Journal 
of Physiology, 468: 729-740. 
Westerblad, H. & Allen, D. G. (1996) Mechanisms underlying changes of tetanic 
i[Ca
2+
] and force in skeletal muscle. Acta Physiologica Scandinavica,  
156: 407-416. 
Westerblad, H., Lee, J., Lannergren, J. & Allen, D. (1991) Cellular mechanisms of 
fatigue in skeletal muscle. American Journal of Physiology- Cell Physiology, 
261(2): C195-C209. 
Whaley, M. H., Brubaker, P. H. & Otto, R. M. (Ed.) (2006) ACSM’s Guidelines for 
exercise testing and prescription. 7
th
 ed., Baltimore: Lippincott Williams & 
Wilkins.  
White, K. M., Lyle, R. M., Flynn, M. G., Teegarden, D. & Donkin, S. S. (2006) The 
acute effects of dairy calcium intake on fat metabolism during exercise and 
endurance exercise performance. International Journal of Sport Nutrition 
and Exercise Metabolism, 16: 565-579. 
257 
 
White, J., Quinn, G., Al-Dawalibi, M. & Mulhall, J. (1982a) Seasonal changes in 
cyclists' performance. Part i. The british olympic road race squad. British 
Medical Journal, 16: 4-12. 
White, J., Quinn, G., Al-Dawalibi, M. & Mulhall, J. (1982b) Seasonal changes in 
cyclists' performance. Part ii. The british olympic track squad. British 
Medical Journal, 16: 13-21. 
Whitehead, J. P., Molero, C. J., Clark, S., Martin, S., Meneilly, G. & David, J. E. 
(2001) The role of Ca
2+
 in insulin-stimulated glucose transport in 3T3-l1 
cells. Journal of Biological Chemistry. 276: 27816–27824. 
Williams, A. D., Raj, I. S., Stucas, K. L., Fell, J. W., Dickenson, D. & Gregory, J. R. 
(2009) Cycling efficiency and performance following short-term training 
using uncoupled cranks. International Journal of Sports Physiology and 
Performance, 4: 18-28. 
 
Wolfe, R., Klein, S., Carraro, F. & Weber, J. (1990) Role of triglyceride-fatty acid 
cycle in controlling fat metabolism in humans during and after exercise. 
American Journal of Physiology- Endocrinology and Metabolism,  
258: E382-E389. 
Wolfe, R. R., Shaw, J. H. & Durkot, M. J. (1985) Effect of sepsis on VLDL kinetics: 
Responses in basal state and during glucose infusion. American Journal of 
Physiology, 248: E732-E740. 
Wooles, A., Keen, P. & Palfreeman, R. (2003) Protocols used for the physiological 
testing of the Great Britain Cycling Team (V 1.6). British Cycling – Testing 
Methods Manual. 
Xue, B., Greenberg, G., Kraemer, B. & Zemel, M. B. (2001) Mechanism of 
intracellular calcium ([Ca
2+
]i) inhibition of lipolysis in human adipocytes. 
The FASEB Journal, 15: 2527-2529. 
Xue, B., Moustaid-moussa, N., Wilkison, W. O. & Zemel, M. B. (1998) The agouti 
gene product inhibits lipolysis in human adipocytes via a Ca
2+
-dependent 
mechanism. The FASEB Journal, 12: 1391-1396. 
Xue, B. & Zemel, M. B. (2000) Relationship between human adipose tissue agouti 
and fatty acid synthase. Journal of Nutrition, 130: 2478-2481. 
Young, C. M. (1981) Dietary methodology. Assessing Changing Food Consumption 
Patterns: 89-118. 
 
Zaloga, G., Willey, S., Tomasic, P. & Chernow, B. (1987) Free fatty acids alter 
calcium binding: A cause for misinterpretation of plasma calcium values and 
hypocalcemia in critical illness. Journal of Clinical Endocrinology & 
Metabolism, 64: 1010-1014. 
Zemel, M. B. (1998) Nutritional and endocrine modulation of intracellular calcium: 
Implications in obesity, insulin resistance and hypertension. Molecular and 
Cellular Biochemistry, 188: 129-136. 
258 
 
Zemel, M. B. (2001) Calcium modulation of hypertension and obesity: Mechanisms 
and implications. Journal of the American College of Nutrition,  
20: 428S-4435. 
Zemel, M. B. (2002) Regulation of adiposity and obesity risk by dietary calcium: 
Mechanisms and implications. Journal of the American College of Nutrition,  
21: 146S-151. 
Zemel, M. B. (2003) Mechanisms of dairy modulation of adiposity. Journal of 
Nutrition, 133: 252S-256. 
Zemel, M. B. (2004) Role of calcium and dairy products in energy partitioning and 
weight management. American Journal of Clinical Nutrition, 79: 907S-9912. 
Zemel, M., Donnelly, J., Smith, B., Sullivan, D., Richards, J., Morgan-Hanusa, D., 
Mayo, M., Sun, X., Cook-Wiens, G., Bailey, B., Van Walleghen, E. & 
Washburn, R. (2008) Effects of dairy intake on weight maintenance. 
Nutrition & Metabolism, 5: 28-36. 
 
Zemel, M. B., Kim, J. H., Woychik, R. P., Michaud, E. J., Kadwell, S. H., Patel, I. R. 
& Wilkison, W. O. (1995) Agouti regulation of intracellular calcium: Role in 
the insulin resistance of viable yellow mice. Proceedings of the National 
Academy of Sciences, 92: 4733-4737. 
Zemel, M. B., Richards, J., Mathis, S., Milstead, A., Gebhardt, L. & Silva, E. (2005) 
Dairy augmentation of total and central fat loss in obese participants. 
International Journal of Obesity Related Metabolic Disorders, 29: 391-397. 
Zemel, M. B., Shi, H., Greer, T., Dirienzo, G. & Paula, C. (2000) Regulation of 
adiposity by dietary calcium. The FASEB Journal, 14: 1132-1138. 
Zemel, M. B. & Sun, X. (2008) Dietary calcium and dairy products modulate 
oxidative and inflammatory stress in mice and humans. The Journal of 
Nutrition, 138: 1047-1052. 
Zhao, X., Yoshida, M., Brotto, L., Takeshima, H., Weisleder, N., Hirata, Y., Nosek, 
T., Ma, J. & Brotto, M. (2005) Enhanced resistance to fatigue and altered 
calcium handling properties of sarcalumenin knockout mice. Physiological 
Genomics, 23(1): 72-78. 
Zittermann, A., Sabatschus, O., Jantzen, S., Platen, P., Danz, A., Dimitriou, T., 
Scheld, K., Klein, K. & Stehle, P. (2000) Exercise-trained young men have 
higher calcium absorption rates and plasma calcitriol levels compared with 
age-matched sedentary controls. Calcified Tissue International, 67: 215-219. 
 
 
 
 
 
259 
 
 
 
 
 
 
 
Appendix A 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
260 
 
 
%CV haematological variables  
FFA  
Assay 
(NEFA) 
Absorbance 
(Blank 1) 
Absorbance 
(Blank 2) 
Absorbance 
(Blank 3) 
mean 
absorbance StdDev %CV 
Study 1- Pl1 0.051 0.053 0.051 0.052 0.001 2.23 
Study 1- Pl2 0.056 0.055 0.055 0.055 0.001 1.04 
Study 1- Ca1 0.052 0.058 0.057 0.056 0.003 5.77 
Study 1- Ca2 0.061 0.058 0.061 0.060 0.002 2.89 
10TT Pl1 0.058 0.057 0.057 0.057 0.001 1.01 
10TT Pl2 0.064 0.065 0.059 0.063 0.003 5.13 
25TT Pl1 0.063 0.063 0.059 0.062 0.002 3.74 
25TT Pl2 0.063 0.063 0.065 0.064 0.001 1.81 
10TT Ca1 0.061 0.061 0.062 0.061 0.001 0.94 
10TT Ca2 0.065 0.064 0.064 0.064 0.001 0.90 
25TT Ca1 0.061 0.067 0.068 0.065 0.004 5.79 
25TT Ca2 0.061 0.062 0.060 0.061 0.001 1.64 
Inter assay    0.062 0.003 4.69 
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iPTH 
Assay 
(iPTH) 
Absorbance 
 
Absorbance 
 
mean 
absorbance StdDev %CV 
Study 1- Pl1 2.25 2.22 2.23 0.02 0.95 
Study 1- Pl2 2.18 2.09 2.13 0.06 2.98 
Study 1- Ca1 2.28 2.26 2.27 0.01 0.62 
Study 1- Ca2 1.83 1.94 1.88 0.07 4.13 
Inter assay   2.16 0.14 6.81 
 
Total calcium  
Assay 
(total plasma 
calcium) 
Absorbance 
 
Absorbance 
 
mean 
absorbance StdDev %CV 
Study 1- Pl1 2.62 2.63 2.62 0.007 0.27 
Study 1- Pl2 2.67 2.67 2.67 0 0.0 
Study 1- Ca1 2.62 2.60 2.61 0.014 0.54 
Study 1- Ca2 2.75 2.77 2.76 0.014 0.51 
Inter assay   2.66 0.06 2.36 
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TAG 
Assay 
(TAG) 
Absorbance 
 
Absorbance 
 
mean 
absorbance StdDev %CV 
Study 1- Pl1 0.877 0.875 0.876 0.001 0.16 
Study 1- Pl2 0.853 0.850 0.851 0.002 0.25 
Study 1- Ca1 0.852 0.855 0.853 0.002 0.25 
Study 1- Ca2 0.869 0.87 0.869 0 0.08 
Inter assay   0.862 0.011 1.30 
 
Glucose 
Assay 
(glucose) 
Absorbance 
 
Absorbance 
 
mean 
absorbance StdDev %CV 
Study 1- Pl1 4.51 4.56 4.53 0.039 0.87 
Study 1- Pl2 4.46 4.47 4.46 0.005 0.13 
Study 1- Ca1 4.55 4.55 4.55 0.003 0.08 
Study 1- Ca2 4.40 4.41 4.40 0.005 0.13 
Inter assay   4.48 0.063 1.39 
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RESEARCH ON THE ERGOGENIC PROPERTIES OF CALCIUM IN ENDURANCE EVENTS 
 
Aim of the project – Is to investigate if calcium supplementation improves 
performance. 
Rationale – There is mounting evidence that calcium rich diets promote the cellular 
processes that increase fat metabolism and thus spare glycogen during a training 
session which could delay fatigue in endurance type events. 
A calcium rich diet over a long period of time helps to keep fat mass low. 
Tests conducted – When an athlete agrees to participate in the study he/she will 
undergo a few tests which would include determination of –  
1. maximal oxygen uptake (V O2max) 
2. maximum heart rate 
3. peak power output  
4. aerobic threshold 
5. anaerobic threshold / Lactate threshold 
6. body composition  
7. Nutritional intake analysis. 
8. Breakdown of percentage of carbohydrate and fat usage during a 
particular training session of set intensity. 
The results of the fitness tests and nutrition assessment can be used to determine 
your strengths and weaknesses during training. 
This information can be used to provide specific training advice and guidance to 
improve your V O2max, reduce sub-maximal V O2, improve peak power, enhance 
recovery, allowing you to train smarter and ultimately improve your training and 
racing performance.  
All of the above mentioned tests in a commercial set up could cost in excess of 
£200. These test results will be provided for free and any guidance required on 
training zones and/or nutritional strategies can be provided to individual athletes 
according to their personal goals and requirements. 
Typical schedule for participating athletes –  
o Participants will be asked to take either a calcium supplement of 1000 mg 
or a placebo for a period of 4 weeks throughout the testing phase. 
o Total commitment of 4 lab visits in a period of 3 months 
o The exercise test will include –  
o 1 V O2max 
o 3 tests of 60 min duration at 50% of  V O2max 
o Tests will include –  
o Expired gas collection. 
o Capillary and venous blood sampling. 
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RESEARCH ON THE ERGOGENIC PROPERTIES OF 
CALCIUM IN ENDURANCE EVENTS 
 
 
Basic structure of the trial –  
 
One of two sets of supplements –  
Placebo or calcium citrate 1000 mg/day for 30 days each in a random order. 
 
Three tests –  
 Max power – BCF protocol (start W/min according to weight and rider 
category with 20 W/min increment until voluntary exhaustion) 
 10-mile time trial – quickest time to complete. 
 25-mile time trial – quickest time to complete. 
 
Tests will be conducted on 2 occasions. Before and after 30 days of supplementation. 
Heart rate and oxygen consumption will be recorded throughout using an online 
Spirometer. These will then be used to calculate Anaerobic/ Aerobic thresholds 
along with blood lactate data.  
Blood analysis –  
 Lactate every min in Max power test 
 Time trial – 1 capillary sample every 5 or 20 min until end of test. 2 min 
recovery sample until 10 min post cessation of test. 
Dietary and activity record –  
 Participants will be required to keep a diet diary of a typical week and 
weekend which will then be analysed for major nutrients, energy and calcium 
intakes. 
 Participants will also need to supply a general log of training over the 
intervention to suitably account for any training related changes. 
 
For further details please contact Rehana Jawadwala on 01772 892483 or 
07737874450. Alternatively email on rjawadwala@uclan.ac.uk 
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University of Central Lancashire Health Questionnaire 
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FREE AND INFORMED CONSENT 
 
 
This study will involve a maximal oxygen uptake test and subsequent cycle 
ergometer exercise program set at 50% of your maximum power output for duration 
of 60 min. You will be required to perform 4 such cycle ergometer exercise sessions 
over a period of 3 months. 
 
Capillary blood samples will be drawn every 20 min during each of the exercise 
sessions. One venous blood sample will be drawn at the beginning of each test. 
 
You will be required to supplement your normal diet with 1000 mg of calcium citrate 
and placebo every day for a period of 4 weeks, with a month break in between the 
two trials. If you experience any discomfort during the period related to the calcium 
supplement or placebo, please inform the researcher as soon as possible. 
 
Body composition will be determined using the Harpenden callipers.  
 
You will be required to maintain a diet record for seven consecutive days. 
 
All the tests will be explained to you prior to commencement. During this time you 
will have an opportunity to ask any questions about the test and are free to withdraw 
at any time. 
 
All the tests are performed in such a way as to minimise any risk of injury. Please 
inform the researcher of any reason why you should not perform exercise. If at any 
time you feel undue pain or discomfort, stop the test and inform the researcher of 
your symptoms. 
 
The tests and measures have been explained to me and I am willing to take part.  
I understand that I can withdraw at any time. 
 
 
Signed: _______________________________ 
 
Witness:   ____________________ 
 
Date:  _______________________________ 
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FREE AND INFORMED CONSENT 
 
 
This study aims to look at the effects of calcium supplementation on endurance 
performance.  
 
The experiment involves one maximal power ramp test followed by two time trials 
of 10 mile and 25 mile. Both the time trials will be conducted before and after the 
intervention. 
 
Capillary blood samples will be drawn every 5 min in the 10 mile time trial and 
every 20 min during the 25 mile time trial. In addition, lactate measurements will be 
continued to be taken after the test every 2.5 min for 10 min. 
 
You will be required to supplement your normal diet with 1000 mg/day of calcium 
citrate or placebo for a period of 4 weeks. If you experience any discomfort during 
the period related to the calcium supplement or placebo, please inform the researcher 
as soon as possible. 
 
Body composition will be determined using the Harpenden callipers and BodPod.  
 
You will be required to maintain a diet and physical activity record for seven 
consecutive days. 
 
All the tests will be explained to you prior to commencement. During this time you 
will have an opportunity to ask any questions about the test and are free to withdraw 
at any time. 
 
All the tests are performed in such a way as to minimise any risk of injury. Please 
inform the researcher of any reason why you should not perform exercise. If at any 
time you feel undue pain or discomfort, stop the test and inform the researcher of 
your symptoms. 
 
The tests and measures have been explained to me and I am willing to take part. 
 I understand that I can withdraw at any time. 
 
 
Signed: _______________________________ 
 
Witness:   ____________________ 
 
Date:  _______________________________ 
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UNIVERSITY OF CENTRAL LANCASHIRE 
 
 
Centre for Applied Sports and Exercise Science 
School of Psychology 
 
 
 
 
 
Food Diary 
 
 
 
 
 
The aim of this diary is to help you keep an accurate record of 
everything you eat and drink over a seven day period.  This will help 
enable us to determine dietary nutrient intake. 
 
If you have any problems or queries regarding this diary, please feel free 
to contact Rehana (01772) 892483 or email rjawadwala@uclan.ac.uk   
278 
 
CHECKLIST 
Given below are a list of commonly eaten foods.  Please tick the kind(s) normally 
used. 
 
Milk Whole   Semi-
skinned 
  Skimmed   Other  
            
Cheese Cream   Hard   Low-fat   Other  
            
Yoghurt Full-
fat 
  Low-fat   Diet   Other  
            
Bread White   Wholemeal   Hovis/brown   Other  
            
Spread Butter   Low-fat   Margarine   Other  
 
 
 
 
DO YOU  Yes  No  If yes, please give amount 
Take milk in tea or coffee?       
       
Take sugar in tea or coffee?       
       
Use jam, honey or 
marmalade? 
      
       
Drink alcohol?       
 
 
 
 
FOOD DESCRIPTIONS 
Please ensure you include the following points in the food description category. 
1)  Fruit.  Is it raw or cooked, fresh or tinned.  If tinned, is it in syrup or juice. 
2)  Vegetables.  Raw or cooked, fresh, frozen or tinned.  In sauce. 
3)  Meat, poultry and fish.  Have you weighed as raw or cooked.  Has the skin or fat 
been removed before weighing. 
4)  Gravy.  Has meat juice or fat been added. 
5)  Mayonnaise and dressings.  Full or low-fat.  Include brand name. 
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Participant I.D. Number ………………  Participant Initials …………  Diary 
Number ………….. 
 
Day ……………… 
 
Meal Food Description Cooking 
Method 
Weight 
in grams 
Amount 
Uneaten 
Breakfast     
    
    
    
    
    
    
    
    
    
    
    
During the 
Morning 
    
    
    
    
    
    
    
    
    
    
Lunch     
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Meal Food Description Cooking 
Method 
Weight 
in grams 
Amount 
Uneaten 
During the 
afternoon 
    
    
    
    
    
    
    
    
    
    
    
    
Dinner or Tea     
    
    
    
    
    
    
    
    
    
    
    
    
    
    
During the 
evening 
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Mean (± SD) Energy, macronutrient, calcium and vitamin D consumption based on seven day diet diaries recorded during each of the 4 week 
intervention period in study 1 
 
 
Pl Mean ± SD 
(%Recommendations) 
Ca Mean ± SD 
(%Recommendations) 
Recommendations*  
Energy (MJ/d) 
 
8.3 ± 1.5 
 
8.3 ± 1.3 
 
10.60 males 
8.10   females 
 
Energy (Kcal/d) 1995 ± 368 1984 ± 330 2,550 males 
1,940 females 
 
Total carbohydrates (g/d) 259 ± 72 
(52 ± 14% EI) 
257 ± 68 
(52 ± 14% EI) 
47% EI  
Non milk extrinsic sugars (g/d) 65.10 ± 16.41 
(11.59 ± 2.92% EI) 
62.70 ± 17.80 
(11.16 ± 3.17% EI) 
10% EI  
Non starch polysaccharide (g/d) 11.51 ± 3.41 
(63 ± 18.9% population mean) 
12.32 ± 3.43 
(68.44 ± 19.05% population mean) 
12 (individual min) 
18 (population mean) 
 
Total fat (g/d) 59 ± 8 
(27 ± 3% EI) 
60 ± 9 
(27 ± 4% EI) 
33% EI  
Saturated fatty acids (g/d) 24.86 ± 7.57 
(9.96 ± 3.03% EI) 
24.93 ± 8.83 
(9.98 ± 3.53% EI) 
10% EI  
Cis-polyunsaturated fatty acids 
(g/d) 
16.77 ± 6.99 
(6.72 ± 2.80% EI) 
15.27 ± 8.00 
(6.11 ± 3.20% EI) 
6% EI  
Cis-monounsaturated fatty acids 
(g/d) 
20.32 ± 7.11 
(8.14 ± 2.85% EI) 
22.17 ± 8.69 
(8.88 ± 3.48% EI) 
12% EI  
Protein (g/d) 85 ± 17 
(17 ± 3% EI) 
(~156 ± 45% RNI) 
84 ± 15 
17 ± 3% EI) 
(~155 ± 35% RNI) 
55.5 g/d  males 
45.0 g/d  females 
 
Calcium (mg/d) 770 ± 97 
(110 ± 14% RNI) 
772 ± 114 
(110 ± 16% RNI) 
700   
Vitamin D (µg/d) 2.85 ± 1.34 2.80 ± 1.24 -  
*Source: COMA-Committee on Medical Aspects of Food Policy (1991)  
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Mean (± SD) Energy, macronutrient, calcium and vitamin D consumption based on seven day diet diaries recorded during the 4 week intervention 
period in study 2 and 3 
 Mean ± SD  
(%Recommendations) 
Recommendations*  
Energy (MJ/d) 
 
9.6 ± 1.4 
(90.56 ± 13.2% EAR) 
10.60 
 
Energy (Kcal/d) 2309 ± 358 
(90.56 ± 13.2% EAR) 
2,550  
 
Total carbohydrates (g/d) 334± 75  
(58 ± 12% EI) 
47% EI 
Non milk extrinsic sugars (g/d) 89.00 ± 42.30  
(16.27 ± 7.73% EI) 
10% EI 
Non starch polysaccharide (g/d) 12.50 ± 4.86  
(69 ± 27% population mean) 
12 (individual min) 
18 (population mean) 
Total fat (g/d) 60 ± 14 
(23 ± 5% EI) 
33% EI 
Saturated fatty acids (g/d) 19.13 ± 5.19  
(7.86 ± 2.13% EI) 
10% EI 
Cis-polyunsaturated fatty acids (g/d) 11.03 ± 4.88  
(4.53 ± 2.00% EI) 
6% EI 
Cis-monounsaturated fatty acids (g/d) 18.03 ± 2.86  
(7.41 ± 1.17% EI) 
12% EI 
Protein (g/d) 93 ± 23  
(16 ± 4% EI)  
(140 ± 13.45% RNI)  
55.5  
 
Calcium (mg/d) 757 ± 108  
(108 ± 15% RNI) 
700  
Vitamin D (µg/d) 2.92 ± 1.36 - 
*Source: COMA-Committee on Medical Aspects of Food Policy (1991)  
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Mean Energy, macronutrient and micronutrient consumption of each participant based on 7 d diet diaries recorded during each 
of the 4 week intervention periods in study 1.  
 
R1 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 5.8 ± 0.2 5.9 ± 0.2 0.41 MUFA (g) 12 ± 11 44 ± 28 4.29 
Energy (kcal) 1408 ± 6  2696 ± 10 0.41 Protein (g) 70.6 ± 1.4 72.6 ± 1.7 1.98 
Fat (g) 58.7 ± 0.5 58.0 ± 0.8 0.85 CHO (g) 123 ± 22 129 ± 17 3.37 
SFA (g) 32.8 ± 3.2 26.4 ± 9.1 15.29 Sugars (g) 66 ± 19 53 ± 22 15.45 
PUFA (g) 12 ± 4 6 ± 3 2.81 Ca (mg) 679 ± 24 713 ± 14 3.45 
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R2 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 7.7 ± 0.3 8.2  ± 0.3 4.77 MUFA (g) 19.6 ± 6.7 25.4 ± 6.9 18.23 
Energy (kcal) 1845  ± 90 1974  ± 77 4.77 Protein (g) 88.3  ± 5 86  ± 7 1.87 
Fat (g) 55  ± 7 63  ± 1 9.72 CHO (g) 232  ± 18 243 ± 12 3.28 
SFA (g) 27.3 ± 13 36.4 ± 24.3 20.2 Sugars (g) 69 ± 13 64 ± 11 4.84 
PUFA (g) 9.7 ± 2 10.3 ± 4 4.24 Ca (mg) 947  ± 24 1002  ± 17 3.99 
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R3 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 7.0  ± 0.6 7.1  ± 0.5 0.89 MUFA (g) 14 ± 2 8.9 ± 3.8 31.5 
Energy (kcal) 1677  ±29 1698  ± 51 0.89 Protein (g) 74  ± 6 77  ± 8 2.81 
Fat (g) 63  ± 5 58.7  ± 3 5.00 CHO (g) 204  ± 29 216  ± 12 4.05 
SFA (g) 13.9 ± 3.3 13.6 ± 6.1 2.06 Sugars (g) 43 ± 16 48 ± 23 8.49 
PUFA (g) 11.1 ± 10 13.8 ± 7 15.33 Ca (mg) 745  ± 8  734  ± 14 1.05 
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R4 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 8.0  ± 0.35 7.5  ± 0.65 4.57 MUFA (g) 16 ± 4 14 ± 11 9.43 
Energy (kcal) 1908  ± 89  1789  ± 71 4.57 Protein (g) 82.7  ± 22 80.5  ± 7 1.91 
Fat (g) 67.2  ± 7 67.9  ± 12 0.73 CHO (g) 224  ± 18 200  ± 17 8.00 
SFA (g) 25.6 ± 6.2 21.1 ± 12 13.96 Sugars (g) 74 ± 24 63 ± 8 11.35 
PUFA (g) 22.1 ± 3 16.8 ± 6.6 19.27 Ca (mg) 687  ± 23 624  ± 39  6.80 
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T1 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 8.2  ± 0.4 8.8  ± 0.3 4.97 MUFA (g) 12 ± 4 18 ± 3.8 28.28 
Energy (kcal) 1976  ± 101 2120  ± 87 4.97 Protein (g) 79.3  ± 9  86.3  ± 3 5.98 
Fat (g) 52.9  ± 16  50.80  ± 29 2.86 CHO (g) 287  ± 22  319  ± 35 7.47 
SFA (g) 16.3 ± 4 14.1 ± 12 10.23 Sugars (g) 56 ± 27 55 ± 24 1.40 
PUFA (g) 12.6 ± 10 14.3 ± 8 8.94 Ca (mg) 749  ± 31 760  ± 26 1.03 
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T2 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 9.3 ± 0.2 8.9 ± 0.4 3.00 MUFA (g) 31 ± 5 34 ± 9 6.53 
Energy (kcal) 2220 ± 126 2128 ± 177 3.00 Protein (g) 81 ± 26 78 ± 34 2.67 
Fat (g) 44.7 ± 9 46 ± 12 2.03 CHO (g) 356 ± 111 340 ± 102 3.25 
SFA (g) 34.1 ± 15 39.6 ± 10 10.55 Sugars (g) 94 ± 32 86 ± 24 6.29 
PUFA (g) 31.1 ± 14 34 ± 17 6.53 Ca (mg) 781 ± 16 803 ± 31 1.96 
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T3 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 9.0 ± 0.7 8.8 ± 0.7 0.8 MUFA (g) 19 ± 16 16 ± 11 12.12 
Energy (kcal) 2150 ± 309 2126 ± 288 0.8 Protein (g) 72.1 ± 23 69.0 ± 16 3.11 
Fat (g) 66 ± 7 69 ± 12 3.04 CHO (g) 289 ± 91 276 ± 122 3.25 
SFA (g) 26.1 ± 4 21.7 ± 15 13.02 Sugars (g) 65 ± 10 61 ± 13 4.49 
PUFA (g) 12.1 ± 6 10 ± 6 13.44 Ca (mg) 900 ± 67 887 ± 22 1.03 
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T4 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 11.4 ± 0.7 10.8 ± 0.7 3.56 MUFA (g) 23 ± 14 26 ± 7 8.66 
Energy (kcal) 2721 ± 123 2587 ± 201 3.56 Protein (g) 128 ± 36 120 ± 45 4.56 
Fat (g) 69.4 ± 18 73 ± 12 3.58 CHO (g) 340 ± 113 324 ± 139 3.41 
SFA (g) 31.1 ± 4.6 25.9 ± 19 12.9 Sugars (g) 42 ± 15 38 ± 13 7.07 
PUFA (g) 16.4 ± 2 18.9 ± 5.2 10.02 Ca (mg) 670 ± 31 670 ± 43 0.00 
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T5 Pl Ca   Pl Ca  
 
Mean ± SD Mean ± SD CV (%)  Mean ± SD Mean ± SD CV (%) 
Energy (MJ) 8.6 ± 0.8 8.5 ± 0.7 0.89 MUFA (g) 32 ± 4 34 ± 1 4.29 
Energy (kcal) 2052 ± 181 2026 ± 176 0.89 Protein (g) 88 ± 26 87 ± 21 0.73 
Fat (g) 56.9 ± 9 58 ± 12 1.35 CHO (g) 276 ± 76 268 ± 61 2.08 
SFA (g) 32.8 ± 15 26.4 ± 17 15.29 Sugars (g) 66 ± 14 55 ±13 15.45 
PUFA (g) 22 ± 4 6 ± 12 80.81 Ca (mg) 769 ± 16 759 ± 24 0.93 
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